Processing 00000000.tx.1: Aluminum-Maltolate Induces Apoptosis and Necrosis in Neuro-2a Cells: Potential Role for p53 Signaling Victor J. 

Phrase: "Aluminum-Maltolate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "Induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "Necrosis in Neuro-2a Cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0027540:Necrosis [Organ or Tissue Function]
   760   C1334928:Necrosis [Finding]

Phrase: ":"

Phrase: "Potential Role for p53 Signaling Victor J."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.2: Johnson*,1, Sang-Hyun Kim and Raghubir P. 

Phrase: "Johnson"

Phrase: "*,"

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "Sang-Hyun Kim"

Phrase: "and"

Phrase: "Raghubir P."
Processing 00000000.tx.3: Sharma*,2 * Department of Physiology and Pharmacology, College of Veterinary Medicine, The University of Georgia, Athens, Georgia 30602, and Research Center for Resistant Cells, College of Medicine, Chosun University, Gwangju 501-759, South Korea Received September 21, 2004; 

Phrase: "Sharma"

Phrase: "*,"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "* Department of Physiology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1704729:Department [Organization]

Phrase: "and"

Phrase: "Pharmacology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "College of Veterinary Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0557806:College [Manufactured Object]

Phrase: "The University of Georgia,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0017452:Georgia [Geographic Area]
   827   C0017454:Georgia [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   755 E C0337804:georgian [Population Group]

Phrase: "Athens,"

Phrase: "Georgia 30602,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0017452:Georgia [Geographic Area]
   861   C0017454:Georgia [Geographic Area]
   789 E C0337804:georgian [Population Group]

Phrase: "and"

Phrase: "Research Center for Resistant Cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0683939:research center [Manufactured Object,Organization]
   760   C0205099:Center [Spatial Concept]

Phrase: "College of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0557806:College [Manufactured Object]

Phrase: "Chosun University,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: "Gwangju 501-759,"

Phrase: "South Korea"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0022773:South Korea [Geographic Area]
   861   C0022771:Korea [Geographic Area]
   789 E C1556095:Korean [Population Group]

Phrase: "Received"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Received [Qualitative Concept]

Phrase: "September 21,"

Phrase: "2004"

Phrase: ";"
Processing 00000000.tx.4: accepted November 1, 2004  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Aluminum maltolate (Al-malt) causes neurodegeneration following in vivo exposure, and apoptosis plays a prominent role. 

Phrase: "accepted November 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2004  ABSTRACT TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Aluminum maltolate (Al-malt)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "in vivo exposure,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a prominent role."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.5: The objective of this study was to define the form of cell death induced by Al-malt and to establish an in vitro model system amenable to mechanistic investigations of Al-malt-induced cell death. 

Phrase: "The objective of this study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C2985627:Study Objective [Idea or Concept]
   760   C0018017:Objective [Intellectual Product]
   760   C1571702:Objective [Qualitative Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the form of cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "induced by Al-malt"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0081548:aluminum maltolate [Organic Chemical]
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0205263:Induced [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "an in vitro model system"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   861   C0026339:Model System [Intellectual Product,Research Device]
   861   C3161035:Model System [Intellectual Product]
   812   C0449913:System [Functional Concept]
   812   C1553451:System [Manufactured Object]
   812   C1704459:System [Medical Device]
   756   C1515654:In Vitro Model [Research Activity]
   741 E C0205373:Systemic [Functional Concept]

Phrase: "amenable to mechanistic investigations of Al-malt-induced cell death."
Processing 00000000.tx.6: Neuro-2a cells, a murine neuroblastoma cell line, were treated with Al-malt for 24 h, following which mode of cell death and alterations in apoptosis-related gene expression were studied. 

Phrase: "Neuro-2a cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "a murine neuroblastoma cell line,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   861   C0007600:Cell Line [Cell]
   861   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cell [Cell]
   812   C0027819:Neuroblastoma [Neoplastic Process]
   812   C0205132:Line [Spatial Concept]
   812   C0700095:neuroblastoma [Neoplastic Process]
   812   C1269647:Cell [Cell]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]
   812   C3540583:Neuroblastoma [Intellectual Product]

Phrase: "were"

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "for 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "which mode of cell death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1513371:Mode [Functional Concept]
   760   C1705738:Mode [Quantitative Concept]
   760   C2347637:Mode [Quantitative Concept]
   760   C2348146:Mode [Quantitative Concept]

Phrase: "and"

Phrase: "alterations in apoptosis-related gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0017263:Gene Expression Alteration [Genetic Function]
   767   C0596611:Gene Alteration [Genetic Function]
   719   C1515926:Alteration [Idea or Concept]

Phrase: "were"

Phrase: "studied."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0557651:Study [Manufactured Object]
   966   C2603343:Study [Research Activity]
Processing 00000000.tx.7: Al-malt concentration-dependently increased cell death. 

Phrase: "Al-malt concentration-dependently increased cell death."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   818   C0007587:Cell Death [Cell Function]
   795   C0007634:Cell [Cell]
   795   C0011065:Death [Organism Function]
   795   C1269647:Cell [Cell]
   795   C1306577:Death, NOS [Finding]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.8: The mode of cell death was a combination of apoptosis and necrosis. 

Phrase: "The mode of cell death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1513371:Mode [Functional Concept]
   760   C1705738:Mode [Quantitative Concept]
   760   C2347637:Mode [Quantitative Concept]
   760   C2348146:Mode [Quantitative Concept]

Phrase: "was"

Phrase: "a combination of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205195:Combination [Qualitative Concept]
   770   C1947911:Combination [Physical Object]

Phrase: "and"

Phrase: "necrosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027540:Necrosis [Organ or Tissue Function]
  1000   C1334928:Necrosis [Finding]
Processing 00000000.tx.9: Treatment with Al-malt resulted in caspase 3 activation and the externalization of phosphatidyl serine, both indicative of apoptosis. 

Phrase: "Treatment with Al-malt"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "resulted in caspase 3 activation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   797   C1159825:Caspase Activation [Molecular Function]
   760   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1879547:Activation [Activity]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "and"

Phrase: "the externalization of phosphatidyl serine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   926   C2753858:externalization of phosphatidylserine [Cell Function]

Phrase: "both indicative of apoptosis."
Processing 00000000.tx.10: In addition, nuclear condensation and fragmentation were evident. 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "nuclear condensation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0233656:Condensation [Mental or Behavioral Dysfunction]
   861   C0598405:condensation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "fragmentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332472:Fragmentation [Anatomical Abnormality]
  1000   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "were"

Phrase: "evident."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.11: Interestingly, pretreatment with cycloheximide (CHX), a potent protein synthesis inhibitor markedly reduced Al-malt-induced apoptosis, indicating that altered gene expression was critical for this form of cell death. 

Phrase: "Interestingly,"

Phrase: "pretreatment with cycloheximide (CHX),"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "a potent protein synthesis inhibitor markedly reduced Al-malt-induced apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0162638:Apoptosis [Cell Function]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "indicating"

Phrase: "that altered gene expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0017262:Gene Expression [Genetic Function]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "critical for this form of cell death."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1511545:Critical [Qualitative Concept]
Processing 00000000.tx.12: Pretreatment with CHX had no effect on necrosis induced by Al-malt. 

Phrase: "Pretreatment with CHX"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "had"

Phrase: "no effect on necrosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C1301751:No effect [Qualitative Concept]
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "induced by Al-malt."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0081548:aluminum maltolate [Organic Chemical]
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0205263:Induced [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.13: Analysis of gene expression showed that p53 mRNA was increased following treatment with Al-malt. 

Phrase: "Analysis of gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   881   C1880945:Gene Expression Analysis [Molecular Biology Research Technique]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that p53 mRNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment with Al-malt."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.14: This increase was accompanied by a marked inhibition of Bcl2 expression and an increase in BAX expression, a pattern of gene expression suggestive of a pro-apoptotic shift. 

Phrase: "This increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "accompanied by a marked inhibition of Bcl2 expression"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0376515:BCL2 [Gene or Genome]
   744   C0522501:Marked [Qualitative Concept]
   744   C0597712:BCL2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1628982:% inhibition [Quantitative Concept]
   744   C1706089:Marked [Qualitative Concept]
   744   C3463820:Inhibition [Activity]

Phrase: "and"

Phrase: "an increase in BAX expression,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "a pattern of gene expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449774:Pattern [Spatial Concept]

Phrase: "suggestive of a pro-apoptotic shift."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332299:Suggestive of [Functional Concept]
           suggestive
Processing 00000000.tx.15: Results show for the first time that p53 is induced by Al in neuron-like cells and suggest that the p53-dependent intrinsic pathway may be responsible for Al-induced apoptosis. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show for the first time"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C1547282:Show [Intellectual Product]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "that p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "is"

Phrase: "induced by Al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002367:Aluminium [Element, Ion, or Isotope]
   790   C0205263:Induced [Functional Concept]
   790   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "in neuron-like cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the p53-dependent intrinsic pathway"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   902   C2984374:p53 pathway [Functional Concept]
   812   C0205102:Intrinsic [Spatial Concept]
   812   C0439674:Intrinsic [Functional Concept]
   812   C1704259:Pathway [Molecular Function]
   812   C1705987:Pathway [Conceptual Entity]

Phrase: "may"

Phrase: "be"

Phrase: "responsible for Al-induced apoptosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]
Processing 00000000.tx.16: Future studies investigating the role of p53 in Al neurotoxicity both in vivo and in vitro are warranted. 

Phrase: "Future studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "investigating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigating [Functional Concept]

Phrase: "the role of p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in Al neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "both in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "are"

Phrase: "warranted."
Processing 00000000.tx.17: Key Words: aluminum; 

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "aluminum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: ";"
Processing 00000000.tx.18: maltolate; 

Phrase: "maltolate"

Phrase: ";"
Processing 00000000.tx.19: apoptosis; 

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.20: necrosis; 

Phrase: "necrosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027540:Necrosis [Organ or Tissue Function]
  1000   C1334928:Necrosis [Finding]

Phrase: ";"
Processing 00000000.tx.21: caspase 3; 

Phrase: "caspase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: ";"
Processing 00000000.tx.22: neurodegeneration; 

Phrase: "neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: ";"
Processing 00000000.tx.23: neurotoxicity; 

Phrase: "neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: ";"
Processing 00000000.tx.24: Neuro-2a; 

Phrase: "Neuro-2a"

Phrase: ";"
Processing 00000000.tx.25: p53; 

Phrase: "p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: ";"
Processing 00000000.tx.26: Bcl2; 

Phrase: "Bcl2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376515:BCL2 [Gene or Genome]
  1000   C0597712:BCL2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.27: BAX.  

Phrase: "BAX."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]
Processing 00000000.tx.28: INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  The etiology of Alzheimer's disease (AD) is exceedingly complex, with contributing factors including oxidative stress (Pratico et al., 1998, 2002), inflammation (Akiyama et al., 2000) and extensive protein and membrane modification (Mattson et al., 2002). 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The etiology of Alzheimer's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1314792:disease etiology [Functional Concept]
           Aetiology
   760   C0015127:aetiology [Functional Concept]
   760   C1524003:Etiology [Conceptual Entity]

Phrase: "(AD)"

Phrase: "is"

Phrase: "exceedingly complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "with contributing factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "(Pratico et al.,"

Phrase: "1998,"

Phrase: "2002"

Phrase: ")"

Phrase: ","

Phrase: "inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]

Phrase: "(Akiyama et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: "and"

Phrase: "extensive protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "membrane modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0392747:Modification [Functional Concept]
   861   C1554963:modification [Qualitative Concept]

Phrase: "(Mattson et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.29: All of these pathophysiological processes are also associated with non-disease aging. 

Phrase: "All of these pathophysiological processes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0444868:All [Quantitative Concept]
   760   C3539085:All [Idea or Concept]
   726   C1184743:Process [Body Part, Organ, or Organ Component]
   726   C1522240:Process [Phenomenon or Process]

Phrase: "are"

Phrase: "also"

Phrase: "associated with non-disease aging."
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   797   C0243083:associated disease [Pathologic Function]
   760   C0001811:Ageing [Organism Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C1518422:Non [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.30: It is not clear why some patients develop AD and others remain healthy into advanced age. 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "why"

Phrase: "some patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "develop"

Phrase: "AD"

Phrase: "and"

Phrase: "others"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1955473:Others [Finding]
   966 E C0205394:Other [Qualitative Concept]

Phrase: "remain"

Phrase: "healthy into advanced age."
Processing 00000000.tx.31: Two major contributing factors in the development of AD are the existence of a genetic predisposition (Combarros et al., 2002) and exacerbation of normal aging-related changes by environmental factors (Mattson et al., 2002). 

Phrase: "Two major contributing factors in the development of AD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C1521761:Factor [Functional Concept]
   708   C2827422:Factor [Conceptual Entity]

Phrase: "are"

Phrase: "the existence of a genetic predisposition"

Phrase: "(Combarros et al.,"

Phrase: "2002"

Phrase: ")"

Phrase: "and"

Phrase: "exacerbation of normal aging-related changes"

Phrase: "by environmental factors"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1516998:Environmental Factors [Functional Concept]
   983 E C0686732:Environmental Factor [Qualitative Concept]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "(Mattson et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.32: Aluminum (Al) represents one such environmental factor that has been linked to the development of AD. 

Phrase: "Aluminum (Al)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "such environmental factor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0686732:Environmental Factor [Qualitative Concept]
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "that"

Phrase: "has"

Phrase: "been"

Phrase: "linked to the development of AD."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0243107:development [Physiologic Function]
   753   C0678723:Development [Organism Function]
   753   C1527148:Development [Functional Concept]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]
Processing 00000000.tx.33: In fact, it has been stated that the use of Al as an experimental neurotoxicant has recapitulated virtually every feature of the neurodegenerative spiral afflicting Alzheimer's patients (Strong, 2002). 

Phrase: "In fact,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "stated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1301808:stated [Geographic Area]
  1000   C1442792:Stated [Functional Concept]
   966 E C3148680:State [Geographic Area]

Phrase: "that"

Phrase: "the use of Al"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "as an experimental neurotoxicant"

Phrase: "has"

Phrase: "recapitulated"

Phrase: "virtually"

Phrase: "every feature of the neurodegenerative spiral afflicting Alzheimer's patients"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C1521970:Feature [Qualitative Concept]
   742   C1706388:Feature [Conceptual Entity]
   742   C2346469:Feature [Qualitative Concept]
   742   C2348519:Feature [Qualitative Concept]

Phrase: "(Strong, 2002"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0442821:Strong [Qualitative Concept]
   789 E C0237897:Strength [Quantitative Concept]
   789 E C0808080:Strength [Idea or Concept]
   789 E C1705922:Strength [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.34: Additional evidence suggests that Al accumulates in the human brain with aging (Markesbery et al., 1981). 

Phrase: "Additional evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "accumulates in the human brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C0086418:Human [Human]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "with aging"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]

Phrase: "(Markesbery et al.,"

Phrase: "1981"

Phrase: ")."
Processing 00000000.tx.35: Given that Al is the third most abundant element in the earths crust and exposure to it is unavoidable, further research into the neurotoxicity of this metal is both warranted and essential. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "the third most abundant element in the earths crust"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0013879:Element [Element, Ion, or Isotope]
   742   C1705248:Element [Conceptual Entity]

Phrase: "and"

Phrase: "exposure to it"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332157:Exposure to [Clinical Attribute]
           Exposure
   790   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "is"

Phrase: "unavoidable, further"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1517331:Further [Spatial Concept]
   827 E C0205108:far [Spatial Concept]

Phrase: "research into the neurotoxicity of this metal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0025552:Metal [Inorganic Chemical]
   748   C0035168:research [Research Activity]
   748   C0235032:Neurotoxicity [Injury or Poisoning]
   748   C0242481:Research [Research Activity]

Phrase: "is"

Phrase: "both warranted"

Phrase: "and"

Phrase: "essential."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205224:Essential [Qualitative Concept]
Processing 00000000.tx.36: Aluminum maltolate (Al-malt) is a lipophilic complex of aluminum that forms a metastable solution of pH 7. 

Phrase: "Aluminum maltolate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: ")"

Phrase: "is"

Phrase: "a lipophilic complex of aluminum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439855:Complex [Qualitative Concept]
   760   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a metastable solution of pH 7."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037633:Solution [Substance]
   753   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.37: This Al complex is advantageous for use in in vitro mechanistic studies because it dose not form insoluble precipitates of Al-hydroxide at physiological pH, as do most other salt forms of Al (Martin, 1991). 

Phrase: "This Al complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "is"

Phrase: "advantageous for use"

Phrase: "in in vitro mechanistic studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   906   C0681828:in vitro study [Research Activity]
   861   C2698671:MECHANISTIC STUDIES [Regulation or Law]
   812   C0947630:studies [Laboratory Procedure]
   779 E C0557651:Study [Manufactured Object]
   779 E C2603343:Study [Research Activity]

Phrase: "because"

Phrase: "it dose"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0178602:Dose [Quantitative Concept]
  1000   C0869039:Dose [Quantitative Concept]
  1000   C1114758:Dose # [Clinical Attribute]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "insoluble precipitates of Al-hydroxide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1882443:PRECIPITATE [Phenomenon or Process]

Phrase: "at physiological pH,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0020283:[pH] [Quantitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]

Phrase: "as"

Phrase: "do"

Phrase: "most"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205393:Most [Quantitative Concept]

Phrase: "other salt"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0036140:Salt [Chemical Viewed Structurally]
  1000   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
  1000   C0206136:Salt [Food,Inorganic Chemical]
   928 E C1537053:salty [Qualitative Concept]
   900 E C0678584:saltiness [Qualitative Concept]

Phrase: "forms of Al"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0002367:Aluminium [Element, Ion, or Isotope]
   790   C0348078:Form [Qualitative Concept]
   790   C0376315:Form [Manufactured Object]
   790   C1522492:Form [Functional Concept]
   790   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(Martin,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.38: Maltolate is also a common component of the human diet. 

Phrase: "Maltolate"

Phrase: "is"

Phrase: "also"

Phrase: "a common component of the human diet."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0449432:Component [Manufactured Object]
   748   C1705248:Component [Conceptual Entity]
Processing 00000000.tx.39: It is a by-product formed during sucrose pyrolysis or thermal degradation of starch (Johnson et al., 1969) and can be found in coffee, soybean, baked cereals, and caramelized and browned foods (Gralla et al., 1969). 

Phrase: "It"

Phrase: "is"

Phrase: "a by-product"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006539:BY [Geographic Area]
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "formed during sucrose pyrolysis"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0205431:Formed [Functional Concept]
   770   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   737 E C0348078:Form [Qualitative Concept]
   737 E C0376315:Form [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "or"

Phrase: "thermal degradation of starch"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C1157783:starch degradation [Molecular Function]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]

Phrase: "(Johnson et al.,"

Phrase: "1969"

Phrase: ")"

Phrase: "and"

Phrase: "can"

Phrase: "be"

Phrase: "found in coffee,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0009237:Coffee [Food]
   790   C0150312:Found [Quantitative Concept]
   790   C1365948:COFFEE [Food]
   756 E C0243095:Find [Finding]

Phrase: "soybean,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0037733:Soy bean [Food]
  1000   C0947608:SOYBEAN [Pharmacologic Substance]
  1000   C1262902:Soybean [Plant]
  1000   C3257531:soybean [Pharmacologic Substance]

Phrase: "baked cereals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0007757:Cereals [Food]

Phrase: "and"

Phrase: "caramelized"

Phrase: "and"

Phrase: "browned foods"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016452:Foods [Food]

Phrase: "(Gralla et al.,"

Phrase: "1969"

Phrase: ")."
Processing 00000000.tx.40: Given the extremely high affinity of maltolate for Al, there is a potential for Al-malt to form in the gastrointestinal tract. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the extremely high affinity of maltolate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205250:High [Qualitative Concept]
   753   C1299351:High [Qualitative Concept]
   753   C1510827:Affinity [Natural Phenomenon or Process]
   753   C2700149:HIGH [Intellectual Product]

Phrase: "for Al,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "there"

Phrase: "is"

Phrase: "a potential for Al-malt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3245505:Potential [Qualitative Concept]

Phrase: "form in the gastrointestinal tract."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0017189:Gastrointestinal Tract [Body System]
   806   C1281182:Gastrointestinal tract [Body System]
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C0521362:gastrointestinal [Spatial Concept]
   760   C1185740:Tract [Body Part, Organ, or Organ Component]
   760   C1522492:Form [Functional Concept]
Processing 00000000.tx.41: Therefore, investigating the enhanced toxicity of Al-malt is relevant to human health. 

Phrase: "Therefore,"

Phrase: "investigating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigating [Functional Concept]

Phrase: "the enhanced toxicity of Al-malt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040539:toxicity [Qualitative Concept]
   753   C0600688:Toxicity [Injury or Poisoning]

Phrase: "is"

Phrase: "relevant to human health."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.42: Numerous studies have demonstrated that Al-malt is a potent neurotoxin. 

Phrase: "Numerous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "a potent neurotoxin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027934:Neurotoxin [Hazardous or Poisonous Substance]
Processing 00000000.tx.43: Intracisternal injection of Al-malt produced cytoskeletal alterations (Klatzo et al., 1965; Savory et al., 1996, 1998) that were reminiscent of the tangles seen in AD. 

Phrase: "Intracisternal injection of Al-malt"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1555355:Injection, intracisternal [Functional Concept]
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1828121:Injection [Functional Concept]

Phrase: "produced"

Phrase: "cytoskeletal alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515926:Alteration [Idea or Concept]

Phrase: "(Klatzo et al.,"

Phrase: "1965"

Phrase: "; Savory et al.,"

Phrase: "1996,"

Phrase: "1998"

Phrase: ")"

Phrase: "that"

Phrase: "were"

Phrase: "reminiscent of the tangles"

Phrase: "seen in AD."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0205397:Seen [Qualitative Concept]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.44: There is also evidence to suggest that maltolate may facilitate the entry of Al into the brain (van Ginkel et al., 1993), thereby increasing the potential for neurotoxicity. 

Phrase: "There"

Phrase: "is"

Phrase: "also evidence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0332120:Evidence [Functional Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that maltolate"

Phrase: "may"

Phrase: "facilitate"

Phrase: "the entry of Al"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705654:Entry [Intellectual Product]

Phrase: "into the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "(van Ginkel et al.,"

Phrase: "1993"

Phrase: ")"

Phrase: ","

Phrase: "thereby"

Phrase: "increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the potential for neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3245505:Potential [Qualitative Concept]
Processing 00000000.tx.45: Recent findings show that the neurofibrillary degenerations induced by Al also contain hyperphosphorylated tau proteins as in AD (Savory et al., 1998). 

Phrase: "Recent findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C2607943:findings [Functional Concept]
   861   C2926606:Findings [Clinical Attribute]
   861   C3539655:Findings [Intellectual Product]
   827 E C0037088:Finding [Sign or Symptom]
   827 E C0243095:Finding [Finding]
   827 E C2825141:Finding [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the neurofibrillary degenerations"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0085400:Neurofibrillary degeneration [Acquired Abnormality]
   861   C0011164:DEGENERATIONS [Pathologic Function]
   827 E C1880269:Degeneration [Functional Concept]

Phrase: "induced by Al also"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0205263:Induced [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "hyperphosphorylated tau proteins"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0085401:tau Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   867 E C2700455:Tau Protein [Amino Acid, Peptide, or Protein]
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "as in AD (Savory et al.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1135885:Savory [Food]

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.46: Increasing evidence suggests that oxidative stress and apoptosis are key events in the neuropathological changes following exposure to Al-malt (Savory et al., 1999). 

Phrase: "Increasing evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "are"

Phrase: "key events in the neuropathological changes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441471:Events [Event]
   753   C3541888:Events [Classification]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "exposure to Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0332157:Exposure to [Clinical Attribute]
           Exposure
   770   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "(Savory et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.47: Al-malt-induced apoptosis in the rabbit hippocampus involves perturbation of the Bcl-2/Bax ratio (Savory et al., 1999). 

Phrase: "Al-malt-induced apoptosis in the rabbit hippocampus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162638:Apoptosis [Cell Function]

Phrase: "involves"

Phrase: "perturbation of the Bcl-2/Bax ratio"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0332453:perturbation [Functional Concept]

Phrase: "(Savory et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.48: More recently, it was shown that the endoplasmic reticulum is involved in Al-malt-induced apoptosis (Ghribi et al., 2001a). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "is"

Phrase: "involved in Al-malt-induced apoptosis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0081548:aluminum maltolate [Organic Chemical]
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0162638:Apoptosis [Cell Function]
   753   C0205263:Induced [Functional Concept]
   753   C1314939:Involved [Functional Concept]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(Ghribi et al.,"

Phrase: "2001a"

Phrase: ")."
Processing 00000000.tx.49: Translocation of Bax to the endoplasmic reticulum and a loss of Bcl-2 have been demonstrated in rabbits treated with Al-malt. 

Phrase: "Translocation of Bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0040715:Translocation [Cell or Molecular Dysfunction]
   790   C2987521:Translocation [Activity]

Phrase: "to the endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "and"

Phrase: "a loss of Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "demonstrated in rabbits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034493:Rabbit [Mammal]

Phrase: "treated with Al-malt."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.50: These effects may be involved in the observed release of cytochrome c from the mitochondria in Al-malt-treated rabbits (Ghribi et al., 2002a). 

Phrase: "These effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "may"

Phrase: "be"

Phrase: "involved in the observed release of cytochrome c"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   770   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   770   C1153524:cytochrome c [Molecular Function]
   770   C1426584:CYTOCHROME C [Gene or Genome]
   744   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0030685:Release [Health Care Activity]
   744   C0391871:Release [Functional Concept]
   744   C0439180:% release [Quantitative Concept]
   744   C0680255:release [Health Care Activity]
   744   C1283071:Release [Functional Concept]
   744   C1314939:Involved [Functional Concept]
   744   C1325304:cytochrome [Molecular Function]
   744   C1441672:Observed [Functional Concept]
   744   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from the mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0026237:Mitochondria [Cell Component]

Phrase: "in Al-malt-treated rabbits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0034493:Rabbit [Mammal]

Phrase: "(Ghribi et al.,"

Phrase: "2002a"

Phrase: ")."
Processing 00000000.tx.51: Once released, cytochrome c can bind to Apaf-1 in the cytoplasm, forming a complex that can activate caspase 9 with subsequent activation of death-inducing caspase 3 (Li et al., 1997). 

Phrase: "Once"

Phrase: "released"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0391871:Released [Functional Concept]
  1000   C1283071:Released [Functional Concept]
   966 E C0030685:Release [Health Care Activity]
   966 E C0439180:% release [Quantitative Concept]
   966 E C0680255:release [Health Care Activity]
   966 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: ","

Phrase: "cytochrome c"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "can"

Phrase: "bind to Apaf-1"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0664613:Apaf-1 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1332098:APAF-1 [Gene or Genome]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "in the cytoplasm,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010834:Cytoplasm [Cell Component]
   928 E C0521449:Cytoplasmic [Body Location or Region]

Phrase: "forming"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205431:Forming [Functional Concept]
  1000   C1522492:Forming [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]

Phrase: "a complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439855:Complex [Qualitative Concept]
  1000   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "can"

Phrase: "activate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "caspase 9 with subsequent activation of death-inducing caspase 3"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0910167:caspase-9 [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   757   C1159825:Caspase Activation [Molecular Function]
   739   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0011065:Death [Organism Function]
   739   C0205263:Inducing [Functional Concept]
   739   C0332282:Subsequent [Temporal Concept]
   739   C1306577:Death, NOS [Finding]
   739   C1879547:Activation [Activity]

Phrase: "(Li et al.,"

Phrase: "1997"

Phrase: ")."
Processing 00000000.tx.52: Ghribi et al. 

Phrase: "Ghribi et al."
Processing 00000000.tx.53: (2001a) demonstrated that caspase 3 was activated following intracisternal injection of Al-malt, and the site of activation was the endoplasmic reticulum (Ghribi et al., 2001a). 

Phrase: "(2001a"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that caspase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "activated"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:Activated [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "intracisternal injection of Al-malt,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1555355:Injection, intracisternal [Functional Concept]
   760   C0021485:injection [Therapeutic or Preventive Procedure]
   760   C1272883:Injection [Biomedical or Dental Material]
   760   C1533685:Injection [Therapeutic or Preventive Procedure]
   760   C1828121:Injection [Functional Concept]

Phrase: "and"

Phrase: "the site of activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C2945843:Site of [Qualitative Concept]
   770   C0205145:Site [Spatial Concept]
   770   C1515974:Site [Body Location or Region]
   770   C2825164:Site [Spatial Concept]

Phrase: "was"

Phrase: "the endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "(Ghribi et al.,"

Phrase: "2001a"

Phrase: ")."
Processing 00000000.tx.54: These biochemical changes were shown to culminate in DNA fragmentation, as evidenced by terminal uridine nucleotide end labeling (TUNEL)-staining in the hippocampus of Al-malt-treated rabbit (Ghribi et al., 2002b; Savory et al., 1999). 

Phrase: "These biochemical changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "culminate in DNA fragmentation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0376669:DNA Fragmentation [Molecular Function]
   770   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0332472:Fragmentation [Anatomical Abnormality]
   770   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "as"

Phrase: "evidenced by terminal uridine nucleotide end labeling (TUNEL)-"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   748   C0028630:Nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0041984:Uridine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   748   C0205088:Terminal [Temporal Concept]
   748   C0444930:End [Spatial Concept]
   748   C1167624:Labeling [Mental Process]
   748   C1705314:Terminal [Manufactured Object]
   748   C1705315:Terminal [Spatial Concept]
   748   C1947902:Labeling [Manufactured Object]
   748   C2746065:End [Temporal Concept]
   748   C2827499:Labeling [Governmental or Regulatory Activity]
   714   C0332120:Evidence [Functional Concept]

Phrase: "staining in the hippocampus of Al-malt-treated rabbit"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   764   C0081548:aluminum maltolate [Organic Chemical]
   742   C0002367:Aluminium [Element, Ion, or Isotope]
   742   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   742   C0034493:Rabbit [Mammal]
   742   C0332293:treated [Therapeutic or Preventive Procedure]
   742   C0487602:Staining [Laboratory Procedure]
   742   C0949582:Hippocampus [Fish]
   742   C1029104:Hippocampus [Fish]
   742   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   742   C1522326:Treated [Functional Concept]
   742   C1704680:Staining [Finding]
   742   C2348254:ALUMINUM [Element, Ion, or Isotope]
   708 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   708 E C1292734:TREAT [Functional Concept]

Phrase: "(Ghribi et al.,"

Phrase: "2002b"

Phrase: "; Savory et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.55: Collectively, these studies provide evidence for the involvement of apoptotic cell death in Al-induced neurodegeneration and strengthen the possible involvement of Al as an early factor in the development of AD. 

Phrase: "Collectively,"

Phrase: "these studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0947630:studies [Laboratory Procedure]
   966 E C0557651:Study [Manufactured Object]
   966 E C2603343:Study [Research Activity]

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence for the involvement of apoptotic cell death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in Al-induced neurodegeneration"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "strengthen"

Phrase: "the possible involvement of Al"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1314939:Involvement [Functional Concept]

Phrase: "as an early factor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1521761:Factor [Functional Concept]
   861   C2827422:Factor [Conceptual Entity]

Phrase: "in the development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0243107:development [Physiologic Function]
  1000   C0678723:Development [Organism Function]
  1000   C1527148:Development [Functional Concept]
   928 E C0458003:Developmental [Qualitative Concept]

Phrase: "of AD."
Processing 00000000.tx.56: The pathway responsible for the observed shift in Bcl2/BAX ratio remains to be identified. 

Phrase: "The pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "responsible for the observed shift"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1273518:Responsible [Finding]

Phrase: "in Bcl2/BAX ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0456603:Ratio [Quantitative Concept]
   827   C1547037:Ratio [Intellectual Product]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "identified."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]
Processing 00000000.tx.57: One likely candidate is p53, which is known to differentially control expression of Bcl2 and BAX as well as other important genes involved in apoptosis. 

Phrase: "One likely candidate"

Phrase: "is"

Phrase: "p53,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "which"

Phrase: "is"

Phrase: "known"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205309:Known [Qualitative Concept]

Phrase: "to differentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "expression of Bcl2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "BAX"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "as well as"

Phrase: "other important genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Genes [Gene or Genome]

Phrase: "involved in apoptosis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0162638:Apoptosis [Cell Function]
   790   C1314939:Involved [Functional Concept]
   718 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.58: Neuronal cell lines are also sensitive to the toxic effects of Al-malt and may provide models to study the mechanisms involved in apoptosis. 

Phrase: "Neuronal cell lines"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   901   C0007600:Cell lines [Cell]
   827   C0007634:Cell [Cell]
   827   C0205132:lines [Spatial Concept]
   827   C0521390:Neuronal [Immunologic Factor]
   827   C1269647:Cell [Cell]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]
   755 E C0027882:Neuron [Cell]

Phrase: "are"

Phrase: "also sensitive to the toxic effects of Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0332324:Sensitive to [Functional Concept]
           Sensitive
   742   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "models"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Model [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in apoptosis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0162638:Apoptosis [Cell Function]
   790   C1314939:Involved [Functional Concept]
   718 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.59: Al-malt-induced apoptosis has been demonstrated in differentiated PC-12 cells (Ohyashiki et al., 2002; Tsubouchi et al., 2001) and human NT2 neuroblastoma cells (Griffioen et al., 2004). 

Phrase: "Al-malt-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated in differentiated PC-12 cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   790   C0085262:PC-12 [Cell]
   790   C0662453:pc-12 [Organic Chemical,Pharmacologic Substance]
   753   C0007589:Differentiated [Cell Function]
           cells differentiation
   753   C0007634:Cells [Cell]
   753   C0205615:Differentiated [Qualitative Concept]
   753   C3282337:Cells [Cell]
   753   C3540812:PC [Gene or Genome]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(Ohyashiki et al.,"

Phrase: "2002"

Phrase: "; Tsubouchi et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: "and"

Phrase: "human NT2 neuroblastoma cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   902   C0427861:Human cells [Laboratory or Test Result]
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(Griffioen et al.,"

Phrase: "2004"

Phrase: ")."
Processing 00000000.tx.60: Neuro-2a (N2a) murine neuroblastoma cells are also sensitive to Al treatment, which up-regulated the expression and accumulation of neurofibrillay tangle protein (Abreo et al., 1999). 

Phrase: "Neuro-2a (N2a) murine neuroblastoma cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   823   C0815000:neuroblastoma cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "also sensitive to Al treatment,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332324:Sensitive to [Functional Concept]
           Sensitive
   760   C1550474:sensitive [Idea or Concept]

Phrase: "which"

Phrase: "up-regulated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0547043:Up [Spatial Concept]
   861   C0851285:Regulated [Governmental or Regulatory Activity]
   861   C1282911:Up [Spatial Concept]

Phrase: "the expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "accumulation of neurofibrillay tangle protein"

Phrase: "(Abreo et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.61: This effect was associated with increased uptake of iron in N2a cells, possibly contributing to Al-induced oxidative stress and neurotoxicity. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "associated with increased uptake of iron"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   783   C0860976:increased iron [Finding]
   753   C0205217:Increased [Quantitative Concept]
   753   C0243144:Uptake [Physiologic Function]
   753   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0347980:% uptake [Quantitative Concept]
   753   C0376520:Iron [Inorganic Chemical]
   753   C0442805:Increased [Functional Concept]
   753   C1166521:iron [Pharmacologic Substance]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in N2a cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "contributing to Al-induced oxidative stress"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0038435:Stress [Finding]
   753   C0205263:Induced [Functional Concept]
   753   C0311404:Oxidative [Functional Concept]
   753   C1880177:Contributing [Activity]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.62: The objective of the present study was to develop an in vitro model that can be used to define the nature of Al-malt-induced cell death, apoptosis versus necrosis. 

Phrase: "The objective of the present study"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C2985627:Study Objective [Idea or Concept]
   753   C0018017:Objective [Intellectual Product]
   753   C1571702:Objective [Qualitative Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "develop"

Phrase: "an in vitro model"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1515654:In Vitro Model [Research Activity]
   827   C3161035:Model [Intellectual Product]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "define"

Phrase: "the nature of Al-malt-induced cell death,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0349590:Nature [Idea or Concept]
   744   C1262865:Nature [Functional Concept]
   731   C0277610:Natural death [Finding]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "versus"

Phrase: "necrosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027540:Necrosis [Organ or Tissue Function]
  1000   C1334928:Necrosis [Finding]
Processing 00000000.tx.63: The results clearly demonstrate the coinvolvement of apoptosis and necrosis in Al-malt neurotoxicity. 

Phrase: "The results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "the coinvolvement of apoptosis"

Phrase: "and"

Phrase: "necrosis in Al-malt neurotoxicity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0027540:Necrosis [Organ or Tissue Function]
   760   C1334928:Necrosis [Finding]
Processing 00000000.tx.64: The apoptotic cell death induced by Al-malt was dependent on de novo protein synthesis as evidenced by inhibition of apoptosis in the presence of cycloheximide (CHX). 

Phrase: "The apoptotic cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:apoptotic cell death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "induced by Al-malt"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0081548:aluminum maltolate [Organic Chemical]
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0205263:Induced [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "dependent on de novo protein synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "as"

Phrase: "evidenced by inhibition of apoptosis"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C1512772:Inhibition of Apoptosis [Cell Function]
           Apoptosis Inhibition
   781   C0332120:Evidence of [Functional Concept]
           Evidence
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C0162638:Apoptosis [Cell Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "(CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: ")."
Processing 00000000.tx.65: Gene expression studies showed altered expression of p53 and downstream signaling molecules, including Bax and Bcl-2, potentially implicating the p53 pathway in Al-malt-induced apoptosis. 

Phrase: "Gene expression studies"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   913   C1273305:Gene studies [Laboratory Procedure]
   827   C0947630:studies [Laboratory Procedure]
   793 E C0557651:Study [Manufactured Object]
   793 E C2603343:Study [Research Activity]
   734   C0017262:Gene Expression [Genetic Function]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "altered expression of p53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "downstream signaling molecules,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   884   C1519315:Signaling Molecule [Biologically Active Substance]
   827   C0567416:molecules [Substance]
   743 E C1521991:Molecular [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "Bax"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "and"

Phrase: "Bcl-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "potentially"

Phrase: "implicating"

Phrase: "the p53 pathway in Al-malt-induced apoptosis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C2984374:p53 pathway [Functional Concept]
   767   C0162638:Apoptosis Pathway [Cell Function]
   744   C1704259:Pathway [Molecular Function]
   744   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.66: The present model will be useful in defining the pathways and mechanisms involved in Al-induced neurotoxicity.  

Phrase: "The present model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "will"

Phrase: "be"

Phrase: "useful in defining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   718   C0042153:use [Functional Concept]
   718   C0457083:Use [Functional Concept]
   718   C1947944:Use [Intellectual Product]

Phrase: "the pathways"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathways [Molecular Function]
  1000   C1705987:Pathways [Conceptual Entity]

Phrase: "and"

Phrase: "mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in Al-induced neurotoxicity."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0002367:Aluminium [Element, Ion, or Isotope]
   760   C0205263:Induced [Functional Concept]
   760   C0235032:Neurotoxicity [Injury or Poisoning]
   760   C1314939:Involved [Functional Concept]
   760   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.67: MATERIALS AND METHODS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Materials. 

Phrase: "MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Materials."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]
Processing 00000000.tx.68: Cell culture reagents were obtained from GIBCO Life Technologies, Inc. 

Phrase: "Cell culture reagents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   734   C0007585:Cell Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "obtained from GIBCO Life Technologies,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0039421:technologies [Occupation or Discipline]
   760   C0376558:Life [Idea or Concept]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]

Phrase: "Inc."
Processing 00000000.tx.69: (Grand Island, NY). 

Phrase: "(Grand Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022130:Island [Geographic Area]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.70: Annexin V-FITC was procured from Pharmingen (BD Biosciences Pharmingen, San Diego, CA). 

Phrase: "Annexin V-FITC"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   734   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332095:ANNEXIN V [Gene or Genome]

Phrase: "was"

Phrase: "procured from Pharmingen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C3274540:Procure [Immunologic Factor,Pharmacologic Substance]

Phrase: "(BD Biosciences Pharmingen,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.71: The CaspACETM assay system was purchased from Promega Corporation (Madison, WI). 

Phrase: "The CaspACETM assay system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   755 E C0205373:Systemic [Functional Concept]

Phrase: "was"

Phrase: "purchased from Promega Corporation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0072149:Promega [Lipid]
   770   C0683758:Corporation [Organization]
   770   C0869011:purchased [Activity]

Phrase: "(Madison,"

Phrase: "WI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043193:WI [Geographic Area]

Phrase: ")."
Processing 00000000.tx.72: Propidium iodide (PI) and CHX were purchased from Sigma Chemical Company (St. Louis, MO). 

Phrase: "Propidium iodide (PI)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0021966:Iodide [Inorganic Chemical]
   861   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "were"

Phrase: "purchased from Sigma Chemical Company"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0220806:Chemical [Chemical]
   760   C0683757:Company [Manufactured Object,Organization]
   760   C0869011:purchased [Activity]
   760   C1719918:Sigma [Intellectual Product]
   760   C3272558:Chemical [Intellectual Product]

Phrase: "(St. Louis,"

Phrase: "MO"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538743:MO [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.73: All other reagents used were purchased from Sigma and were tissue culture grade. 

Phrase: "All"

Phrase: "other reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "purchased from Sigma"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0869011:purchased [Activity]
   790   C1719918:Sigma [Intellectual Product]

Phrase: "and"

Phrase: "were"

Phrase: "tissue culture grade."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0441800:Grade [Classification]
   827   C0919553:Grade [Classification]
   827   C3244287:grade [Finding]
   734   C0040284:Tissue culture [Laboratory Procedure]
Processing 00000000.tx.74: Cell culture and treatment. 

Phrase: "Cell culture"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0007585:Cell Culture [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Culture [Idea or Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "and"

Phrase: "treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.75: Murine neuroblastoma Neuro-2a (N2a; CCL-131, American Type Culture Collection, Manassas, VA) cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum (FCS) and 1% penicillin-streptomycin (Pen-Strep, GIBCO, Grand Island, NY). 

Phrase: "Murine neuroblastoma Neuro-2a"

Phrase: "(N2a"

Phrase: "; CCL-131,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1852438:CCL [Disease or Syndrome]
   861   C2752420:Ccl [Molecular Function]

Phrase: "American Type Culture Collection,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
  1000   C0598079:American Type Culture Collection [Intellectual Product]
   812   C0010453:Culture [Idea or Concept]
   812   C0220814:culture [Functional Concept]
   812   C0332307:Type [Qualitative Concept]
   812   C0430400:Culture [Laboratory Procedure]
   812   C0596070:American [Population Group]
   812   C1516698:Collection [Functional Concept]
   812   C1547052:*Type [Quantitative Concept]
   812   C1704814:Collection [Idea or Concept]
   812   C2242979:Culture [Laboratory Procedure]
   741 E C1516695:Collected [Idea or Concept]

Phrase: "Manassas,"

Phrase: "VA) cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "grown in Dulbecco's modified Eagle's medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0009458:Medium [Intellectual Product]
   753   C0325564:Eagle [Bird]
   753   C0392747:Modified [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C1551720:Eagle [Population Group]
   753   C1705217:Medium [Substance]
   753   C3244283:medium [Intellectual Product]

Phrase: "(DMEM"

Phrase: ")"

Phrase: "supplemented with 10% heat-inactivated fetal calf serum (FCS)"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   744   C0015965:Fetal [Embryonic Structure]
   744   C0018837:Heat [Natural Phenomenon or Process]
   744   C0229671:Serum [Body Substance]
   744   C0230445:Calf [Body Location or Region]
   744   C0521457:Fetal [Functional Concept]
   744   C1305418:Calf [Body Part, Organ, or Organ Component]
   744   C1546774:Serum [Intellectual Product]
   744   C1550100:Serum [Body Substance]
   711   C0242295:Supplement [Food]
   711   C1947943:Supplement [Intellectual Product]
   711   C2348609:Supplement [Functional Concept]

Phrase: "and"

Phrase: "1% penicillin-streptomycin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0038425:Streptomycin [Antibiotic,Carbohydrate]

Phrase: "(Pen-Strep,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0038395:Strep [Disease or Syndrome]

Phrase: "GIBCO,"

Phrase: "Grand Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022130:Island [Geographic Area]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.76: Cultures were maintained in plastic tissue culture vessels in a humidified atmosphere at 37C with 5% CO2. 

Phrase: "Cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "were"

Phrase: "maintained in plastic tissue culture vessels"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   790   C0040284:Tissue culture [Laboratory Procedure]
   753   C0005847:Vessels [Body Part, Organ, or Organ Component]
   753   C0010453:Culture [Idea or Concept]
   753   C0032167:Plastic [Substance]
   753   C0040300:Tissue [Tissue]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C1314677:Maintained [Functional Concept]
   753   C1547928:Tissue [Intellectual Product]
   753   C2242979:Culture [Laboratory Procedure]
   719 E C0024501:Maintain [Activity]
   719 E C1511228:Vessel [Tissue]

Phrase: "in a humidified atmosphere"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0004178:Atmosphere [Natural Phenomenon or Process]
   861   C0678214:atmosphere [Quantitative Concept]

Phrase: "at 37C"

Phrase: "with 5% CO2."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347816:Co2+ [Element, Ion, or Isotope]
Processing 00000000.tx.77: Cells were seeded at 2 x 105/ml for each experiment and allowed to grow for 18 h prior to treatment with Al-malt. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0036563:Seed [Plant]
   966   C1705192:Seed [Laboratory Procedure]
   966   C1882540:{Seed} [Quantitative Concept]
   966   C2346495:Seed [Conceptual Entity]

Phrase: "at 2 x 105/ml for each experiment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "grow for 18 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "prior to treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with Al-malt."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.78: All treatments were performed in DMEM with 10% FCS for duration of 24 h unless stated otherwise. 

Phrase: "All treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0087111:Treatments [Therapeutic or Preventive Procedure]
   966 E C0039798:treatment [Functional Concept]
   966 E C1522326:Treatment [Functional Concept]
   966 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   966 E C1705169:Treatment [Conceptual Entity]
   966 E C3538994:TREATMENT [Research Activity]

Phrase: "were"

Phrase: "performed in DMEM"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "with 10% FCS"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0230445:Calf [Body Location or Region]
   812   C0521457:Fetal [Functional Concept]
   812   C1305418:Calf [Body Part, Organ, or Organ Component]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]
   756 E C0626053:sural [Pharmacologic Substance]

Phrase: "for duration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449238:Duration [Temporal Concept]
  1000   C2926735:Duration [Pharmacologic Substance]

Phrase: "of 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "unless"

Phrase: "stated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C1301808:stated [Geographic Area]
  1000   C1442792:Stated [Functional Concept]
   966 E C3148680:State [Geographic Area]

Phrase: "otherwise."
Processing 00000000.tx.79: The toxicity of both Al3+ and Al-malt was investigated in the present study. 

Phrase: "The toxicity of both Al3+"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "investigated in the present study."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   760   C0557651:Study [Manufactured Object]
   760   C1292732:investigated [Functional Concept]
   760   C2603343:Study [Research Activity]
Processing 00000000.tx.80: The speciation chemistry of Al is very complex, and aqueous solutions of Al3+ undergo extensive hydrolysis over time, yielding colloidal complexes that may influence the bioavailability of Al (Campbell et al., 1999). 

Phrase: "The speciation chemistry of Al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0007996:Chemistry [Occupation or Discipline]
   760   C0079107:chemistry [Classification]
   760   C0201682:Chemistry [Laboratory Procedure]

Phrase: "is"

Phrase: "very complex,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439855:Complex [Qualitative Concept]
   861   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "aqueous solutions of Al3+"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C3255993:aqueous solution [Pharmacologic Substance]
   770   C0037633:Solutions [Substance]
   770   C0599956:Aqueous [Qualitative Concept]
   737 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "undergo"

Phrase: "extensive hydrolysis over time,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0020291:Hydrolysis [Natural Phenomenon or Process]

Phrase: "yielding"

Phrase: "colloidal complexes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1704241:Complexes [Chemical Viewed Structurally]
   827 E C0439855:Complex [Qualitative Concept]

Phrase: "that"

Phrase: "may"

Phrase: "influence"

Phrase: "the bioavailability of Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0005508:Bioavailability [Quantitative Concept]
   770   C1706947:BIO-AVAILABILITY [Research Activity]

Phrase: "(Campbell et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.81: To control this, Al3+ stocks were made immediately prior to treatment by dissolving AlCl3 in deionized water at a concentration of 10 mM, and this stock was used to make the treatment solutions (11000 M AlCl3). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "this,"

Phrase: "Al3+ stocks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1710198:Stock [Idea or Concept]

Phrase: "were"

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "immediately prior to treatment"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   833   C0332152:Prior to [Temporal Concept]
           Prior
   819   C1514463:Prior Treatment [Clinical Attribute]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0205548:Immediately [Temporal Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C2826257:PRIOR [Event]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "by dissolving AlCl3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0102840:AlCl3 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "in deionized water"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   861   C0599638:WATER [Substance]
   861   C1550678:Water [Inorganic Chemical]
   789 E C0443350:Watery [Qualitative Concept]

Phrase: "at a concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 10 mM,"

Phrase: "and"

Phrase: "this stock"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710198:Stock [Idea or Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "make"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "the treatment solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037633:Solutions [Substance]
   827 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "(11000 M AlCl3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0102840:AlCl3 [Inorganic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.82: The pH of the treatment solutions was adjusted to 7 prior to addition to the cells. 

Phrase: "The pH of the treatment solutions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0020283:[pH] [Quantitative Concept]
   753   C0450407:ph+ [Finding]
   753   C0450408:ph++ [Finding]
   753   C0450409:ph+++ [Finding]

Phrase: "was"

Phrase: "adjusted to 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0456081:Adjusted [Functional Concept]

Phrase: "prior to addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "to the cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.83: Several dietary ligands, including citrate, lactate, and maltolate, have a high affinity for Al and can influence both the solubility of the metal and its toxicity. 

Phrase: "Several dietary ligands,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0023688:Ligands [Chemical]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "citrate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008857:Citrate [Organic Chemical]
  1000   C0376259:Citrate [Organic Chemical,Pharmacologic Substance]

Phrase: "lactate,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0022924:lactate [Organic Chemical]
  1000   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "maltolate,"

Phrase: "have"

Phrase: "a high affinity for Al"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C0861041:aluminum high [Finding]
   760   C0205250:High [Qualitative Concept]
   760   C1299351:High [Qualitative Concept]
   760   C1510827:Affinity [Natural Phenomenon or Process]
   760   C2700149:HIGH [Intellectual Product]

Phrase: "and"

Phrase: "can"

Phrase: "influence"

Phrase: "both the solubility of the metal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0037628:Solubility [Qualitative Concept]

Phrase: "and"

Phrase: "its toxicity."
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]
Processing 00000000.tx.84: Numerous studies have demonstrated that maltolate greatly enhances the toxicity of Al both in vitro (Levesque et al., 2000; Ohyashiki et al., 2002; Tsubouchi et al., 2001) and in vivo (Savory et al., 1999). 

Phrase: "Numerous studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "that maltolate greatly"

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the toxicity of Al"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0040539:toxicity [Qualitative Concept]
   770   C0600688:Toxicity [Injury or Poisoning]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(Levesque et al.,"

Phrase: "2000"

Phrase: "; Ohyashiki et al.,"

Phrase: "2002"

Phrase: "; Tsubouchi et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Savory et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.85: Al-malt was prepared as previously described in detail (Bertholf et al., 1989), and a 20 mM stock solution was prepared immediately prior to use. 

Phrase: "Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "prepared as previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: "described in detail"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1522508:Detail [Qualitative Concept]
   790   C1552738:described [Idea or Concept]
   790   C1561567:detail [Functional Concept]

Phrase: "(Bertholf et al.,"

Phrase: "1989"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "a 20 mM stock solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "prepared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1521827:Prepare [Functional Concept]

Phrase: "immediately prior to use."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C0332152:Prior to [Temporal Concept]
           Prior
   770   C0042153:use [Functional Concept]
   770   C0205548:Immediately [Temporal Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]
   770   C2826257:PRIOR [Event]
Processing 00000000.tx.86: Al-malt forms a metastable solution with a pH of 7. 

Phrase: "Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "forms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "a metastable solution with a pH of 7."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0037633:Solution [Substance]
   744   C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.87: Each molecule of Al binds three molecules of maltolate, and for this reason the maltolate control was added to cells at 3x molar concentrations. 

Phrase: "Each molecule of Al"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0567416:Molecule [Substance]

Phrase: "binds"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "three molecules of maltolate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0567416:molecules [Substance]

Phrase: "and for this"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "reason"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:Reason [Idea or Concept]

Phrase: "the maltolate control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "added to cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C1524062:Added [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1883712:Add [Functional Concept]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "at 3x molar concentrations."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0026367:Molar [Body Part, Organ, or Organ Component]
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.88: The role of de novo protein synthesis in the observed toxicity was examined using cell cultures pretreated with CHX (0.5 M final concentration) for 30 min prior to treatment with Al-malt or maltolate. 

Phrase: "The role of de novo protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in the observed toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "cell cultures"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0007585:Cell Cultures [Laboratory Procedure]
   861   C0007634:Cell [Cell]
   861   C0010453:Cultures [Idea or Concept]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]

Phrase: "pretreated with CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   734 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "(0.5 M final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   804   C0086045:Concentration [Mental Process]
   804   C1446561:Concentration [Quantitative Concept]
   733 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")"

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "prior to treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "or"

Phrase: "maltolate."
Processing 00000000.tx.89: All solutions were filter sterilized using 0.22-m syringe filters immediately after preparation. 

Phrase: "All solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "filter"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0180860:Filter [Manufactured Object]
  1000   C0581406:Filter [Medical Device]
  1000   C1522664:Filter [Intellectual Product]
  1000   C1704449:Filter [Conceptual Entity]
  1000   C1704684:Filter [Medical Device]
  1000   C1875155:FILTER [Medical Device]
   944 E C0080194:Strain [Injury or Poisoning]
   944 E C0442694:Straining [Physiologic Function]
   944 E C0456178:strain [Intellectual Product]
   944 E C1518614:Strain [Organism]
   944 E C2987481:Strain [Mental Process]

Phrase: "sterilized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0038280:Sterilize [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "0.22-m syringe"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0039142:Syringe [Medical Device]
   812   C1706072:Syringe [Manufactured Object]

Phrase: "filters"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
  1000   C0180860:Filter [Manufactured Object]
  1000   C0581406:Filter [Medical Device]
  1000   C1522664:Filter [Intellectual Product]
  1000   C1704449:Filter [Conceptual Entity]
  1000   C1704684:Filter [Medical Device]
  1000   C1875155:FILTER [Medical Device]
   944 E C0080194:Strain [Injury or Poisoning]
   944 E C0442694:Straining [Physiologic Function]
   944 E C0456178:strain [Intellectual Product]
   944 E C1518614:Strain [Organism]
   944 E C2987481:Strain [Mental Process]

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "after"

Phrase: "preparation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0455052:Preparation [Health Care Activity]
  1000   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.90: Determination of Al cytotoxicity in N2a cells. 

Phrase: "Determination of Al cytotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "in N2a cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.91: Mitochondrial enzyme activity, an indirect measure of the number of viable respiring cells, was determined using the 3[4,5-dimethyl thiazolyl-2]2,5-diphenyl tetrazolium bromide (MTT) assay. 

Phrase: "Mitochondrial enzyme activity,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   901   C0243102:enzyme activity [Molecular Function]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "an indirect measure of the number of viable respiring cells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0079809:Measure [Quantitative Concept]
   739   C0242485:Measure [Functional Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "[4,"

Phrase: "5-dimethyl thiazolyl-2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439084:>5 [Quantitative Concept]
   812   C0728893:+5 [Quantitative Concept]

Phrase: "]2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "5-diphenyl tetrazolium bromide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0006222:Bromide [Inorganic Chemical]

Phrase: "(MTT) assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.92: N2a cells were seeded in 96-well culture plates at a density of 20,000 cells/well in 100 l volume and allowed to grow for 18 h before treatments. 

Phrase: "N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded in 96-well culture plates"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   790   C0180454:culture plates [Medical Device]
   753   C0010453:Culture [Idea or Concept]
   753   C0205170:Well [Qualitative Concept]
   753   C0220814:culture [Functional Concept]
   753   C0430400:Culture [Laboratory Procedure]
   753   C1139930:plates [Medical Device]
   753   C2242979:Culture [Laboratory Procedure]
   753   C3146287:Well [Manufactured Object]
   719 E C0005971:Plate [Medical Device]
   719   C0036563:Seed [Plant]
   719   C1705192:Seed [Laboratory Procedure]
   719   C1882540:{Seed} [Quantitative Concept]
   719   C2346495:Seed [Conceptual Entity]
   719 E C3537155:Plate [Manufactured Object]

Phrase: "at a density"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0178587:density [Quantitative Concept]
   928 E C0439794:Dense [Qualitative Concept]

Phrase: "of 20,000 cells/well"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C2347578:Cells/well [Quantitative Concept]
   812   C0007634:Cells [Cell]
   812   C0205170:Well [Qualitative Concept]
   812   C3146287:Well [Manufactured Object]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "in 100 l volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "allowed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allowed [Social Behavior]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "grow for 18 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "before treatments."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0087111:Treatments [Therapeutic or Preventive Procedure]
   966 E C0039798:treatment [Functional Concept]
   966 E C1522326:Treatment [Functional Concept]
   966 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   966 E C1705169:Treatment [Conceptual Entity]
   966 E C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.93: Cells were treated by adding 100 l of a 2x concentration of the respective reagent (AlCl3, Al-malt, or maltolate as detailed in figures), and 24 h later, MTT was added to each well at a final concentration of 0.5 mg/ml for 4 h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated by adding 100 l of a 2x concentration of the respective reagent"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   735   C0034760:Reagent [Indicator, Reagent, or Diagnostic Aid]
   735   C0086045:Concentration [Mental Process]
   735   C0332293:treated [Therapeutic or Preventive Procedure]
   735   C1446561:Concentration [Quantitative Concept]
   735   C1522326:Treated [Functional Concept]
   702 E C1292734:TREAT [Functional Concept]
   702   C1883712:Add [Functional Concept]

Phrase: "(AlCl3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0102840:AlCl3 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "Al-malt,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "or"

Phrase: "maltolate"

Phrase: "as"

Phrase: "detailed in figures"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1522508:Detailed [Qualitative Concept]
   756 E C1561567:detail [Functional Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "24 h later,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: "MTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0647210:mtt [Lipid]

Phrase: "was"

Phrase: "added to each well"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0205170:Well [Qualitative Concept]
   770   C1524062:Added [Functional Concept]
   770   C3146287:Well [Manufactured Object]
   737 E C1883712:Add [Functional Concept]

Phrase: "at a final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of 0.5 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439294:mg ml [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "for 4 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.94: Media was removed and the purple formazan crystals were dissolved in 100% dimethyl sulfoxide. 

Phrase: "Media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "removed"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0849355:Removed [Qualitative Concept]
   966 E C1883720:Remove [Activity]
   966 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "the purple formazan crystals"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0427896:Crystals [Body Substance]
   827   C0444626:Crystals [Chemical Viewed Structurally]
   827   C1378554:Crystals [Biomedical or Dental Material]
   827   C1533132:Crystals [Body Substance]
   827   C2699477:Crystals [Laboratory Procedure]
   793 E C1704641:Crystal [Manufactured Object]

Phrase: "were"

Phrase: "dissolved in 100% dimethyl sulfoxide."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0012403:Dimethyl Sulfoxide [Organic Chemical,Pharmacologic Substance]
   760   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0038771:sulfoxide [Organic Chemical]
   760   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   726   C1549535:Dissolve [Functional Concept]
Processing 00000000.tx.95: Absorbance at 570 nm was determined using a PowerWaveXTM absorbance microplate reader (Bio-Tek Instruments, Inc., Winooski, VT). 

Phrase: "Absorbance at 570 nm"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1268822:Absorbance [Clinical Attribute]
   770   C2825050:Absorbance [Phenomenon or Process]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PowerWaveXTM absorbance microplate reader"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0182258:Microplate Reader [Medical Device]
   812   C1514743:Reader [Professional or Occupational Group]
   812   C1706461:Reader [Manufactured Object]

Phrase: "(Bio-Tek Instruments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0348000:instruments [Medical Device]

Phrase: "Inc.,"

Phrase: "Winooski,"

Phrase: "VT"

Phrase: ")."
Processing 00000000.tx.96: Data are expressed as relative absorbance at 570 nm. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "expressed as relative absorbance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0080103:Relative [Family Group]
   770   C0205345:Relative [Qualitative Concept]
   770   C1268822:Absorbance [Clinical Attribute]
   770   C1547039:*Relative [Quantitative Concept]
   770   C2825050:Absorbance [Phenomenon or Process]

Phrase: "at 570 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]
Processing 00000000.tx.97: Cytotoxicity was determined using the lactate dehydrogenase (LDH) release assay as previously described (He et al., 2002). 

Phrase: "Cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   928 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   928 E C1511636:cytotoxic [Functional Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the lactate dehydrogenase (LDH) release assay"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   861   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0005507:Assay [Laboratory Procedure]
   812   C0022924:lactate [Organic Chemical]
   812   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030685:Release [Health Care Activity]
   812   C0243073:assay [Qualitative Concept]
   812   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1510438:Assay [Laboratory Procedure]
   812   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "("

Phrase: "He et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.98: N2a cells were seeded as described above for the MTT assay. 

Phrase: "N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded as described above"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C1552738:described [Idea or Concept]
   737   C0036563:Seed [Plant]
   737   C1705192:Seed [Laboratory Procedure]
   737   C1882540:{Seed} [Quantitative Concept]
   737   C2346495:Seed [Conceptual Entity]

Phrase: "for the MTT assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.99: Treatments were added after 18 h as 2x concentrations. 

Phrase: "Treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0087111:Treatments [Therapeutic or Preventive Procedure]
   966 E C0039798:treatment [Functional Concept]
   966 E C1522326:Treatment [Functional Concept]
   966 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   966 E C1705169:Treatment [Conceptual Entity]
   966 E C3538994:TREATMENT [Research Activity]

Phrase: "were"

Phrase: "added after 18 h"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "as 2x concentrations."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]
Processing 00000000.tx.100: Plates were then incubated for 24 h, following which 40 l of the supernatant was added to a new 96-well plate to determine LDH release, and 40 l of 6% Triton X-100 was added to the original plate for determination of total LDH. 

Phrase: "Plates"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1139930:plates [Medical Device]
   966 E C0005971:Plate [Medical Device]
   966 E C3537155:Plate [Manufactured Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated for 24 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "which 40 l of the supernatant"

Phrase: "was"

Phrase: "added to a new 96-well plate to"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   744   C0005971:Plate [Medical Device]
   744   C0205170:Well [Qualitative Concept]
   744   C0205314:New [Temporal Concept]
   744   C1139930:plate [Medical Device]
   744   C1524062:Added [Functional Concept]
   744   C3146287:Well [Manufactured Object]
   744   C3537155:Plate [Manufactured Object]
   711 E C1883712:Add [Functional Concept]

Phrase: "determine"

Phrase: "LDH release,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   734   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "40 l of 6% Triton X-100"

Phrase: "was"

Phrase: "added to the original plate"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0005971:Plate [Medical Device]
   760   C0205313:Original [Idea or Concept]
   760   C1139930:plate [Medical Device]
   760   C1524062:Added [Functional Concept]
   760   C2347409:Original [Occupational Activity]
   760   C3537155:Plate [Manufactured Object]
   726 E C1883712:Add [Functional Concept]

Phrase: "for determination"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1148554:determination [Laboratory Procedure]

Phrase: "of total LDH."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0022924:lactate [Organic Chemical]
   827   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.101: An aliquot of 100 l of 4.6 mM pyruvic acid in 0.1 M potassium phosphate buffer (pH 7.5) was mixed with the supernatant using repeated pipetting. 

Phrase: "An aliquot of 100 l of 4.6 mM pyruvic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1510844:Aliquot [Quantitative Concept]

Phrase: "in 0.1 M potassium phosphate buffer"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   827   C0071778:potassium phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   799   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   799   C0031701:phosphate [Organophosphorus Compound]
   799   C0032821:Potassium [Element, Ion, or Isotope]
   799   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   799   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "was"

Phrase: "mixed with the supernatant"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205430:Mixed [Functional Concept]
   770   C1550101:Supernatant [Body Substance]
   770   C3160715:Mixed [Finding]
   737 E C1421951:MIX [Gene or Genome]
   737 E C1720722:Mix [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "repeated pipetting."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0182301:Pipette [Medical Device]
   827   C1706407:Pipette [Medical Device]
Processing 00000000.tx.102: Then 100 l of 0.4 mg/ml reduced -NADH in 0.1 M potassium phosphate buffer (pH 7.5) was added to the wells, and the kinetic change in absorbance at 340 nm was read for 1 min using a PowerWaveXTM absorbance microplate reader. 

Phrase: "Then 100 l of 0.4 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0439268:mg/L [Quantitative Concept]
   767   C1635169:mL/L [Quantitative Concept]

Phrase: "reduced -"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "NADH in 0.1 M potassium phosphate buffer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0027303:NADH phosphate [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   744   C0027289:NADH [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide,Pharmacologic Substance]

Phrase: "(pH 7.5"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: "was"

Phrase: "added to the wells,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1524062:Added [Functional Concept]
   737   C0205170:Well [Qualitative Concept]
   737 E C1883712:Add [Functional Concept]
   737   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "the kinetic change in absorbance"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C0025320:The change [Physiologic Function]
   760   C0392747:Change [Functional Concept]
   760   C0443172:change [Quantitative Concept]
   760   C1705241:Change [Quantitative Concept]

Phrase: "at 340 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "was"

Phrase: "read for 1 min"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   819   C1301862:Min 1 [Temporal Concept]
   770   C0034754:Read [Daily or Recreational Activity]
   770   C0702093:/min [Temporal Concept]
   770   C1705179:read [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a PowerWaveXTM absorbance microplate reader."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0182258:Microplate Reader [Medical Device]
   812   C1514743:Reader [Professional or Occupational Group]
   812   C1706461:Reader [Manufactured Object]
Processing 00000000.tx.103: This procedure was repeated with 40 l of the total cell lysate to determine total LDH U/well. 

Phrase: "This procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
  1000   C1948041:Procedure [Therapeutic or Preventive Procedure]
  1000   C2700391:Procedure [Activity]
  1000   C3274430:PROCEDURE [Health Care Activity]
  1000   C3538935:Procedure [Idea or Concept]
  1000   C3539779:Procedure [Intellectual Product]

Phrase: "was"

Phrase: "repeated with 40 l of the total cell lysate to"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   760   C1881488:Cell Lysate [Physical Object]
           Lysate
   757   C0022827:cell l [Cell]
   739   C0007634:Cell [Cell]
   739   C0205341:Repeated [Functional Concept]
   739   C0439175:% total [Quantitative Concept]
   739   C0439509:/40 [Temporal Concept]
   739   C0439810:Total [Qualitative Concept]
   739   C1269647:Cell [Cell]
   739   C1704653:Cell [Medical Device]
   739   C1948049:Cell [Spatial Concept]
   706 E C1547730:Repeat [Temporal Concept]
   706 E C1705914:Repeat [Conceptual Entity]

Phrase: "determine"

Phrase: "total LDH U/well."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0022924:lactate [Organic Chemical]
   804   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0205170:Well [Qualitative Concept]
   804   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   804   C0439175:% total [Quantitative Concept]
   804   C0439810:Total [Qualitative Concept]
   804   C3146287:Well [Manufactured Object]
Processing 00000000.tx.104: A change of 0.001 absorbance units/min is equivalent to 1 U/l of LDH activity (Jemmerson et al., 2002). 

Phrase: "A change of 0.001 absorbance units/min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0392747:Change [Functional Concept]
   744   C0443172:change [Quantitative Concept]
   744   C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "equivalent to 1 U/l of LDH activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0205163:Equivalent [Qualitative Concept]
   742   C0439185:equivalent [Quantitative Concept]

Phrase: "(Jemmerson et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.105: The percentage of LDH release was determined by dividing the LDH released into the media by the total LDH following cell lysis in the same well. 

Phrase: "The percentage of LDH release"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0439165:Percentage [Quantitative Concept]
   753   C1549488:Percentage [Idea or Concept]
   753   C1561533:Percentage [Idea or Concept]

Phrase: "was"

Phrase: "determined by dividing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0332849:dividing [Functional Concept]

Phrase: "the LDH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "released into the media"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0391871:Released [Functional Concept]
   770   C1254021:Media [Tissue]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1705217:Medium [Substance]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]
   737 E C3244283:medium [Intellectual Product]

Phrase: "by the total LDH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0022924:lactate [Organic Chemical]
   827   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "cell lysis in the same well."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0024348:Lysis [Pathologic Function]
   753   C1536403:lysis [Cell Function]
Processing 00000000.tx.106: Determination of DNA synthesis as an index of cell proliferation. 

Phrase: "Determination of DNA synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1148554:determination [Laboratory Procedure]

Phrase: "as an index"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0918012:Index [Intellectual Product]
  1000   C1552854:index [Idea or Concept]
  1000   C1637833:% index [Quantitative Concept]

Phrase: "of cell proliferation."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0596290:Cell Proliferation [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0334094:Proliferation [Pathologic Function]
   861   C1269647:Cell [Cell]
   861   C1514485:Proliferation [Functional Concept]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.107: The effects of Al treatment on N2a cell proliferation and DNA synthesis was determined using a modification of the [methyl-3H]thymidine incorporation assay previously described (Johnson and Sharma, 2001). 

Phrase: "The effects of Al treatment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1518681:Treatment Effect [Finding]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on N2a cell proliferation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0596290:Cell Proliferation [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0334094:Proliferation [Pathologic Function]
   812   C1269647:Cell [Cell]
   812   C1514485:Proliferation [Functional Concept]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "DNA synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598312:DNA Synthesis [Genetic Function]
  1000   C1328870:DNA synthesis [Laboratory Procedure]
  1000   C1817262:DNA synthesis [Genetic Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a modification of the [methyl-3H]thymidine incorporation assay previously"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0392747:Modification [Functional Concept]
   739   C1554963:modification [Qualitative Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Johnson"

Phrase: "and"

Phrase: "Sharma,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.108: N2a cells were treated with Al-malt for 24 h, following which 25 Ci/ml of [methyl-3H]thymidine was added for an additional 6 h. 

Phrase: "N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "for 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "which 25 Ci/ml of [methyl-3H]thymidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   795   C1442460:3H [Temporal Concept]

Phrase: "was"

Phrase: "added for an additional 6 h."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   783   C0444953:H 6 [Intellectual Product]
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1524062:Added [Functional Concept]
           Additional
   719 E C1883712:Add [Functional Concept]
Processing 00000000.tx.109: Cells were then harvested onto glass fiber filter paper (Cambridge Technology, Watertown, MA) using a cell harvester (PHD, Cambridge Technology). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "harvested onto glass fiber filter paper"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   790   C0060317:Glass Fiber [Biomedical or Dental Material,Hazardous or Poisonous Substance]
   790   C0180859:filter paper [Medical Device]
   753   C0012173:Fiber [Food]
   753   C0017596:Glass [Manufactured Object]
   753   C0030351:Paper [Manufactured Object]
   753   C0180860:Filter [Manufactured Object]
   753   C0225326:Fiber [Pharmacologic Substance]
   753   C0304068:Fiber [Plant]
   753   C0581406:Filter [Medical Device]
   753   C1260603:Fiber [Plant]
   753   C1304649:Fiber [Tissue]
   753   C1522664:Filter [Intellectual Product]
   753   C1547566:Paper [Idea or Concept]
   753   C1704449:Filter [Conceptual Entity]
   753   C1704684:Filter [Medical Device]
   753   C1875155:FILTER [Medical Device]
   753   C1947936:Glass [Medical Device]
   719   C1512335:Harvest [Health Care Activity]

Phrase: "(Cambridge Technology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:Technology [Occupation or Discipline]

Phrase: "Watertown,"

Phrase: "MA)"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a cell harvester"

Phrase: "(PHD,"

Phrase: "Cambridge Technology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:Technology [Occupation or Discipline]

Phrase: ")."
Processing 00000000.tx.110: The harvested cells were lysed with deionized water, and filters dried with 95% ethanol. 

Phrase: "The harvested cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed with deionized water,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0024348:lysed [Pathologic Function]
   770   C0043047:Water [Inorganic Chemical,Pharmacologic Substance]
   770   C0599638:WATER [Substance]
   770   C1550678:Water [Inorganic Chemical]

Phrase: "and"

Phrase: "filters"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]

Phrase: "dried with 95% ethanol."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0001962:Ethanol [Organic Chemical]
   770   C1512080:Dried [Qualitative Concept]
   770   C2827485:Dried [Body Substance]
   737 E C0011682:Dry [Natural Phenomenon or Process]
   737 E C0205222:Dry [Qualitative Concept]
Processing 00000000.tx.111: The filter papers were placed in scintillation vials containing 2 ml of liquid scintillation cocktail (Ready-Solv, Beckman, Fullerton, CA) and counted in a liquid scintillation counter (Pharmacia, Turku, Finland). 

Phrase: "The filter papers"
Meta Candidates (Total=14; Excluded=6; Pruned=0; Remaining=8)
  1000   C0180859:filter papers [Medical Device]
   861   C0030351:Papers [Manufactured Object]
   861   C0180860:Filter [Manufactured Object]
   861   C0581406:Filter [Medical Device]
   861   C1522664:Filter [Intellectual Product]
   861   C1704449:Filter [Conceptual Entity]
   861   C1704684:Filter [Medical Device]
   861   C1875155:FILTER [Medical Device]
   827 E C1547566:Paper [Idea or Concept]
   805 E C0080194:Strain [Injury or Poisoning]
   805 E C0442694:Straining [Physiologic Function]
   805 E C0456178:strain [Intellectual Product]
   805 E C1518614:Strain [Organism]
   805 E C2987481:Strain [Mental Process]

Phrase: "were"

Phrase: "placed in scintillation vials"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   770   C0184301:vials [Medical Device]
   770   C0678573:scintillation [Natural Phenomenon or Process]
   770   C1533199:Vials [Quantitative Concept]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737 E C1706497:VIAL [Medical Device]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "2 ml of liquid scintillation cocktail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439526:/mL [Quantitative Concept]

Phrase: "(Ready-Solv,"

Phrase: "Beckman,"

Phrase: "Fullerton,"

Phrase: "CA)"

Phrase: "and"

Phrase: "counted in a liquid scintillation counter"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0036405:Scintillation Counter [Medical Device]
   790   C1710025:Scintillation Counter [Manufactured Object]
   753   C0302908:Liquid [Substance]
   753   C0677601:Counter [Manufactured Object]
   753   C0678573:scintillation [Natural Phenomenon or Process]
   753   C1304698:Liquid [Finding]
   753   C1546699:Liquid NOS [Intellectual Product]
   753   C1561501:Liquid NOS [Substance]
   753   C1705206:Counter [Medical Device]
   719   C0750480:Count [Activity]
   719   C1705566:Count [Quantitative Concept]

Phrase: "(Pharmacia,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331955:Pharmacia [Health Care Related Organization]

Phrase: "Turku,"

Phrase: "Finland"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016132:Finland [Geographic Area]

Phrase: ")."
Processing 00000000.tx.112: Proliferative responses (uptake of 3H-thymidine) were expressed as stimulation index [disintegrations per minute (DPM)treated/DPMcontrol]. 

Phrase: "Proliferative responses"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0871261:responses [Organism Attribute]
   827 E C1704632:Response [Finding]
   827 E C1706817:Response [Intellectual Product]
   827 E C2911692:Response [Mental Process]

Phrase: "(uptake of 3H-thymidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0243144:Uptake [Physiologic Function]
   770   C0347980:% uptake [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "expressed as stimulation index"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0918012:Index [Intellectual Product]
   770   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   770   C1552854:index [Idea or Concept]
   770   C1637833:% index [Quantitative Concept]
   770   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "[disintegrations per minute (DPM)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1634619:Disintegrations per minute [Quantitative Concept]
           Disintegration/Minute
   756   C1265875:Disintegration [Acquired Abnormality]

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "/DPMcontrol"

Phrase: "]."
Processing 00000000.tx.113: Determination of apoptosis using the acridine orange/ethidium bromide assay. 

Phrase: "Determination of apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1148554:determination [Laboratory Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the acridine orange/ethidium bromide assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0005507:Assay [Laboratory Procedure]
   804   C0243073:assay [Qualitative Concept]
   804   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.114: The ability of acridine orange and ethidium bromide dual-staining to differentiate live from apoptotic and necrotic cells has been useful in cell death research. 

Phrase: "The ability of acridine orange"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "and"

Phrase: "ethidium bromide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]

Phrase: "dual-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1554184:Dual [Intellectual Product]

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "differentiate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205615:differentiate [Qualitative Concept]

Phrase: "live from apoptotic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1548795:Live [Qualitative Concept]
   790   C1634625:% live [Qualitative Concept]
   790   C2982691:Live [Activity]

Phrase: "and"

Phrase: "necrotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "has"

Phrase: "been"

Phrase: "useful in cell death research."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0035168:research [Research Activity]
   804   C0242481:Research [Research Activity]
Processing 00000000.tx.115: The assay was performed as previously described (Kern and Kehrer, 2002). 

Phrase: "The assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005507:Assay [Laboratory Procedure]
  1000   C0243073:assay [Qualitative Concept]
  1000   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "performed as previously"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Kern"

Phrase: "and"

Phrase: "Kehrer,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.116: N2a cells were treated with Al-malt for 24 h, following which the cells were harvested by trypsinization. 

Phrase: "N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "for 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "which the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "harvested by trypsinization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1512335:Harvest [Health Care Activity]
Processing 00000000.tx.117: The floating and adherent cells were collected and combined. 

Phrase: "The floating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1708071:Float [Qualitative Concept]

Phrase: "and"

Phrase: "adherent cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0007634:Cells [Cell]
   861   C0334154:Adherent [Functional Concept]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "and"

Phrase: "combined."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205195:Combined [Qualitative Concept]
   966 E C0336789:Combine [Manufactured Object]
Processing 00000000.tx.118: Cells (106) were centrifuged at 200 x g for 10 min at 4C and resuspended in 1 ml PBS, and 2 l of acridine orange and 2 l of ethidium bromide (final concentration 200 ng/ml for each) were added to each tube, and the cells were stained for 5 min. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "(106"

Phrase: ")"

Phrase: "were"

Phrase: "centrifuged at 200 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439267:g% [Quantitative Concept]
   726   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "and"

Phrase: "resuspended in 1 ml PBS,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0439526:/mL [Quantitative Concept]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "2 l of acridine orange"

Phrase: "and"

Phrase: "2 l of ethidium bromide"

Phrase: "(final concentration 200 ng/ml for each"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0439275:ng/mL [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "added to each tube,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0175730:Tube [Medical Device]
   770   C1524062:Added [Functional Concept]
   770   C1547937:Tube NOS [Intellectual Product]
   770   C1561954:tube [Conceptual Entity]
   770   C1704730:TUBE [Medical Device]
   737 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained for 5 min."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0702093:/min [Temporal Concept]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.119: Two-parameter fluorescence was acquired from 20,000 individual cells per sample using an EPICS XL/MCL flow cytometer (Coulter Cytometry, Hialeah, FL, USA) with a 488 nm argon-ion laser. 

Phrase: "Two-parameter fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "acquired from 20,000 individual cells"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   753   C0007634:Cells [Cell]
   753   C0027361:Individual [Population Group]
   753   C0237401:Individual [Human]
   753   C0439661:Acquired [Temporal Concept]
   753   C3245488:acquired [Intellectual Product]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1706701:Acquire [Activity]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "per sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0370003:Sample [Substance]
  1000   C2347026:Sample [Conceptual Entity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an EPICS XL/MCL flow cytometer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0180279:Flow Cytometer [Medical Device]
   804   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "(Coulter Cytometry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0814048:Cytometry [Laboratory Procedure]

Phrase: "Hialeah,"

Phrase: "FL,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")"

Phrase: "with a 488 nm argon-ion laser."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0392247:Argon ion laser [Medical Device]
           Argon laser
   840   C1289853:Ion laser [Manufactured Object]
   804   C0022023:Ion [Element, Ion, or Isotope]
   804   C0023089:Laser [Manufactured Object]
   804   C0458142:Laser [Phenomenon or Process]
   804   C1023865:Laser [Plant]
   804   C1700702:ION [Functional Concept]
   804   C1706315:Laser [Medical Device]
Processing 00000000.tx.120: Green emissions from acridine orange and red emissions from ethidium bromide were captured at 525 and 620 nm, respectively. 

Phrase: "Green emissions from acridine orange"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0233929:emissions [Body Substance]
   726 E C2349995:Emission [Substance]

Phrase: "and"

Phrase: "red emissions from ethidium bromide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0233929:emissions [Body Substance]
   726 E C2349995:Emission [Substance]

Phrase: "were"

Phrase: "captured at 525"

Phrase: "and"

Phrase: "620 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "respectively."
Processing 00000000.tx.121: Live, apoptotic, and necrotic populations were analyzed using WinMDITM flow analysis software. 

Phrase: "Live, apoptotic,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1516044:Apoptotic [Qualitative Concept]
   789 E C0162638:Apoptosis [Cell Function]

Phrase: "and"

Phrase: "necrotic populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "WinMDITM flow analysis software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.122: Discrimination between cell populations was based on previously published diagrams and descriptions (Kern and Kehrer, 2002; Liegler et al., 1995). 

Phrase: "Discrimination between cell populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012632:Discrimination [Mental Process]
   770   C2987623:Discrimination [Social Behavior]

Phrase: "was"

Phrase: "based on previously published diagrams"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   760   C0034037:Published [Occupational Activity]
   760   C0681494:diagrams [Intellectual Product]
   760   C1527178:Based [Functional Concept]
   760   C1704324:Published [Intellectual Product]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "descriptions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678257:descriptions [Idea or Concept]

Phrase: "(Kern"

Phrase: "and"

Phrase: "Kehrer,"

Phrase: "2002"

Phrase: "; Liegler et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.123: Determination of phosphatidyl serine externalization: annexin V binding assay. 

Phrase: "Determination of phosphatidyl serine externalization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1148554:determination [Laboratory Procedure]
   733   C2753858:externalization of phosphatidylserine [Cell Function]

Phrase: ":"

Phrase: "annexin V binding assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.124: The externalization of phosphatidyl serine is an early event in apoptosis and serves as a signal for phagocytosis by macrophages (Anderson et al., 2002). 

Phrase: "The externalization of phosphatidyl serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   926   C2753858:externalization of phosphatidylserine [Cell Function]

Phrase: "is"

Phrase: "an early event in apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0441471:Event [Event]

Phrase: "and"

Phrase: "serves as a signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1710082:Signal [Phenomenon or Process]

Phrase: "for phagocytosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031308:Phagocytosis [Cell Function]

Phrase: "by macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "(Anderson et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.125: Flow cytometry analysis was performed to determine this event using the annexin V binding assay (BD Biosciences Pharmingen, San Diego, CA). 

Phrase: "Flow cytometry analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0016263:Flow Cytometry [Laboratory Procedure]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "this event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441471:Event [Event]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the annexin V binding assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "(BD Biosciences Pharmingen,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)."
Processing 00000000.tx.126: N2a cells were treated with Al-malt for 24 h, following which 100,000 cells were washed 2x in cold PBS and resuspended in 100 l 1x binding buffer. 

Phrase: "N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "for 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "which 100,000 cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   913   C1441340:100 cells [Cell]
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "washed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1548982:Washed [Idea or Concept]
   966 E C0441648:Wash [Activity]

Phrase: "2x in cold PBS"

Phrase: "and"

Phrase: "resuspended in 100 l 1x binding buffer."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
Processing 00000000.tx.127: Five l of annexin V-FITC and 5 l of PI (final concentrations 2.5 g/ml) were added and gently mixed, followed by incubation protected from light for 15 min. 

Phrase: "Five l of annexin V-FITC"

Phrase: "and"

Phrase: "5 l of PI"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   806   C2348935:.5 L [Quantitative Concept]

Phrase: "(final concentrations 2.5 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0439267:g% [Quantitative Concept]

Phrase: "ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439526:/mL [Quantitative Concept]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "gently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1638411:Gently [Qualitative Concept]

Phrase: "mixed"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205430:Mixed [Functional Concept]
  1000   C3160715:Mixed [Finding]
   966 E C1421951:MIX [Gene or Genome]
   966 E C1720722:Mix [Qualitative Concept]

Phrase: ","

Phrase: "followed by incubation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   882   C0332283:Followed by [Temporal Concept]
           followed
   756 E C1719822:Follow [Intellectual Product]

Phrase: "protected from light"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   988   C1550583:Protect from Light [Functional Concept]
   790   C0023693:Light [Natural Phenomenon or Process]
   790   C1306462:Light [Functional Concept]
   790   C1881376:Light [Qualitative Concept]

Phrase: "for 15 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.128: Cells were acquired within 60 min using an EPICS XL/MCL flow cytometer. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "acquired within 60 min"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0439661:Acquired [Temporal Concept]
   770   C0702093:/min [Temporal Concept]
   770   C3245488:acquired [Intellectual Product]
   737 E C1706701:Acquire [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an EPICS XL/MCL flow cytometer."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0180279:Flow Cytometer [Medical Device]
   804   C0806140:Flow [Natural Phenomenon or Process]
Processing 00000000.tx.129: The fluorochrome was excited using the 488 nm line of argon-ion laser, and annexin V and PI emissions were monitored at 525 and 620 nm, respectively. 

Phrase: "The fluorochrome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "excited"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excited [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the 488 nm line of argon-ion laser,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0205132:Line [Spatial Concept]
   744   C1550648:Line [Substance]
   744   C1552960:Line [Quantitative Concept]

Phrase: "and"

Phrase: "annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "PI emissions"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0233929:emissions [Body Substance]
   793 E C2349995:Emission [Substance]
   734   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "were"

Phrase: "monitored at 525"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]

Phrase: "and"

Phrase: "620 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "respectively."
Processing 00000000.tx.130: A total of 20,000 events were acquired for each sample. 

Phrase: "A total of 20,000 events"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "were"

Phrase: "acquired for each sample."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   773   C1277697:Sample obtained [Finding]
   770   C0370003:Sample [Substance]
   770   C0439661:Acquired [Temporal Concept]
   770   C2347026:Sample [Conceptual Entity]
   770   C3245488:acquired [Intellectual Product]
   737 E C1706701:Acquire [Activity]
Processing 00000000.tx.131: The following controls were run at the time of assay (1) unstained cells, (2) annexin V only, and (3) PI only. 

Phrase: "The following controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "were"

Phrase: "run at the time of assay"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0005507:Assay [Laboratory Procedure]
   753   C0035953:run [Daily or Recreational Activity]
   753   C0040223:Time [Temporal Concept]
   753   C0243073:assay [Qualitative Concept]
   753   C0600140:run [Finding]
   753   C1510438:Assay [Laboratory Procedure]
   753   C1704688:Run [Functional Concept]
   753   C2346414:Run [Finding]
   753   C3541383:Time [Temporal Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "unstained cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "annexin V only,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1332095:ANNEXIN V [Gene or Genome]
   827   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and ("

Phrase: "3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "PI only."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0021966:Iodide [Inorganic Chemical]
   827   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.132: Determination of caspase 3 activation. 

Phrase: "Determination of caspase 3 activation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1148554:determination [Laboratory Procedure]
Processing 00000000.tx.133: Caspase 3-like activity was determined using the CaspACETM fluorometric activity assay (Promega Corporation, Madison, WI) with modifications as noted. 

Phrase: "Caspase 3-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "like activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the CaspACETM fluorometric activity assay"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0205177:Activity [Functional Concept]
   812   C0243073:assay [Qualitative Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1510438:Assay [Laboratory Procedure]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "(Promega Corporation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corporation [Organization]

Phrase: "Madison,"

Phrase: "WI) with modifications"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0043193:WI [Geographic Area]

Phrase: "as"

Phrase: "noted."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1316572:Note [Clinical Attribute]
   966   C1317574:Note [Intellectual Product]
   966   C1369612:Note [Clinical Attribute]
Processing 00000000.tx.134: Recently it was reported that approximately 15% and 58% of the active caspase 3 enzyme is released into the media within 4 and 24 h, respectively, following induction of apoptosis (Jemmerson et al., 2002). 

Phrase: "Recently"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "it"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that approximately 15%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332232:Approximately [Qualitative Concept]

Phrase: "and"

Phrase: "58% of the active caspase 3 enzyme"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   778   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0014442:Enzyme [Enzyme,Organic Chemical]
   748   C0205177:Active [Functional Concept]

Phrase: "is"

Phrase: "released into the media"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   770   C0009458:Media [Intellectual Product]
   770   C0162867:Media [Tissue]
   770   C0391871:Released [Functional Concept]
   770   C1254021:Media [Tissue]
   770   C1283071:Released [Functional Concept]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0439536:Medium [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1705217:Medium [Substance]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]
   737 E C3244283:medium [Intellectual Product]

Phrase: "within 4"

Phrase: "and"

Phrase: "24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "respectively,"

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "induction of apoptosis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C3266896:Induction of Apoptosis [Cell Function]
           Apoptosis Induction
   790   C0205263:Induction [Functional Concept]
   790   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "(Jemmerson et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.135: Traditional assays require a wash step prior to lysis of the cells that may result in the loss of the active enzyme and a false negative result. 

Phrase: "Traditional assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]

Phrase: "require"

Phrase: "a wash step prior to lysis of the cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C1261552:Step [Conceptual Entity]
   742   C1704379:Step [Functional Concept]
   742   C1705117:Step [Quantitative Concept]
   742   C2825408:Step [Manufactured Object]

Phrase: "that"

Phrase: "may"

Phrase: "result in the loss of the active enzyme"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0014442:Enzyme [Enzyme,Organic Chemical]
   744   C0205177:Active [Functional Concept]
   744   C1274040:Result [Functional Concept]
   744   C1517945:Loss [Quantitative Concept]
   744   C1546471:Result [Idea or Concept]
   744   C2825142:Result [Finding]

Phrase: "and"

Phrase: "a false negative result."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1880722:FALSE NEGATIVE RESULT [Finding]
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
   734   C0205558:False Negative [Laboratory or Test Result]
Processing 00000000.tx.136: For this reason, we lysed the cells in the treatment media using 1% Triton X-100. 

Phrase: "For this reason,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392360:Reason [Idea or Concept]

Phrase: "we"

Phrase: "lysed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024348:lysed [Pathologic Function]

Phrase: "the cells in the treatment media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   773   C0007634:THE CELL [Cell]
           Cells
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "1% Triton X-100."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   861   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   812   C0242759:Triton [Geographic Area]
Processing 00000000.tx.137: N2a cells were treated in 24-well plates at a density of 200,000/ml for 24 h, following which Triton X-100 was added to a final concentration of 1%. 

Phrase: "N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated in 24-well"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0205170:Well [Qualitative Concept]
   770   C0332293:treated [Therapeutic or Preventive Procedure]
   770   C1522326:Treated [Functional Concept]
   770   C3146287:Well [Manufactured Object]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "plates at a density of 200,000/ml"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0005971:Plate [Medical Device]
   744   C0178587:density [Quantitative Concept]
   744   C0439526:/mL [Quantitative Concept]
   744   C1139930:plate [Medical Device]
   744   C3537155:Plate [Manufactured Object]

Phrase: "for 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "which Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   901   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   827   C0242759:Triton [Geographic Area]

Phrase: "was"

Phrase: "added to a final concentration of 1%."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   757   C0945818:Add 1 [Quantitative Concept]
   748   C0086045:Concentration [Mental Process]
   748   C0205088:Final [Temporal Concept]
   748   C1446561:Concentration [Quantitative Concept]
   748   C1524062:Added [Functional Concept]
   748   C1546485:Final [Idea or Concept]
   714 E C1883712:Add [Functional Concept]
Processing 00000000.tx.138: The cells were lysed by trituration and centrifuged at 10,000 x g for 10 min to remove cell debris. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "lysed by trituration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0024348:lysed [Pathologic Function]
   790   C0885614:trituration [Inorganic Chemical]

Phrase: "and"

Phrase: "centrifuged at 10,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0456692:/10 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "cell debris."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0440266:Debris [Substance]
Processing 00000000.tx.139: The supernatant was assayed for active caspase 3-like activity using the CaspACETM system according to manufacturer's instructions. 

Phrase: "The supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "assayed for active caspase 3-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0205177:Active [Functional Concept]
   726   C0005507:Assay [Laboratory Procedure]
   726   C0243073:assay [Qualitative Concept]
   726   C1510438:Assay [Laboratory Procedure]

Phrase: "like activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the CaspACETM system according to manufacturer's instructions."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0449913:System [Functional Concept]
   748   C1553451:System [Manufactured Object]
   748   C1704459:System [Medical Device]
Processing 00000000.tx.140: The fluorescence of 7-amino-4-methyl coumarin (AMC) following cleavage of the substrate was determined using a Spectramax Gemini fluorescent plate reader (Molecular Devices, Irvine, CA, USA). 

Phrase: "The fluorescence of 7-amino-4-methyl coumarin (AMC)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0016315:Fluorescence [Natural Phenomenon or Process]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "cleavage of the substrate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0010813:cleavage [Cell Function]
   770   C0596311:Cleavage [Phenomenon or Process]
   770   C1330957:cleavage [Cell Function]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Spectramax Gemini fluorescent plate reader"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C1514743:Reader [Professional or Occupational Group]
   804   C1706461:Reader [Manufactured Object]

Phrase: "(Molecular Devices,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025080:DEVICES [Medical Device]
   861   C0220819:devices [Manufactured Object]
   861   C0699733:Devices [Manufactured Object]

Phrase: "Irvine,"

Phrase: "CA,"

Phrase: "USA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041703:USA [Geographic Area]

Phrase: ")."
Processing 00000000.tx.141: The fluorescence signal was digitized and analyzed using SoftMax ProTM (version 3.1.1, Molecular Devices), and the concentration of caspase 3-like activity determined from an AMC standard curve. 

Phrase: "The fluorescence signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "digitized"

Phrase: "and"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SoftMax ProTM"

Phrase: "(version 3.1.1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0333052:Version [Functional Concept]
   812   C2607870:Version [Spatial Concept]

Phrase: "Molecular Devices"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025080:DEVICES [Medical Device]
   861   C0220819:devices [Manufactured Object]
   861   C0699733:Devices [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the concentration of caspase 3-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "like activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "determined from an AMC standard curve."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0010206:Cumarin [Organic Chemical,Pharmacologic Substance]
   742   C0205134:Curve [Spatial Concept]
   742   C1442989:Standard [Qualitative Concept]
   742   C2828392:Standard [Intellectual Product]
Processing 00000000.tx.142: Cell cycle analysis. 

Phrase: "Cell cycle analysis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0007586:Cell Cycle [Cell Function]
   734   C1155839:Cell Cycle [Cell Function]
Processing 00000000.tx.143: The cell cycle distribution of N2a cells treated with Al-malt was determined using flow cytometry. 

Phrase: "The cell cycle distribution of N2a cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0520511:distribution [Idea or Concept]
   744   C1704711:Distribution [Functional Concept]

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "flow cytometry."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]
Processing 00000000.tx.144: Cells were treated with Al-malt for 24 h and then floating and trypsinzed cells were resuspended in nuclear isolation media (NIM; 50 g/ml PI, 1 mg/ml RNase A, 0.1% Triton X-100). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "then floating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708071:Float [Qualitative Concept]

Phrase: "and"

Phrase: "trypsinzed cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "resuspended in nuclear isolation media"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0009458:Media [Intellectual Product]
   760   C0162867:Media [Tissue]
   760   C0204727:Isolation [Therapeutic or Preventive Procedure]
   760   C0205409:Isolation [Functional Concept]
   760   C0220862:isolation [Laboratory Procedure]
   760   C0521447:Nuclear [Spatial Concept]
   760   C1254021:Media [Tissue]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "(NIM"

Phrase: "; 50 g/ml PI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   804   C0021966:Iodide [Inorganic Chemical]
   804   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "1 mg/ml RNase A,"

Phrase: "0.1% Triton X-100"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   840   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   804   C0242759:Triton [Geographic Area]

Phrase: ")."
Processing 00000000.tx.145: Nuclear DNA content from 50,000 cells was determined using an EPICS XL/MCL flow cytometer with a 488 nm argon-ion laser and an emission wavelength of 620 nm. 

Phrase: "Nuclear DNA content from 50,000 cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an EPICS XL/MCL flow cytometer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0180279:Flow Cytometer [Medical Device]
   804   C0806140:Flow [Natural Phenomenon or Process]

Phrase: "with a 488 nm argon-ion laser"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   884   C0392247:Argon ion laser [Medical Device]
           Argon laser
   840   C1289853:Ion laser [Manufactured Object]
   804   C0022023:Ion [Element, Ion, or Isotope]
   804   C0023089:Laser [Manufactured Object]
   804   C0458142:Laser [Phenomenon or Process]
   804   C1023865:Laser [Plant]
   804   C1700702:ION [Functional Concept]
   804   C1706315:Laser [Medical Device]

Phrase: "and"

Phrase: "an emission wavelength of 620 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449819:Wavelength [Quantitative Concept]
Processing 00000000.tx.146: DNA histograms were analyzed using WinMDITM flow analysis software. 

Phrase: "DNA histograms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2348974:Histogram [Manufactured Object]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "WinMDITM flow analysis software."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]
Processing 00000000.tx.147: Analysis of cellular and nuclear morphology. 

Phrase: "Analysis of cellular"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002778:Analysis [Laboratory Procedure]
   790   C0936012:Analysis [Research Activity]
   790   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "nuclear morphology."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1749565:nuclear morphology [Cell Function]
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.148: Cellular morphology was examined using phase and scanning electron microscopy, and nuclear morphology was examined using an epifluorescence microscope following staining with Hoechst 33258 (H33258). 

Phrase: "Cellular morphology"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243091:cellular morphology [Qualitative Concept]
  1000   C1521816:Cellular Morphology [Clinical Attribute]
  1000   C2700385:Cellular Morphology [Biomedical Occupation or Discipline]
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205390:Phase [Temporal Concept]

Phrase: "and"

Phrase: "scanning electron microscopy,"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0026020:Scanning Electron Microscopy [Laboratory Procedure]
   901   C0026019:Electron Microscopy [Laboratory Procedure]
   901   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   827   C0013852:Electron [Quantitative Concept]
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0034606:Scanning [Diagnostic Procedure]
   827   C0441633:Scanning [Diagnostic Procedure]
   827   C3463986:Electron [Bird]
   793 E C2826292:SCAN [Finding]
   755 E C0013850:Electronic [Manufactured Object]
   755 E C0205288:Microscopic [Qualitative Concept]
   755 E C1547561:Electronic [Idea or Concept]

Phrase: "and"

Phrase: "nuclear morphology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1749565:nuclear morphology [Cell Function]
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an epifluorescence microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0181839:Microscope [Medical Device]
   861   C1706379:Microscope [Medical Device]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "staining with Hoechst 33258 (H33258)."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
Processing 00000000.tx.149: Cells were seeded (2 x 105/ml) in 6-well plates for phase contrast and nuclear morphology imaging. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "seeded"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0036563:Seed [Plant]
   966   C1705192:Seed [Laboratory Procedure]
   966   C1882540:{Seed} [Quantitative Concept]
   966   C2346495:Seed [Conceptual Entity]

Phrase: "(2 x 105/ml) in 6-well"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0439526:/mL [Quantitative Concept]

Phrase: "plates for phase contrast"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0444701:Phase contrast [Laboratory Procedure]
   770   C0005971:Plate [Medical Device]
   770   C0205390:Phase [Temporal Concept]
   770   C1139930:plate [Medical Device]
   770   C1979874:Contrast [Qualitative Concept]
   770   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "nuclear morphology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1749565:nuclear morphology [Cell Function]
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "imaging."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]
Processing 00000000.tx.150: Following 24-h treatment with Al-malt, cells were stained with H33258 (1 g/ml) for 5 min, and phase and fluorescence microscopy was performed using an IX71 inverted microscope (Olympus America, Inc., Melville, NY). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "24-h treatment with Al-malt,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "stained with H33258"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   833   C0878435:Hoechst 33258 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   802   C1441607:Hoechst stain [Laboratory Procedure]
   770   C2986582:Stained [Qualitative Concept]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(1 g/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "ml) for 5 min,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0439445:mL/min [Quantitative Concept]
   770   C0439526:/mL [Quantitative Concept]

Phrase: "and"

Phrase: "phase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205390:Phase [Temporal Concept]

Phrase: "and"

Phrase: "fluorescence microscopy"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0026022:Microscopy, Fluorescence [Laboratory Procedure]
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   861   C0026018:Microscopy [Laboratory Procedure]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an IX71"

Phrase: "inverted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443241:Inverted [Qualitative Concept]

Phrase: "microscope"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0181839:Microscope [Medical Device]
  1000   C1706379:Microscope [Medical Device]

Phrase: "(Olympus America,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0002454:America [Geographic Area]
   789 E C0596070:American [Population Group]

Phrase: "Inc.,"

Phrase: "Melville,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.151: Digital images were captured using a MagnaFire SP digital camera. 

Phrase: "Digital images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "captured"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a MagnaFire SP digital camera."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0179533:Camera [Medical Device]
   812   C1654607:Camera [Eukaryote]
   812   C1706254:CAMERA [Medical Device]
Processing 00000000.tx.152: Scanning electron microscopy was performed on cells seeded on 13-mm ThermanoxTM cover slips (Nalge Nuc International, Rochester, NY) in 24-well plates and treated with Al-malt for 24 h. 

Phrase: "Scanning electron microscopy"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0026020:Scanning Electron Microscopy [Laboratory Procedure]
   901   C0026019:Electron Microscopy [Laboratory Procedure]
   901   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   827   C0013852:Electron [Quantitative Concept]
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0034606:Scanning [Diagnostic Procedure]
   827   C0441633:Scanning [Diagnostic Procedure]
   827   C3463986:Electron [Bird]
   793 E C2826292:SCAN [Finding]
   755 E C0013850:Electronic [Manufactured Object]
   755 E C0205288:Microscopic [Qualitative Concept]
   755 E C1547561:Electronic [Idea or Concept]

Phrase: "was"

Phrase: "performed on cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0884358:Performed [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "seeded on 13-mm ThermanoxTM cover slips"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0180153:cover [Medical Device]
   748   C1707529:Cover [Medical Device]
   748   C1999244:Cover [Functional Concept]
   714   C0036563:Seed [Plant]
   714   C0337209:slip [Phenomenon or Process]
   714   C1705192:Seed [Laboratory Procedure]
   714   C1882540:{Seed} [Quantitative Concept]
   714   C2346495:Seed [Conceptual Entity]

Phrase: "(Nalge Nuc International, Rochester,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "in 24-well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205170:Well [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "plates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0005971:Plate [Medical Device]
  1000   C1139930:plate [Medical Device]
  1000   C3537155:Plate [Manufactured Object]

Phrase: "and"

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.153: Following the treatment, cover slips were removed from the well and rinsed with ice cold PBS for 5 s and immediately plunge-frozen in liquid nitrogen. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "the treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "cover slips"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0180153:cover [Medical Device]
   861   C1707529:Cover [Medical Device]
   861   C1999244:Cover [Functional Concept]
   827   C0337209:slip [Phenomenon or Process]

Phrase: "were"

Phrase: "removed from the well"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0205170:Well [Qualitative Concept]
   770   C0849355:Removed [Qualitative Concept]
   770   C3146287:Well [Manufactured Object]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "rinsed with ice cold PBS"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0456963:Ice cold [Qualitative Concept]
   760   C0009264:Cold [Natural Phenomenon or Process]
   760   C0009443:Cold [Disease or Syndrome]
   760   C0020746:Ice [Inorganic Chemical]
   760   C0234192:Cold [Physiologic Function]
   760   C1720830:PBS [Disease or Syndrome]
   760   C1823521:PBS [Gene or Genome]
   726   C1701810:Rinse [Functional Concept]
   726   C1882955:Rinse [Activity]

Phrase: "for 5 s"

Phrase: "and"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "plunge"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882408:PLUNGE [Phenomenon or Process]

Phrase: "-"

Phrase: "frozen in liquid nitrogen."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0260055:Liquid nitrogen [Element, Ion, or Isotope]
   833   C1550121:Liquid nitrogen [Intellectual Product]
   770   C0016701:Frozen [Natural Phenomenon or Process]
   770   C0028158:Nitrogen [Element, Ion, or Isotope]
   770   C0302908:Liquid [Substance]
   770   C0677542:Frozen [Functional Concept]
   770   C1304698:Liquid [Finding]
   770   C1546699:Liquid NOS [Intellectual Product]
   770   C1550581:nitrogen [Human-caused Phenomenon or Process]
   770   C1561501:Liquid NOS [Substance]
Processing 00000000.tx.154: The frozen monolayers were freeze-dried for 18 h at 50C and carbon coated using a Denton DV502A vacuum evaporator (Denton Vacuum, Moorsetown, NJ). 

Phrase: "The frozen monolayers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0872351:monolayers [Clinical Drug]

Phrase: "were"

Phrase: "freeze-dried for 18 h"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   806   C0016698:freeze-dried [Laboratory Procedure]
   760   C0016701:Freeze [Natural Phenomenon or Process]
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C1512080:Dried [Qualitative Concept]
   760   C2827485:Dried [Body Substance]
   726 E C0011682:Dry [Natural Phenomenon or Process]
   726 E C0205222:Dry [Qualitative Concept]

Phrase: "at 50C"

Phrase: "and"

Phrase: "carbon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007009:Carbon [Element, Ion, or Isotope]

Phrase: "coated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1522408:Coated [Qualitative Concept]
   966 E C0453946:Coat [Manufactured Object]
   966 E C2987482:Coat [Body Part, Organ, or Organ Component]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Denton DV502A vacuum evaporator"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0180765:EVAPORATOR [Medical Device]
   812   C1705655:Evaporator [Manufactured Object]

Phrase: "(Denton Vacuum,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0042221:Vacuum [Natural Phenomenon or Process]

Phrase: "Moorsetown,"

Phrase: "NJ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0027971:NJ [Geographic Area]

Phrase: ")."
Processing 00000000.tx.155: This fixation method does not affect cellular morphology (Fernandez-Segura et al., 1999). 

Phrase: "This fixation method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025663:Method [Intellectual Product]
   861   C0449851:Method [Functional Concept]
   861   C0871511:METHOD [Intellectual Product]

Phrase: "does"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "cellular morphology"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0243091:cellular morphology [Qualitative Concept]
  1000   C1521816:Cellular Morphology [Clinical Attribute]
  1000   C2700385:Cellular Morphology [Biomedical Occupation or Discipline]
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "(Fernandez-Segura et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.156: Imaging was conducted using a LEO 982 field emission scanning electron microscope (Leo Electron Microscopy Inc., Thornwood, NY). 

Phrase: "Imaging"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0011923:Imaging [Diagnostic Procedure]
  1000   C0079595:Imaging [Diagnostic Procedure]
   966 E C1704254:Image [Intellectual Product]
   966 E C1704922:Image [Entity]
   966 E C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "conducted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0004927:Conduct [Individual Behavior]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a LEO 982 field emission scanning electron microscope"
Meta Candidates (Total=19; Excluded=3; Pruned=0; Remaining=16)
   845   C0262878:Scanning Electron Microscope [Medical Device]
   818   C0181845:Electron Microscope [Medical Device]
   801   C2986746:Emission scan [Diagnostic Procedure]
   795   C0013852:Electron [Quantitative Concept]
   795   C0034606:Scanning [Diagnostic Procedure]
   795   C0181839:Microscope [Medical Device]
   795   C0233929:Emission [Body Substance]
   795   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   795   C0441633:Scanning [Diagnostic Procedure]
   795   C1521738:Field [Conceptual Entity]
   795   C1706379:Microscope [Medical Device]
   795   C2346620:Field [Conceptual Entity]
   795   C2349184:Field [Conceptual Entity]
   795   C2349995:Emission [Substance]
   795   C3463986:Electron [Bird]
   795   C3539073:FIELD [Spatial Concept]
   762 E C2826292:SCAN [Finding]
   724 E C0013850:Electronic [Manufactured Object]
   724 E C1547561:Electronic [Idea or Concept]

Phrase: "(Leo Electron Microscopy Inc.,"

Phrase: "Thornwood,"

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.157: Real-time PCR analysis of gene expression. 

Phrase: "Real-time PCR analysis of gene expression."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   804   C1880945:Gene Expression Analysis [Molecular Biology Research Technique]
   800   C1718396:Time of analysis [Temporal Concept]
   778   C0200931:PCR analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   748   C0677874:pCR [Finding]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
Processing 00000000.tx.158: N2a cells were treated with Al-malt for 24 h, followed by preservation of RNA with RNAlater (Qiagen, Valencia, CA) according to manufacturer's directions. 

Phrase: "N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "for 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "followed by preservation of RNA"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0332283:Followed by [Temporal Concept]
           followed
   760   C0033085:Preservation [Laboratory Procedure]
   760   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C1514402:Preservation [Laboratory Procedure]
   726 E C1719822:Follow [Intellectual Product]

Phrase: "with RNAlater"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882529:RNALater [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Qiagen,"

Phrase: "Valencia,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1217267:Valencia [Fish]
   928 E C1553365:Valencian [Population Group]

Phrase: "CA) according to manufacturer's directions."
Processing 00000000.tx.159: Total cellular RNA was isolated using RNeasy kits (Qiagen) according to the instructions provided. 

Phrase: "Total cellular RNA"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   827   C0007634:Cellular [Cell]
   827   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]
   827   C0178539:Cellular [Functional Concept]
   827   C0439175:% total [Quantitative Concept]
   827   C0439810:Total [Qualitative Concept]
   755 E C1516377:Cellularity [Qualitative Concept]

Phrase: "was"

Phrase: "isolated"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205409:Isolated [Functional Concept]
  1000   C1548221:Isolated [Idea or Concept]
   966 E C0370215:Isolate [Substance]
   966 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "RNeasy kits"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C1690540:Kits [Qualitative Concept]
   827 E C0812225:KIT [Medical Device]
   827 E C1150635:KIT [Molecular Function]
   827 E C1705212:Kit [Medical Device]
   827 E C1705213:KIT [Medical Device]
   827 E C3273202:Kit [Manufactured Object]

Phrase: "(Qiagen"

Phrase: ")"

Phrase: "according to the instructions"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302828:instructions [Intellectual Product]
  1000   C1442085:Instructions [Idea or Concept]
  1000   C3263700:Instructions [Clinical Attribute]
   966 E C0039401:Instruction [Educational Activity]

Phrase: "provided."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]
Processing 00000000.tx.160: One microgram of RNA was reverse-transcribed using oligo dT and 60 U of Superscript II (Life Technologies, Grand Island, NY). 

Phrase: "One microgram of RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439211:microgram [Quantitative Concept]

Phrase: "was"

Phrase: "reverse-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555029:Reverse [Idea or Concept]

Phrase: "transcribed"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "oligo dT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0069417:oligo (dT) [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C3539739:DT [Gene or Genome]
   861   C3542920:DT [Idea or Concept]

Phrase: "and"

Phrase: "60 U of Superscript II"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   797   C1421413:U-II [Gene or Genome]

Phrase: "(Life Technologies,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:technologies [Occupation or Discipline]

Phrase: "Grand Island,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022130:Island [Geographic Area]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.161: Real-time Sybr Green primers (see Table 1) for Bcl-2, Bax, Mdm2, p53 and GAPDH (reference gene) were designed using Beacon Designer (PREMIER, Biosoft International, Palo Alto, CA). 

Phrase: "Real-time Sybr Green primers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "for Bcl-2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "Bax,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "Mdm2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812222:MDM2 [Gene or Genome]
  1000   C0971008:MDM2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "and"

Phrase: "GAPDH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414968:GAPDH [Gene or Genome]

Phrase: "(reference gene"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0017337:Gene [Gene or Genome]

Phrase: ")"

Phrase: "were"

Phrase: "designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Beacon Designer"

Phrase: "(PREMIER,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309847:PREMIER [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "Biosoft International, Palo Alto,"

Phrase: "CA)."
Processing 00000000.tx.162: Template was combined with primers and 2X Taqman Universal Sybr Green PCR Master Mix (contains PCR buffer, passive reference dye ROX, deoxynucleotides, uridine, uracil-N-glycosylase, and AmpliTaq Gold DNA polymerase; Perkin-Elmer, Applied Biosystems, Foster City, CA) in a 25-l reaction volume, and amplification was performed using an ABI Prism 7900HT (PE, Applied Biosystems) real-time thermal cycler. 

Phrase: "Template"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0728990:TEMPLATE [Medical Device]
  1000   C1514575:Template [Conceptual Entity]
  1000   C1705542:Template [Idea or Concept]

Phrase: "was"

Phrase: "combined with primers"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0205195:Combined [Qualitative Concept]
   756   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   756 E C0336789:Combine [Manufactured Object]

Phrase: "and"

Phrase: "2X Taqman Universal Sybr Green PCR Master Mix"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205430:Mix [Functional Concept]
   793   C1421951:MIX [Gene or Genome]
   793   C1720722:Mix [Qualitative Concept]

Phrase: "("

Phrase: "contains"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "PCR buffer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "passive reference dye ROX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1417222:ROX [Gene or Genome]

Phrase: "deoxynucleotides,"

Phrase: "uridine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0041984:Uridine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "uracil-N-glycosylase,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0077845:Uracil N-Glycosylase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C1817832:glycosylase [Molecular Function]

Phrase: "and"

Phrase: "AmpliTaq Gold DNA polymerase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0012892:DNA Polymerase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   812   C1335439:Polymerase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "; Perkin-Elmer,"

Phrase: "Applied Biosystems,"

Phrase: "Foster City,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0008848:City [Geographic Area]
   861   C0242298:foster [Daily or Recreational Activity]
   861   C0344349:foster [Family Group]
   861   C3262831:City [Clinical Attribute]

Phrase: "CA) in a 25-l reaction volume,"

Phrase: "and"

Phrase: "amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1517480:Amplification [Molecular Biology Research Technique]
  1000   C1521871:Amplification [Phenomenon or Process]
  1000   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an ABI Prism 7900HT"

Phrase: "(PE,"

Phrase: "Applied Biosystems"

Phrase: ")"

Phrase: "real-time thermal cycler."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1611676:Thermal Cycler [Medical Device]
Processing 00000000.tx.163: Cycling conditions were 2 min at 50C; 

Phrase: "Cycling conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "2 min at 50C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.164: 10 min at 95C; 

Phrase: "10 min at 95C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0456692:/10 min [Temporal Concept]
   770   C0702093:/min [Temporal Concept]

Phrase: ";"
Processing 00000000.tx.165: 50 cycles of 92C for 30 s; 

Phrase: "50 cycles of 92C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1511572:Cycle [Temporal Concept]

Phrase: "for 30 s"

Phrase: ";"
Processing 00000000.tx.166: 60C for 1 min. 

Phrase: "60C for 1 min."
Processing 00000000.tx.167: Real-time fluorescence detection was performed during the 60C annealing/extension step of each cycle. 

Phrase: "Real-time fluorescence detection"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C1511790:Detection [Therapeutic or Preventive Procedure]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "performed during the 60C annealing/extension step of each cycle."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   739   C0231448:Extension [Functional Concept]
   739   C0884358:Performed [Functional Concept]
   739   C1261552:Step [Conceptual Entity]
   739   C1511572:Cycle [Temporal Concept]
   739   C1704379:Step [Functional Concept]
   739   C1705117:Step [Quantitative Concept]
   739   C1880641:Extension [Conceptual Entity]
   739   C2825408:Step [Manufactured Object]
   706 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.168: Melt-curve analysis was performed on each primer set to ensure that no primer dimmer or nonspecific amplification was present under the optimized cycling conditions. 

Phrase: "Melt-curve analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "was"

Phrase: "performed on each primer"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0206415:Primer [Nucleic Acid, Nucleoside, or Nucleotide]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "set"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0036849:Set [Mental Process]
  1000   C1442518:Set [Functional Concept]
  1000   C1705195:Set [Conceptual Entity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "no primer dimmer"

Phrase: "or"

Phrase: "nonspecific amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1517480:Amplification [Molecular Biology Research Technique]
   861   C1521871:Amplification [Phenomenon or Process]
   861   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "present under the optimized cycling conditions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
Processing 00000000.tx.169: The fold difference in mRNA expression between treatment groups was determined using the relative quantification method utilizing real-time PCR efficiencies (Pfaffl et al., 2002) and normalized to the housekeeping gene, GAPDH, thus comparing relative CT changes between control and experimental samples. 

Phrase: "The fold difference in mRNA expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1705241:*Difference [Quantitative Concept]
   753   C1705242:Difference [Qualitative Concept]

Phrase: "between treatment groups"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705169:Treatment [Conceptual Entity]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the relative quantification method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "utilizing"

Phrase: "real-time PCR efficiencies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0013682:efficiencies [Quantitative Concept]
   756   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   729 E C0442799:Efficient [Qualitative Concept]

Phrase: "(Pfaffl et al.,"

Phrase: "2002"

Phrase: ")"

Phrase: "and"

Phrase: "normalized to the housekeeping gene,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C1334046:House-keeping Gene [Gene or Genome]
   760   C0017337:Gene [Gene or Genome]
   760   C0020053:Housekeeping [Occupational Activity]
   760   C1882115:Normalized [Research Activity]

Phrase: "GAPDH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1414968:GAPDH [Gene or Genome]

Phrase: "thus"

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "relative CT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "changes between control"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0243148:control [Qualitative Concept]
   790   C0392747:Change [Functional Concept]
   790   C0443172:change [Quantitative Concept]
   790   C1550141:Control [Substance]
   790   C1705241:Change [Quantitative Concept]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "experimental samples."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]
Processing 00000000.tx.170: Prior to conducting statistical analyses, the fold change from the mean of the control group was calculated for each individual sample (including individual control samples to assess variability in this group). 

Phrase: "Prior to conducting statistical analyses,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   884   C0871424:statistical analysis [Research Activity]
   793   C0002778:Analysis [Laboratory Procedure]
   793   C0936012:Analysis [Research Activity]
   793   C1524024:analysis [Functional Concept]

Phrase: "the fold change from the mean of the control group"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1880833:Fold Change [Quantitative Concept]
   757   C0025320:The change [Physiologic Function]
   739   C0392747:Change [Functional Concept]
   739   C0443172:change [Quantitative Concept]
   739   C1705241:Change [Quantitative Concept]

Phrase: "was"

Phrase: "calculated for each individual sample"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0027361:Individual [Population Group]
   760   C0237401:Individual [Human]
   760   C0370003:Sample [Substance]
   760   C0444686:Calculated [Functional Concept]
   760   C1441506:Calculated [Activity]
   760   C1443182:Calculated [Laboratory Procedure]
   760   C2347026:Sample [Conceptual Entity]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "individual control samples to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0370003:Sample [Substance]
   779   C2347026:Sample [Conceptual Entity]

Phrase: "assess"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1516048:Assess [Activity]

Phrase: "variability in this group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2827666:Variability [Conceptual Entity]

Phrase: ")."
Processing 00000000.tx.171: View this table: [in this window] [in a new window]  TABLE 1 Sybr Green Primer Sets Designed Using Beacon Designer  Statistical analysis. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE 1 Sybr Green Primer Sets"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0036849:Set [Mental Process]
   799   C1442518:Set [Functional Concept]
   799   C1705195:Set [Conceptual Entity]

Phrase: "Designed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1707689:Design [Activity]
   966   C2983265:DESIGN [Intellectual Product]

Phrase: "Using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Beacon Designer  Statistical analysis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0871424:statistical analysis [Research Activity]
   812   C0002778:Analysis [Laboratory Procedure]
   812   C0936012:Analysis [Research Activity]
   812   C1524024:analysis [Functional Concept]
Processing 00000000.tx.172: All statistical analyses were performed using Minitab statistical software (Minitab Inc., State College, PA). 

Phrase: "All statistical analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0871424:statistical analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "were"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Minitab statistical software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Minitab Inc.,"

Phrase: "State College,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0557806:College [Manufactured Object]
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "PA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.173: Treatment effects were determined using one-way analysis of variance followed by Tukey's post hoc analysis. 

Phrase: "Treatment effects"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   966   C1518681:Treatment Effect [Finding]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1280500:effects [Qualitative Concept]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "one-way analysis of variance"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C1709320:One-way Analysis of Variance [Quantitative Concept]
   862   C0002780:Analysis of Variance [Quantitative Concept]
           Variance Analysis
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "followed by Tukey's post hoc analysis."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332283:Followed by [Temporal Concept]
           followed
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0687676:Post [Temporal Concept]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1704687:Post [Manufactured Object]
   719 E C1719822:Follow [Intellectual Product]
Processing 00000000.tx.174: A value of p < 0.05 was considered significant unless indicated otherwise.  

Phrase: "A value of p < 0.05"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1522609:Value [Quantitative Concept]

Phrase: "was"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "significant"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0237881:significant [Quantitative Concept]
  1000   C0750502:Significant [Idea or Concept]
  1000   C1546944:Significant [Qualitative Concept]

Phrase: "unless"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "otherwise."
Processing 00000000.tx.175: RESULTS TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Al-Malt Induces Cell Death in Neuro-2a Cells The complex speciation chemistry of Al presents a difficulty when comparing the cytotoxicity of various forms used for in vitro experiments. 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Al-Malt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0024651:malt [Food]
   861   C2985262:MALT [Qualitative Concept]

Phrase: "Induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "Cell Death in Neuro-2a Cells"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0007587:Cell Death [Cell Function]
           cells death
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "The complex speciation chemistry of Al"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0007996:Chemistry [Occupation or Discipline]
   753   C0079107:chemistry [Classification]
   753   C0201682:Chemistry [Laboratory Procedure]

Phrase: "presents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "a difficulty"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1299586:Difficulty [Finding]
   928 E C0332218:Difficult [Qualitative Concept]

Phrase: "when"

Phrase: "comparing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1707455:Compare [Activity]

Phrase: "the cytotoxicity of various forms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596402:cytotoxicity [Cell or Molecular Dysfunction]

Phrase: "used for in vitro experiments."
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   806   C0021135:In Vitro [Intellectual Product]
   806   C1533691:in vitro [Qualitative Concept]
           vitro
   806   C2827718:In Vitro [Functional Concept]
   760   C0681814:Experiments [Research Activity]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1706386:Experiment [Conceptual Entity]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.176: Our first goal was to determine the susceptibility of N2a cells to an inorganic and an organic form of Al. 

Phrase: "Our first goal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0018017:Goal [Intellectual Product]
   861   C1571704:Goal [Idea or Concept]

Phrase: "was"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the susceptibility of N2a cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0012655:Susceptibility [Clinical Attribute]
   753   C0220898:Susceptibility [Organism Attribute]
   753   C1264642:Susceptibility [Functional Concept]
   753   C1547045:*Susceptibility [Quantitative Concept]

Phrase: "to an inorganic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881215:Inorganic [Conceptual Entity]

Phrase: "and"

Phrase: "an organic form of Al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]
Processing 00000000.tx.177: Treatment of N2a cells for 24 h with up to 1000 M of AlCl3 did not induce cell death as indicated by the MTT cytotoxicity assay (Fig. 1). 

Phrase: "Treatment of N2a cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "with"

Phrase: "up to 1000 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "of AlCl3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0102840:AlCl3 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "as"

Phrase: "indicated by the MTT cytotoxicity assay"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0201622:Cytotoxicity assay [Laboratory Procedure]
   783   C2986858:MTT Assay [Research Activity]
   753   C0005507:Assay [Laboratory Procedure]
   753   C0243073:assay [Qualitative Concept]
   753   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   753   C0647210:mtt [Lipid]
   753   C1444656:Indicated [Finding]
   753   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.178: In contrast, a dose-dependent increase in cell death was observed in N2a cells treated with Al-malt. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "a dose-dependent increase in cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0007587:Cell Death [Cell Function]
   799   C0011065:Death [Organism Function]
   799   C1306577:Death, NOS [Finding]

Phrase: "was"

Phrase: "observed in N2a cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "treated with Al-malt."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.179: Mitochondrial function was reduced to 80 and 40% of control levels in cells treated with 250 and 500 M Al-malt, respectively, for 24 h (Fig. 1). 

Phrase: "Mitochondrial function"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "was"

Phrase: "reduced to 80"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0392756:Reduced [Qualitative Concept]

Phrase: "and"

Phrase: "40% of control levels"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   770   C0243148:control [Qualitative Concept]
   770   C0439509:/40 [Temporal Concept]
   770   C0441889:Levels [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737 E C0456079:Level [Classification]
   737 E C1547707:Level [Geographic Area]
   737 E C2946261:Level [Pharmacologic Substance]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with 250"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "500 M Al-malt,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0081548:aluminum maltolate [Organic Chemical]
   812   C0002367:Aluminium [Element, Ion, or Isotope]
   812   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "respectively,"

Phrase: "for 24 h (Fig. 1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   875   C0700308:h 1 [Element, Ion, or Isotope]
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0349966:Fig [Food]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]
   812   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.180: Previously, it was reported that maltolate can cause cell death in N2a cells (Hironishi et al., 1996). 

Phrase: "Previously,"

Phrase: "it"

Phrase: "was"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that maltolate"

Phrase: "can"

Phrase: "cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "cell death in N2a cells"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0007587:Cell Death [Cell Function]
           cells death
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]

Phrase: "(Hironishi et al.,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.181: Therefore, we tested the ability of maltolate to induce cell death in our system. 

Phrase: "Therefore,"

Phrase: "we"

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "the ability of maltolate to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cell death in our system."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0007587:Cell Death [Cell Function]
   760   C0007634:Cell [Cell]
   760   C0011065:Death [Organism Function]
   760   C1269647:Cell [Cell]
   760   C1306577:Death, NOS [Finding]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.182: Since three molecules of maltolate are bound to each ion of Al, we used 3x molar concentration of maltolate as an appropriate control group. 

Phrase: "Since"

Phrase: "three molecules of maltolate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0567416:molecules [Substance]

Phrase: "are"

Phrase: "bound to each ion of Al,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C2346726:Aluminum Ion [Element, Ion, or Isotope]
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0022023:Ion [Element, Ion, or Isotope]
   753   C0332297:bound [Spatial Concept]
   753   C1145667:Bound [Activity]
   753   C1167622:Bound [Molecular Function]
   753   C1689898:% bound [Quantitative Concept]
   753   C1700702:ION [Functional Concept]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]
   753   C2349209:Bound [Conceptual Entity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "3x molar concentration of maltolate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0026367:Molar [Body Part, Organ, or Organ Component]
   760   C0086045:Concentration [Mental Process]
   760   C1446561:Concentration [Quantitative Concept]

Phrase: "as an appropriate control group."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   901   C0009932:Control Group [Group]
   827   C0243148:control [Qualitative Concept]
   827   C0441833:Group [Idea or Concept]
   827   C0687744:group [Population Group]
   827   C1257890:Group [Population Group]
   827   C1550141:Control [Substance]
   827   C1552516:Group [Health Care Related Organization]
   827   C1705428:Group [Conceptual Entity]
   827   C1705429:Group [Population Group]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]
Processing 00000000.tx.183: Contrary to the results of Hironishi et al. 

Phrase: "Contrary to the results of Hironishi et al."
Processing 00000000.tx.184: (1996) we did not observe any change in viable cell number by the MTT assay (Fig. 1). 

Phrase: "(1996"

Phrase: ")"

Phrase: "we"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observe"

Phrase: "any change in viable cell number"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0392747:Change [Functional Concept]
   753   C0443172:change [Quantitative Concept]
   753   C1705241:Change [Quantitative Concept]

Phrase: "by the MTT assay"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "(Fig. 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.185: It can be concluded that 24-h exposure is insufficient for the manifestation of maltolate toxicity in N2a cells. 

Phrase: "It"

Phrase: "can"

Phrase: "be"

Phrase: "concluded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0917903:conclude [Biomedical or Dental Material,Organic Chemical]

Phrase: "that 24-h exposure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0274281:Exposure, NOS [Injury or Poisoning]
   827   C0332157:Exposure [Clinical Attribute]

Phrase: "is"

Phrase: "insufficient for the manifestation of maltolate toxicity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205412:Insufficient [Qualitative Concept]
   748   C0231180:Insufficient [Qualitative Concept]

Phrase: "in N2a cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.186: N2a cells exposed to 1500 M maltolate did show a small decrease in viability, although the effect was not significant. 

Phrase: "N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "exposed to 1500 M maltolate"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0332157:Exposed to [Clinical Attribute]
           Exposed
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "did"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a small decrease in viability,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]

Phrase: "although"

Phrase: "the effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "not significant."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]
Processing 00000000.tx.187: Perhaps toxicity would be evident at 72 h, as seen previously in this cell line (Hironishi et al., 1996) and in brain rotation aggregate cultures (Johnson and Sharma, 2003). 

Phrase: "Perhaps toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   861   C0040539:toxicity [Qualitative Concept]
   861   C0600688:Toxicity [Injury or Poisoning]
   789 E C1407029:Toxic [Qualitative Concept]
   768 E C0032346:Poison [Hazardous or Poisonous Substance]
   768 E C1548769:Poison [Intellectual Product]
   768 E C1550590:poison [Idea or Concept]

Phrase: "would"

Phrase: "be"

Phrase: "evident at 72 h,"

Phrase: "as"

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "previously in this cell line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0007600:Cell Line [Cell]
   760   C0007634:Cell [Cell]
   760   C0205132:Line [Spatial Concept]
   760   C1269647:Cell [Cell]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "(Hironishi et al.,"

Phrase: "1996"

Phrase: ")"

Phrase: "and in brain rotation aggregate cultures"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C0010453:Cultures [Idea or Concept]
   753   C0035868:Rotation [Functional Concept]
   753   C0205418:Aggregate [Qualitative Concept]
   753   C0677597:Rotation [Functional Concept]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1515981:And [Idea or Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "(Johnson"

Phrase: "and"

Phrase: "Sharma,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.188: The findings of the mitochondrial MTT assay were confirmed by examining the release of lactate dehydrogenase (LDH) from the cells. 

Phrase: "The findings of the mitochondrial MTT assay"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C2607943:findings [Functional Concept]
   748   C2926606:Findings [Clinical Attribute]
   748   C3539655:Findings [Intellectual Product]
   714 E C0037088:Finding [Sign or Symptom]
   714 E C0243095:Finding [Finding]
   714 E C2825141:Finding [Finding]

Phrase: "were"

Phrase: "confirmed by examining"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0332128:examining [Finding]
   790   C0750484:Confirmed [Idea or Concept]
   790   C2004054:Examining [Activity]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "the release of lactate dehydrogenase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(LDH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "from the cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.189: Figure 1 indicates that Al-malt induced a dose-dependent increase in the release of LDH, indicating a loss of integrity of the cell membrane. 

Phrase: "Figure 1"

Phrase: "indicates"

Phrase: "that Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a dose-dependent increase in the release of LDH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0442805:Increase [Functional Concept]

Phrase: "indicating"

Phrase: "a loss of integrity of the cell membrane."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1517945:Loss [Quantitative Concept]
Processing 00000000.tx.190: The increase was significant at concentrations above 62.5 M. 

Phrase: "The increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "significant at concentrations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0237881:significant [Quantitative Concept]
   790   C0750502:Significant [Idea or Concept]
   790   C1546944:Significant [Qualitative Concept]

Phrase: "above 62.5 M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.191: Maltolate alone did not increase LDH release from N2a cells (data not shown). 

Phrase: "Maltolate"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "LDH release from N2a cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030685:Release [Health Care Activity]
   748   C0391871:Release [Functional Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.192: View larger version (18K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.193: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.194: The effects of two different aluminum compounds on the viability of N2a neuroblastoma cells. 

Phrase: "The effects of two different aluminum compounds"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C1280500:effects [Qualitative Concept]
   714 E C2348382:Effect [Qualitative Concept]

Phrase: "on the viability"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:viability [Qualitative Concept]

Phrase: "of N2a neuroblastoma cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   844   C0815000:neuroblastoma cell [Cell]
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.195: Cells were treated with AlCl3 (11000 M), Al-malt (62.5500 M), and maltolate (1500 M) at the indicated concentrations for 24 h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with AlCl3"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C0102840:AlCl3 [Inorganic Chemical,Pharmacologic Substance]
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "(11000"

Phrase: "M)"

Phrase: ","

Phrase: "Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(62.5500"

Phrase: "M)"

Phrase: ","

Phrase: "and"

Phrase: "maltolate"

Phrase: "(1500"

Phrase: "M) at the indicated concentrations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086045:Concentrations [Mental Process]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1444656:Indicated [Finding]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.196: The relative number of live cells was then determined using the MTT assay. 

Phrase: "The relative number of live cells"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0007584:Cell Number [Laboratory Procedure]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the MTT assay."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C2986858:MTT Assay [Research Activity]
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C0647210:mtt [Lipid]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.197: The dotted line represents the LDH release (% of total) from cells treated with Al-malt (62.5500 M). 

Phrase: "The dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the LDH release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   734   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(%"

Phrase: "of total"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439175:% total [Quantitative Concept]
  1000   C0439810:Total [Qualitative Concept]

Phrase: ")"

Phrase: "from cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(62.5500"

Phrase: "M)."
Processing 00000000.tx.198: Mean  SE (n = 5 wells/treatment). 

Phrase: "Mean  SE (n = 5 wells/treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0039798:treatment [Functional Concept]
   799   C0087111:Treatment [Therapeutic or Preventive Procedure]
   799   C1522326:Treatment [Functional Concept]
   799   C1533734:Treatment [Therapeutic or Preventive Procedure]
   799   C1705169:Treatment [Conceptual Entity]
   799   C3538994:TREATMENT [Research Activity]

Phrase: ")."
Processing 00000000.tx.199: Data are representative of three independent experiments with similar results. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.200: Significantly different from the control group at *p < 0.01, **p < 0.001.  

Phrase: "Significantly different from the control group at *p < 0.01,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1705242:Different [Qualitative Concept]

Phrase: "*"

Phrase: "*p < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.201: The toxicity of Al-malt was also evident in the marked drop in DNA synthesis by 24 h of treatment (Fig. 2). 

Phrase: "The toxicity of Al-malt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "was"

Phrase: "also evident in the marked drop"

Phrase: "in DNA synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598312:DNA Synthesis [Genetic Function]
  1000   C1328870:DNA synthesis [Laboratory Procedure]
  1000   C1817262:DNA synthesis [Genetic Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "by 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "of treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.202: Incorporation of 3H-thymidine into N2a was completely abolished by 500 M Al-malt. 

Phrase: "Incorporation of 3H-thymidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0243126:incorporation [Functional Concept]

Phrase: "into N2a"

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "abolished by 500 M Al-malt."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0081548:aluminum maltolate [Organic Chemical]
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.203: Maltolate alone did not decrease DNA synthesis at the doses tested. 

Phrase: "Maltolate"

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "decrease"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "DNA synthesis at the doses"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   806   C0598312:DNA Synthesis [Genetic Function]
   806   C1328870:DNA synthesis [Laboratory Procedure]
   806   C1817262:DNA synthesis [Genetic Function]
   762 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0220781:synthesis [Biologic Function]
   760   C1883254:Synthesis [Activity]

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.204: All concentrations of maltolate except for 1500 M induced DNA synthesis in N2a cells, indicative of a proliferative effect (Fig. 2). 

Phrase: "All concentrations of maltolate"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "except for 1500 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "DNA synthesis in N2a cells,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0598312:DNA Synthesis [Genetic Function]
   790   C1328870:DNA synthesis [Laboratory Procedure]
   790   C1817262:DNA synthesis [Genetic Function]
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]
   748 E C0598279:synthetic DNA [Nucleic Acid, Nucleoside, or Nucleotide]
   748   C2936320:Synthetic Cells [Manufactured Object]

Phrase: "indicative of a proliferative effect"

Phrase: "(Fig. 2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.205: These findings confirm that the enhanced toxicity of Al-malt is specific for the complex and not simply due to the presence of maltolate. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the enhanced toxicity of Al-malt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0040539:toxicity [Qualitative Concept]
   753   C0600688:Toxicity [Injury or Poisoning]

Phrase: "is"

Phrase: "specific for the complex"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205369:Specific [Qualitative Concept]
   770   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "not simply due to the presence of maltolate."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0678226:Due to [Functional Concept]
           due
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1518422:Not [Functional Concept]
   744   C3146286:Due [Idea or Concept]
   731   C0332197:Not Present [Quantitative Concept]
   731   C1549059:not present [Qualitative Concept]
Processing 00000000.tx.206: View larger version (12K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(12K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.207: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.208: Treatment of N2a cells with Al-malt reduced DNA synthesis, an index of proliferation. 

Phrase: "Treatment of N2a cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with Al-malt reduced DNA synthesis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0598312:DNA Synthesis [Genetic Function]
   840   C1328870:DNA synthesis [Laboratory Procedure]
   840   C1817262:DNA synthesis [Genetic Function]
   804   C0220781:synthesis [Biologic Function]
   804   C1883254:Synthesis [Activity]

Phrase: "an index of proliferation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0812425:proliferation index [Laboratory or Test Result]
   819   C1514489:Proliferation Index [Quantitative Concept]
   770   C0918012:Index [Intellectual Product]
   770   C1552854:index [Idea or Concept]
   770   C1637833:% index [Quantitative Concept]
Processing 00000000.tx.209: Cells were treated with Al-malt (62.5500 M) and maltolate (1500 M) at the indicated concentrations for 24 h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(62.5500"

Phrase: "M)"

Phrase: "and"

Phrase: "maltolate"

Phrase: "(1500"

Phrase: "M) at the indicated concentrations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086045:Concentrations [Mental Process]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1444656:Indicated [Finding]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.210: 3H-Thymidine was then added for an additional 4 h, and DNA synthesis was determined according to the Materials and Methods. 

Phrase: "3H-Thymidine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040077:Thymidine [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1442460:3H [Temporal Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "added for an additional 4 h,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   753   C0033727:H+ [Element, Ion, or Isotope]
   753   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441932:H+ [Classification]
   753   C0564385:/h [Quantitative Concept]
   753   C1524062:Added [Functional Concept]
           Additional
   719 E C1883712:Add [Functional Concept]

Phrase: "and"

Phrase: "DNA synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0598312:DNA Synthesis [Genetic Function]
  1000   C1328870:DNA synthesis [Laboratory Procedure]
  1000   C1817262:DNA synthesis [Genetic Function]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "was"

Phrase: "determined according to the Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520510:Materials [Substance]
   760   C0680240:according [Social Behavior]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.211: Mean  SE (n = 5 wells/treatment). 

Phrase: "Mean  SE (n = 5 wells/treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0039798:treatment [Functional Concept]
   799   C0087111:Treatment [Therapeutic or Preventive Procedure]
   799   C1522326:Treatment [Functional Concept]
   799   C1533734:Treatment [Therapeutic or Preventive Procedure]
   799   C1705169:Treatment [Conceptual Entity]
   799   C3538994:TREATMENT [Research Activity]

Phrase: ")."
Processing 00000000.tx.212: Data are representative of three independent experiments with similar results. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.213: Significantly different from the control group at *p < 0.05, **p < 0.001.  

Phrase: "Significantly different from the control group at *p < 0.05,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1705242:Different [Qualitative Concept]

Phrase: "*"

Phrase: "*p < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.214: Apoptosis and Necrosis Are Involved in Al-Malt Neurotoxicity Dual staining with cell-permeant acridine orange and cell-impermeant ethidium bromide is an effective flow cytometric method for discriminating apoptotic from necrotic cell death (Lecoeur, 2002). 

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "Necrosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027540:Necrosis [Organ or Tissue Function]
  1000   C1334928:Necrosis [Finding]

Phrase: "Are"

Phrase: "Involved in Al-Malt Neurotoxicity Dual staining"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0002367:Aluminium [Element, Ion, or Isotope]
   748   C0024651:malt [Food]
   748   C0235032:Neurotoxicity [Injury or Poisoning]
   748   C0487602:Staining [Laboratory Procedure]
   748   C1314939:Involved [Functional Concept]
   748   C1554184:Dual [Intellectual Product]
   748   C1704680:Staining [Finding]
   748   C2348254:ALUMINUM [Element, Ion, or Isotope]
   748   C2985262:MALT [Qualitative Concept]

Phrase: "with cell-permeant acridine orange"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0001185:Acridine Orange [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0001186:Acridine [Organic Chemical]
   812   C0440277:Orange [Food]
   812   C0475654:orange [Food]
   812   C1313858:Orange [Qualitative Concept]

Phrase: "and"

Phrase: "cell-impermeant ethidium bromide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   812   C0006222:Bromide [Inorganic Chemical]
   812   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]

Phrase: "is"

Phrase: "an effective flow cytometric method for discriminating"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "apoptotic from necrotic cell death"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C0162638:apoptotic cell death [Cell Function]
   760   C1516044:Apoptotic [Qualitative Concept]

Phrase: "(Lecoeur,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.215: Live cells (Fig. 3, population L) stain with acridine orange and fluoresce green with low orange-red signal from ethidium bromide. 

Phrase: "Live cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "L)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "stain with acridine orange"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   881   C0001185:Acridine orange stain [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
           Acridine Orange
   770   C0001186:Acridine [Organic Chemical]
   770   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   770   C0440277:Orange [Food]
   770   C0475654:orange [Food]
   770   C1313858:Orange [Qualitative Concept]

Phrase: "and"

Phrase: "fluoresce"

Phrase: "green with low orange-red signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332583:Green [Qualitative Concept]

Phrase: "from ethidium bromide."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.216: Apoptotic cells (Fig. 3, population Ap) exhibit a reduced green fluorescence but maintain a low ethidium bromide signal. 

Phrase: "Apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "Ap)"

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a reduced green fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "but"

Phrase: "maintain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "a low ethidium bromide signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.217: The reduction in acridine orange signal is likely due to nuclear fragmentation and cell shrinkage. 

Phrase: "The reduction in acridine orange signal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0301630:Reduction [Natural Phenomenon or Process]
   753   C0392756:Reduction [Qualitative Concept]
   753   C0441610:Reduction [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "likely due to nuclear fragmentation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0678226:Due to [Functional Concept]
           due
   760   C0332148:Likely [Qualitative Concept]
   760   C0332472:Fragmentation [Anatomical Abnormality]
   760   C0521447:Nuclear [Spatial Concept]
   760   C0750492:Likely [Idea or Concept]
   760   C1881708:FRAGMENTATION [Phenomenon or Process]
   760   C3146286:Due [Idea or Concept]

Phrase: "and"

Phrase: "cell shrinkage."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332513:Shrinkage [Functional Concept]
Processing 00000000.tx.218: Necrotic cells (Fig. 3, population N) lose the ability to exclude ethidium bromide and, as a result, fluoresce as bright orange-red (Fig. 3). 

Phrase: "Necrotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032659:Population [Quantitative Concept]
  1000   C1257890:Population [Population Group]

Phrase: "N)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "lose"

Phrase: "the ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "exclude"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332196:Exclude [Functional Concept]
  1000   C2828389:Exclude [Activity]

Phrase: "ethidium bromide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0019873:Ethidium Bromide [Organic Chemical,Pharmacologic Substance]
   861   C0006222:Bromide [Inorganic Chemical]
   861   C0015008:Ethidium [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: ","

Phrase: "as"

Phrase: "a result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "fluoresce as bright orange-red"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   797   C1096868:Bright Red [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   797   C1272329:Bright red [Finding]
   760   C0332575:Red [Finding]
   760   C0423899:Bright [Finding]
   760   C0440277:Orange [Food]
   760   C0475654:orange [Food]
   760   C1260956:Red [Qualitative Concept]
   760   C1313858:Orange [Qualitative Concept]
   760   C3539536:BRIGHT [Gene or Genome]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.219: Treatment of N2a cells with Al-malt resulted in a dose-dependent increase in the apoptotic and the necrotic populations (Figs. 3c3f). 

Phrase: "Treatment of N2a cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "resulted in a dose-dependent increase"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C1512045:Dose-dependent [Quantitative Concept]
   753   C0178602:Dose [Quantitative Concept]
   753   C0442805:Increase [Functional Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C0869039:Dose [Quantitative Concept]
   753   C1114758:Dose # [Clinical Attribute]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "in the apoptotic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1516044:Apoptotic [Qualitative Concept]
   928 E C0162638:Apoptosis [Cell Function]

Phrase: "and"

Phrase: "the necrotic populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "(Figs. 3c3f"

Phrase: ")."
Processing 00000000.tx.220: The group treated with maltolate alone (Fig. 3b) showed a slight increase in the apoptotic population over that of the control (Fig. 3a). 

Phrase: "The group"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0441833:Group [Idea or Concept]
  1000   C0687744:group [Population Group]
  1000   C1257890:Group [Population Group]
  1000   C1552516:Group [Health Care Related Organization]
  1000   C1705428:Group [Conceptual Entity]
  1000   C1705429:Group [Population Group]

Phrase: "treated with maltolate"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522326:Treated [Functional Concept]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(Fig. 3b"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a slight increase in the apoptotic population"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "over that"

Phrase: "of the control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(Fig. 3a"

Phrase: ")."
Processing 00000000.tx.221: This may reflect the beginning of an increase in apoptosis as reported earlier (Hironishi et al., 1996) or may represent a slowing of the normal apoptotic turnover of cells observed in all cell cultures. 

Phrase: "This"

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the beginning of an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439659:Beginning [Temporal Concept]

Phrase: "in apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "as"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "(Hironishi et al.,"

Phrase: "1996"

Phrase: ")"

Phrase: "or"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a slowing of the normal apoptotic turnover of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439834:slowing [Qualitative Concept]

Phrase: "observed in all cell cultures."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0007585:Cell Cultures [Laboratory Procedure]
   760   C0007634:Cell [Cell]
   760   C0010453:Cultures [Idea or Concept]
   760   C1269647:Cell [Cell]
   760   C1441672:Observed [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C0220814:culture [Functional Concept]
   726 E C0430400:Culture [Laboratory Procedure]
   726 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.222: These cell changes in response to Al-malt treatment, nuclear condensation, and cell shrinkage are early events in the apoptotic cascade. 

Phrase: "These cell"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007634:Cell [Cell]
  1000   C1269647:Cell [Cell]
  1000   C1704653:Cell [Medical Device]
  1000   C1948049:Cell [Spatial Concept]

Phrase: "changes in response"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0392747:Change [Functional Concept]
   790   C0443172:change [Quantitative Concept]
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1705241:Change [Quantitative Concept]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to Al-malt treatment,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0081548:aluminum maltolate [Organic Chemical]

Phrase: "nuclear condensation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0233656:Condensation [Mental or Behavioral Dysfunction]
   861   C0598405:condensation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "cell shrinkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332513:Shrinkage [Functional Concept]

Phrase: "are"

Phrase: "early events in the apoptotic cascade."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441471:Events [Event]
   753   C3541888:Events [Classification]
Processing 00000000.tx.223: View larger version (28K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.224: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.225: Al-malt induces apoptosis and necrosis in N2a cells. 

Phrase: "Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "necrosis in N2a cells."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0027540:Necrosis [Organ or Tissue Function]
   760   C1334928:Necrosis [Finding]
Processing 00000000.tx.226: Cells were treated with Al-malt and maltolate at the indicated concentrations for 24 h. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "maltolate at the indicated concentrations"

Phrase: "for 24 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.227: Discrimination of live, apoptotic, and necrotic cell populations was determined using the acridine orange/ethidium bromide flow cytometry assay as outlined in the Materials and Methods. 

Phrase: "Discrimination of live, apoptotic,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012632:Discrimination [Mental Process]
   770   C2987623:Discrimination [Social Behavior]

Phrase: "and"

Phrase: "necrotic cell populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the acridine orange/ethidium bromide flow cytometry assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0005507:Assay [Laboratory Procedure]
   795   C0243073:assay [Qualitative Concept]
   795   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "outlined in the Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.228: Live cells are defined by the oval labeled L, and apoptotic and necrotic populations are labeled Ap and N, respectively. 

Phrase: "Live cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "defined by the oval labeled L,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C1704788:Defined [Conceptual Entity]
   753   C1708632:Labeled [Qualitative Concept]
   753   C1709367:Oval [Qualitative Concept]
   753   C3539106:Defined [Intellectual Product]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "apoptotic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1516044:Apoptotic [Qualitative Concept]
   928 E C0162638:Apoptosis [Cell Function]

Phrase: "and"

Phrase: "necrotic populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "are"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "Ap"

Phrase: "and"

Phrase: "N,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.229: (a) control; 

Phrase: "(a) control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.230: (b) 1500 M maltolate; 

Phrase: "(b) 1500 M maltolate"

Phrase: ";"
Processing 00000000.tx.231: (c) 62.5 M Al-malt; 

Phrase: "(c) 62.5 M Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0081548:aluminum maltolate [Organic Chemical]
   799   C0002367:Aluminium [Element, Ion, or Isotope]
   799   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: ";"
Processing 00000000.tx.232: (d) 125 M Al-malt; 

Phrase: "("

Phrase: "d)"

Phrase: "125 M Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0081548:aluminum maltolate [Organic Chemical]
   812   C0002367:Aluminium [Element, Ion, or Isotope]
   812   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: ";"
Processing 00000000.tx.233: (e) 250 M Al-malt; 

Phrase: "(e) 250 M Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0081548:aluminum maltolate [Organic Chemical]
   804   C0002367:Aluminium [Element, Ion, or Isotope]
   804   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: ";"
Processing 00000000.tx.234: (f) 500 M Al-malt. 

Phrase: "(f) 500 M Al-malt."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0081548:aluminum maltolate [Organic Chemical]
   804   C0002367:Aluminium [Element, Ion, or Isotope]
   804   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.235: Data are representative of three independent experiments with similar results.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.236: The externalization of phosphatidyl serine (PS) is another early event in apoptosis and represents a flag to induce phagocytosis by mononuclear cells (Anderson et al., 2002). 

Phrase: "The externalization of phosphatidyl serine (PS)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   926   C2753858:externalization of phosphatidylserine [Cell Function]

Phrase: "is"

Phrase: "another early event in apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0441471:Event [Event]

Phrase: "and"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a flag to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708067:Flag [Functional Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "phagocytosis by mononuclear cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C2936268:Cell Phagocytosis [Cell Function]
   770   C0031308:Phagocytosis [Cell Function]

Phrase: "(Anderson et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.237: This event was determined using the annexin V binding assay and flow cytometry. 

Phrase: "This event"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441471:Event [Event]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the annexin V binding assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "and"

Phrase: "flow cytometry."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016263:Flow Cytometry [Laboratory Procedure]
   861   C0806140:Flow [Natural Phenomenon or Process]
   861   C0814048:Cytometry [Laboratory Procedure]
Processing 00000000.tx.238: Al-malt concentration-dependently increased the externalization of PS as shown in Figures 4c4f. 

Phrase: "Al-malt concentration-dependently"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0081548:aluminum maltolate [Organic Chemical]
   812   C0002367:Aluminium [Element, Ion, or Isotope]
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   812   C2348254:ALUMINUM [Element, Ion, or Isotope]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the externalization of PS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   926   C2753858:externalization of phosphatidylserine [Cell Function]

Phrase: "as"

Phrase: "shown in Figures 4c4f."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.239: A slight increase in annexin V binding was also observed in the maltolate-treated cultures (Fig. 4b), confirming the findings of the acridine orange/ethidium bromide assay. 

Phrase: "A slight increase in annexin V binding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "also"

Phrase: "observed in the maltolate-treated cultures"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   753   C0010453:Cultures [Idea or Concept]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C1441672:Observed [Functional Concept]
   753   C1522326:Treated [Functional Concept]
   719 E C0220814:culture [Functional Concept]
   719 E C0430400:Culture [Laboratory Procedure]
   719 E C1292734:TREAT [Functional Concept]
   719 E C2242979:Culture [Laboratory Procedure]

Phrase: "(Fig. 4b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the findings of the acridine orange/ethidium bromide assay."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   742   C2607943:findings [Functional Concept]
   742   C2926606:Findings [Clinical Attribute]
   742   C3539655:Findings [Intellectual Product]
   708 E C0037088:Finding [Sign or Symptom]
   708 E C0243095:Finding [Finding]
   708 E C2825141:Finding [Finding]
Processing 00000000.tx.240: Annexin V can also bind to PS on the inner leaflet when the integrity of the plasma membrane is compromised and is indicative of necrosis or secondary necrosis following apoptosis. 

Phrase: "Annexin V"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1332095:ANNEXIN V [Gene or Genome]
   861   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "also"

Phrase: "bind to PS"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0031623:phosphatidylserine [Lipid]
   833   C0301704:Phosphatidyl serine [Lipid]
   770   C0036720:Serine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C1145667:Bind [Activity]
   770   C1167622:bind [Molecular Function]

Phrase: "on the inner leaflet"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1708664:Leaflet [Manufactured Object]
   861   C3273178:Leaflet [Intellectual Product]

Phrase: "when"

Phrase: "the integrity of the plasma membrane"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205266:integrity [Qualitative Concept]
   753   C0872403:integrity [Individual Behavior]
   753   C1947912:Integrity [Qualitative Concept]

Phrase: "is"

Phrase: "compromised"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2945640:compromise [Finding]

Phrase: "and"

Phrase: "is"

Phrase: "indicative of necrosis"

Phrase: "or"

Phrase: "secondary necrosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027540:Necrosis [Organ or Tissue Function]
   861   C1334928:Necrosis [Finding]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.241: To control for this, PI, a cell-impermeant nuclear stain was used. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control for this,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0243148:control [Qualitative Concept]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "PI,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0021966:Iodide [Inorganic Chemical]
   861   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "a cell-impermeant nuclear stain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
   804   C0521447:Nuclear [Spatial Concept]

Phrase: "was"

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.242: Live cells are displayed in the lower left quadrant and are negative for both stains. 

Phrase: "Live cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "displayed in the lower left quadrant"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0439737:lower left quadrant [Spatial Concept]
   753   C0205091:Left [Spatial Concept]
   753   C0441994:Lower [Spatial Concept]
   753   C0870432:displayed [Functional Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C1552822:left [Functional Concept]
   753   C1631280:Quadrant [Spatial Concept]
   753   C2003888:Lower [Activity]
   719 E C1705417:Display [Manufactured Object]

Phrase: "and"

Phrase: "are"

Phrase: "negative for both stains."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205160:Negative [Qualitative Concept]
   770   C1513916:Negative [Finding]
   770   C2825415:Negative [Conceptual Entity]
   770   C2825491:Negative [Qualitative Concept]
Processing 00000000.tx.243: The upper right quadrant of the panels in Figure 4 represents cells that are staining for annexin V and PI and have thus undergone necrotic cell death. 

Phrase: "The upper right quadrant of the panels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   814   C0439734:upper right quadrant [Spatial Concept]
   748   C1631280:Quadrant [Spatial Concept]

Phrase: "in Figure 4"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "that"

Phrase: "are"

Phrase: "staining for annexin V"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1332095:ANNEXIN V [Gene or Genome]
   770   C0065042:Annexin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0487602:Staining [Laboratory Procedure]
   770   C1704680:Staining [Finding]
   737 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "and"

Phrase: "PI"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0033470:Propidium Iodide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0021966:Iodide [Inorganic Chemical]
   861   C0033468:Propidium [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "have"

Phrase: "thus undergone necrotic cell death."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   884   C0027540:necrotic cell death [Organ or Tissue Function]
   840   C0007587:Cell Death [Cell Function]
   804   C0007634:Cell [Cell]
   804   C0011065:Death [Organism Function]
   804   C1269647:Cell [Cell]
   804   C1306577:Death, NOS [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.244: The cells in the lower right quadrant are the early apoptotic cells showing a characteristic redistribution of PS. 

Phrase: "The cells in the lower right quadrant"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   762   C0007634:THE CELL [Cell]
           Cells
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "the early apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a characteristic redistribution of PS."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0332620:Redistribution [Functional Concept]
Processing 00000000.tx.245: The amount of cells in the upper and lower right quadrants were increased by Al-malt. 

Phrase: "The amount of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1265611:Amount [Quantitative Concept]

Phrase: "in the upper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282910:Upper [Spatial Concept]

Phrase: "and"

Phrase: "lower right quadrants"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   966   C0439736:lower right quadrant [Spatial Concept]
   827   C0205090:Right [Spatial Concept]
   827   C0441994:Lower [Spatial Concept]
   827   C1548802:Lower [Body Location or Region]
   827   C2003888:Lower [Activity]
   793 E C0205251:low [Qualitative Concept]
   793 E C1299352:Low [Qualitative Concept]
   793 E C1550472:low [Idea or Concept]
   793   C1631280:Quadrant [Spatial Concept]

Phrase: "were"

Phrase: "increased by Al-malt."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0081548:aluminum maltolate [Organic Chemical]
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0205217:Increased [Quantitative Concept]
   770   C0442805:Increased [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.246: Thus, the annexin V binding assay confirms the coexistence of apoptotic and necrotic cell death in N2a cells treated with Al-malt. 

Phrase: "Thus,"

Phrase: "the annexin V binding assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0005507:Assay [Laboratory Procedure]
   812   C0243073:assay [Qualitative Concept]
   812   C1510438:Assay [Laboratory Procedure]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the coexistence of apoptotic"

Phrase: "and"

Phrase: "necrotic cell death in N2a cells"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0027540:necrotic cell death [Organ or Tissue Function]
   778   C0007587:Cell Death [Cell Function]
           cells death
   748   C0007634:Cell [Cell]
   748   C0011065:Death [Organism Function]
   748   C1269647:Cell [Cell]
   748   C1306577:Death, NOS [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]

Phrase: "treated with Al-malt."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.247: View larger version (21K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.248: 4. 

Phrase: "4."
Processing 00000000.tx.249: Externalization of phosphatidyl serine is induced in cells treated with Al-malt. 

Phrase: "Externalization of phosphatidyl serine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2753858:externalization of phosphatidylserine [Cell Function]

Phrase: "is"

Phrase: "induced in cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0007634:Cells [Cell]
   790   C0205263:Induced [Functional Concept]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "treated with Al-malt."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.250: Cells were treated with Al-malt and maltolate at the indicated concentrations for 24 h, following which annexin V binding was performed according to the Materials and Methods. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "maltolate at the indicated concentrations"

Phrase: "for 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "which annexin V binding"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243122:binding [Functional Concept]
   827   C1145667:Binding [Activity]
   827   C1167622:Binding [Molecular Function]
   734   C0059249:Annexin V [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1332095:ANNEXIN V [Gene or Genome]

Phrase: "was"

Phrase: "performed according to the Materials"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0520510:Materials [Substance]
   760   C0680240:according [Social Behavior]
   760   C0884358:Performed [Functional Concept]
   726 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.251: Live cells are in the lower left quadrant. 

Phrase: "Live cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are in the lower left quadrant."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0439737:lower left quadrant [Spatial Concept]
   753   C0205091:Left [Spatial Concept]
   753   C0441994:Lower [Spatial Concept]
   753   C1548802:Lower [Body Location or Region]
   753   C1551058:Are [Quantitative Concept]
   753   C1552822:left [Functional Concept]
   753   C1631280:Quadrant [Spatial Concept]
   753   C2003888:Lower [Activity]
Processing 00000000.tx.252: The upper right quadrant represents necrotic and late apoptotic cells, and the lower right quadrant represents early apoptotic cells. 

Phrase: "The upper right quadrant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439734:upper right quadrant [Spatial Concept]
   827   C1631280:Quadrant [Spatial Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "necrotic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027540:Necrotic [Organ or Tissue Function]
   928 E C1334928:Necrosis [Finding]

Phrase: "and"

Phrase: "late apoptotic cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the lower right quadrant"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C0439736:lower right quadrant [Spatial Concept]
   827   C0205090:Right [Spatial Concept]
   827   C0441994:Lower [Spatial Concept]
   827   C1548802:Lower [Body Location or Region]
   827   C1631280:Quadrant [Spatial Concept]
   827   C2003888:Lower [Activity]
   793 E C0205251:low [Qualitative Concept]
   793 E C1299352:Low [Qualitative Concept]
   793 E C1550472:low [Idea or Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "early apoptotic cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.253: (a) control; 

Phrase: "(a) control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.254: (b) 1500 M maltolate; 

Phrase: "(b) 1500 M maltolate"

Phrase: ";"
Processing 00000000.tx.255: (c) 62.5 M Al-malt; 

Phrase: "(c) 62.5 M Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0081548:aluminum maltolate [Organic Chemical]
   799   C0002367:Aluminium [Element, Ion, or Isotope]
   799   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: ";"
Processing 00000000.tx.256: (d) 125 M Al-malt; 

Phrase: "("

Phrase: "d)"

Phrase: "125 M Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0081548:aluminum maltolate [Organic Chemical]
   812   C0002367:Aluminium [Element, Ion, or Isotope]
   812   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: ";"
Processing 00000000.tx.257: (e) 250 M Al-malt; 

Phrase: "(e) 250 M Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0081548:aluminum maltolate [Organic Chemical]
   804   C0002367:Aluminium [Element, Ion, or Isotope]
   804   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: ";"
Processing 00000000.tx.258: (f) 500 M Al-malt. 

Phrase: "(f) 500 M Al-malt."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0081548:aluminum maltolate [Organic Chemical]
   804   C0002367:Aluminium [Element, Ion, or Isotope]
   804   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.259: Data are representative of three independent experiments with similar results.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.260: Microscopic analysis of cellular and nuclear morphology also suggests that apoptosis and necrosis are both induced in N2a cells following treatment with Al-malt. 

Phrase: "Microscopic analysis of cellular"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "and"

Phrase: "nuclear morphology also"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1749565:nuclear morphology [Cell Function]
   827   C0332437:Morphology [Qualitative Concept]
   827   C0543482:morphology [Spatial Concept]
   827   C0700329:Morphology, NOS [Finding]
   827   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "necrosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027540:Necrosis [Organ or Tissue Function]
  1000   C1334928:Necrosis [Finding]

Phrase: "are"

Phrase: "both"

Phrase: "induced in N2a cells"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0205263:Induced [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment with Al-malt."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.261: Cells treated with 500 M Al-malt show cellular shrinkage (Fig. 5c) as well as nuclear condensation and fragmentation (Fig. 5d inset, arrow), both hallmark features of apoptosis. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with 500 M Al-malt"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0081548:aluminum maltolate [Organic Chemical]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1522326:Treated [Functional Concept]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "cellular shrinkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332513:Shrinkage [Functional Concept]

Phrase: "(Fig. 5c"

Phrase: ")"

Phrase: "as well as"

Phrase: "nuclear condensation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0233656:Condensation [Mental or Behavioral Dysfunction]
   861   C0598405:condensation [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "fragmentation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332472:Fragmentation [Anatomical Abnormality]
  1000   C1881708:FRAGMENTATION [Phenomenon or Process]

Phrase: "(Fig. 5d inset,"

Phrase: "arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "both hallmark"

Phrase: "features of apoptosis."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0162638:Apoptosis [Cell Function]
   790   C1521970:Feature [Qualitative Concept]
   790   C1706388:Feature [Conceptual Entity]
   790   C2346469:Feature [Qualitative Concept]
   790   C2348519:Feature [Qualitative Concept]
   718 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.262: In addition, treated cells exhibit dramatic membrane blebbing (Fig. 5j, arrow). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "treated cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "dramatic membrane blebbing"

Phrase: "(Fig. 5j,"

Phrase: "arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.263: Signs of necrosis are also evident in the same cultures that display apoptosis. 

Phrase: "Signs of necrosis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0220912:signs [Functional Concept]
   790   C0220913:signs [Manufactured Object]
   790   C0311392:SIGNS [Finding]
   756 E C1547188:Sign [Idea or Concept]

Phrase: "are"

Phrase: "also evident in the same cultures"

Phrase: "that display apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0162638:Apoptosis [Cell Function]
   789 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.264: Cell swelling (Fig. 5c) and loss of membrane integrity without nuclear condensation (Fig. 5d inset, arrow head) are evident in cultures treated with 500 M Al-malt. 

Phrase: "Cell swelling"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013604:SWELLING [Pathologic Function]
   861   C0038999:Swelling [Finding]
   768 E C1709317:Oncosis [Cell Function]

Phrase: "(Fig. 5c"

Phrase: ")"

Phrase: "and"

Phrase: "loss of membrane integrity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1517945:Loss [Quantitative Concept]

Phrase: "without nuclear condensation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0233656:Condensation [Mental or Behavioral Dysfunction]
   861   C0598405:condensation [Natural Phenomenon or Process]

Phrase: "(Fig. 5d inset,"

Phrase: "arrow head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0018670:Head [Body Location or Region]
   861   C1281590:Head [Body Part, Organ, or Organ Component]
   861   C1706305:Head [Manufactured Object]
   805 E C0205096:Cephalic [Spatial Concept]

Phrase: ")"

Phrase: "are"

Phrase: "evident in cultures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   718   C0332120:Evidence [Functional Concept]

Phrase: "treated with 500 M Al-malt."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0081548:aluminum maltolate [Organic Chemical]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1522326:Treated [Functional Concept]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]
   719 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.265: The loss of membrane integrity is also apparent in the scanning electron micrograph of cells treated with Al-malt (Fig. 5j, arrow head). 

Phrase: "The loss of membrane integrity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1517945:Loss [Quantitative Concept]

Phrase: "is"

Phrase: "also apparent in the scanning electron micrograph of cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0750489:apparent [Idea or Concept]

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(Fig. 5j,"

Phrase: "arrow head"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0018670:Head [Body Location or Region]
   861   C1281590:Head [Body Part, Organ, or Organ Component]
   861   C1706305:Head [Manufactured Object]
   805 E C0205096:Cephalic [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.266: All of these features of cell death were not evident in control cultures (Figs. 5a, 5b, and 5i). 

Phrase: "All of these features of cell death"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   778   C0007587:Cell Death [Cell Function]
   757   C1562749:Cell feature [Organism Attribute]
   748   C0007634:Cell [Cell]
   748   C0011065:Death [Organism Function]
   748   C0444868:All [Quantitative Concept]
   748   C1269647:Cell [Cell]
   748   C1306577:Death, NOS [Finding]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   748   C3539085:All [Idea or Concept]
   714   C1521970:Feature [Qualitative Concept]
   714   C1706388:Feature [Conceptual Entity]
   714   C2346469:Feature [Qualitative Concept]
   714   C2348519:Feature [Qualitative Concept]

Phrase: "were"

Phrase: "not evident in control cultures"

Phrase: "(Figs. 5a,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "5b,"

Phrase: "and"

Phrase: "5i"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552169:5i [Medical Device]

Phrase: ")."
Processing 00000000.tx.267: Pretreatment with CHX (CHX controls are shown in Figs. 5e and 5f) greatly reduced the cell shrinkage (Fig. 5g) and nuclear alterations (Fig. 5h) induced by Al-malt. 

Phrase: "Pretreatment with CHX"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]

Phrase: "(CHX controls"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0243148:control [Qualitative Concept]
   827   C1550141:Control [Substance]
   827   C1882979:Control [Conceptual Entity]
   827   C2587213:Control [Functional Concept]
   827   C3274648:Control [Qualitative Concept]

Phrase: "are"

Phrase: "shown in Figs. 5e"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0349966:Figs [Food]
   737 E C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "5f"

Phrase: ")"

Phrase: "greatly"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the cell shrinkage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332513:Shrinkage [Functional Concept]

Phrase: "(Fig. 5g"

Phrase: ")"

Phrase: "and"

Phrase: "nuclear alterations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0333901:Nuclear Alterations [Cell or Molecular Dysfunction]
   827   C1515926:Alteration [Idea or Concept]

Phrase: "(Fig. 5h"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442467:5H [Temporal Concept]

Phrase: ")"

Phrase: "induced by Al-malt."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0081548:aluminum maltolate [Organic Chemical]
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0205263:Induced [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.268: In addition, neuronal processes were still evident in cultures pretreated with CHX (Fig. 5g, arrows), whereas treatment with Al-malt alone completely eliminated process formation (Fig. 5c). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "neuronal processes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   947   C0085103:neuron process [Cell Component]
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]

Phrase: "were"

Phrase: "still evident in cultures"

Phrase: "pretreated with CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   734 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "(Fig. 5g,"

Phrase: "arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "treatment with Al-malt alone completely eliminated process formation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   742   C0039798:treatment [Functional Concept]
   742   C0087111:Treatment [Therapeutic or Preventive Procedure]
   742   C1522326:Treatment [Functional Concept]
   742   C1533734:Treatment [Therapeutic or Preventive Procedure]
   742   C1705169:Treatment [Conceptual Entity]
   742   C3538994:TREATMENT [Research Activity]

Phrase: "(Fig. 5c"

Phrase: ")."
Processing 00000000.tx.269: View larger version (76K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(76K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.270: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.271: Cellular and nuclear morphology indicative of apoptosis and necrosis can be seen in N2a cells treated with Al-malt. 

Phrase: "Cellular"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0007634:Cellular [Cell]
  1000   C0178539:Cellular [Functional Concept]
   928 E C1516377:Cellularity [Qualitative Concept]

Phrase: "and"

Phrase: "nuclear morphology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1749565:nuclear morphology [Cell Function]
   861   C0332437:Morphology [Qualitative Concept]
   861   C0543482:morphology [Spatial Concept]
   861   C0700329:Morphology, NOS [Finding]
   861   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "indicative of apoptosis"

Phrase: "and"

Phrase: "necrosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027540:Necrosis [Organ or Tissue Function]
  1000   C1334928:Necrosis [Finding]

Phrase: "can"

Phrase: "be"

Phrase: "seen in N2a cells"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C0205397:Seen [Qualitative Concept]
   760   C3282337:Cells [Cell]
   726 E C0042789:see [Organism Function]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1947903:See [Activity]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "treated with Al-malt."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.272: Cells were treated with Al-malt and maltolate at the indicated concentrations for 24 h and then examined by light microscopy (all x200) and scanning electron microscopy (SEM). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "maltolate at the indicated concentrations"

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "examined by light microscopy"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0430389:Light microscopy [Laboratory Procedure]
   770   C0023693:Light [Natural Phenomenon or Process]
   770   C0026018:Microscopy [Laboratory Procedure]
   770   C0332128:Examined [Finding]
   770   C1306462:Light [Functional Concept]
   770   C1881376:Light [Qualitative Concept]

Phrase: "("

Phrase: "all x200"

Phrase: ")"

Phrase: "and"

Phrase: "scanning electron microscopy (SEM)."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0026020:Scanning Electron Microscopy [Laboratory Procedure]
   901   C0026019:Electron Microscopy [Laboratory Procedure]
   901   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   827   C0013852:Electron [Quantitative Concept]
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0034606:Scanning [Diagnostic Procedure]
   827   C0441633:Scanning [Diagnostic Procedure]
   827   C3463986:Electron [Bird]
   793 E C2826292:SCAN [Finding]
   755 E C0013850:Electronic [Manufactured Object]
   755 E C0205288:Microscopic [Qualitative Concept]
   755 E C1547561:Electronic [Idea or Concept]
Processing 00000000.tx.273: CHX was added to some cell cultures 30 min before the addition of Al-malt. 

Phrase: "CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "was"

Phrase: "added to some cell cultures 30 min"
Meta Candidates (Total=14; Excluded=4; Pruned=0; Remaining=10)
   778   C0007585:Cell Cultures [Laboratory Procedure]
   778   C0456693:/30 min [Temporal Concept]
   778   C1442458:30 min [Temporal Concept]
   748   C0007634:Cell [Cell]
   748   C0010453:Cultures [Idea or Concept]
   748   C0702093:/min [Temporal Concept]
   748   C1269647:Cell [Cell]
   748   C1524062:Added [Functional Concept]
   748   C1704653:Cell [Medical Device]
   748   C1948049:Cell [Spatial Concept]
   714 E C0220814:culture [Functional Concept]
   714 E C0430400:Culture [Laboratory Procedure]
   714 E C1883712:Add [Functional Concept]
   714 E C2242979:Culture [Laboratory Procedure]

Phrase: "before the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of Al-malt."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.274: (a) control phase contrast; 

Phrase: "(a)"

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "phase contrast"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444701:Phase contrast [Laboratory Procedure]
   861   C0205390:Phase [Temporal Concept]
   861   C1979874:Contrast [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.275: (b) control H33258; 

Phrase: "(b)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "H33258"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0878435:Hoechst 33258 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.276: (c) 500 M Al-malt phase contrast; 

Phrase: "(c) 500 M Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   840   C0081548:aluminum maltolate [Organic Chemical]
   804   C0002367:Aluminium [Element, Ion, or Isotope]
   804   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "phase contrast"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444701:Phase contrast [Laboratory Procedure]
   861   C0205390:Phase [Temporal Concept]
   861   C1979874:Contrast [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.277: (d) 500 M Al-malt H33258; 

Phrase: "("

Phrase: "d)"

Phrase: "500 M Al-malt H33258"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0081548:aluminum maltolate [Organic Chemical]
   827   C0878435:Hoechst 33258 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   799   C0002367:Aluminium [Element, Ion, or Isotope]
   799   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   799   C0441923:M+ [Intellectual Product]
   799   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: ";"
Processing 00000000.tx.278: (e) CHX phase contrast; 

Phrase: "(e) CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   805 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "phase contrast"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444701:Phase contrast [Laboratory Procedure]
   861   C0205390:Phase [Temporal Concept]
   861   C1979874:Contrast [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.279: (f) CHX H33258; 

Phrase: "(f) CHX H33258"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   861   C0878435:Hoechst 33258 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   812   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   812   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   812   C0439133:(f) [Intellectual Product]
   812   C1553038:[f] [Quantitative Concept]
   756 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.280: (g) 500 M Al-malt + CHX phase contrast; 

Phrase: "(g) 500 M Al-malt + CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   743 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "phase contrast"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0444701:Phase contrast [Laboratory Procedure]
   861   C0205390:Phase [Temporal Concept]
   861   C1979874:Contrast [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.281: (h) 500 M Al-malt + CHX H33258; 

Phrase: "(h) 500 M Al-malt + CHX H33258"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   822   C2348952:H/m [Quantitative Concept]
   812   C0081548:aluminum maltolate [Organic Chemical]
   812   C0878435:Hoechst 33258 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   793   C0002367:Aluminium [Element, Ion, or Isotope]
   793   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   793   C0033727:H+ [Element, Ion, or Isotope]
   793   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   793   C0441923:M+ [Intellectual Product]
   793   C0441932:H+ [Classification]
   793   C0564385:/h [Quantitative Concept]
   793   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.282: (i) control SEM; 

Phrase: "(i)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "SEM"
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
  1000   C0026020:Scanning Electron Microscopy [Laboratory Procedure]
   901   C0026019:Electron Microscopy [Laboratory Procedure]
   901   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   827   C0013852:Electron [Quantitative Concept]
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0034606:Scanning [Diagnostic Procedure]
   827   C0441633:Scanning [Diagnostic Procedure]
   827   C3463986:Electron [Bird]
   793 E C2826292:SCAN [Finding]
   755 E C0013850:Electronic [Manufactured Object]
   755 E C0205288:Microscopic [Qualitative Concept]
   755 E C1547561:Electronic [Idea or Concept]

Phrase: ";"
Processing 00000000.tx.283: (j) 500 M Al-malt SEM. 

Phrase: "(j) 500 M Al-malt SEM."
Meta Candidates (Total=12; Excluded=4; Pruned=0; Remaining=8)
   835   C0026020:Scanning Electron Microscopy [Laboratory Procedure]
   812   C0026019:Electron Microscopy [Laboratory Procedure]
   812   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   793   C0013852:Electron [Quantitative Concept]
   793   C0026018:Microscopy [Laboratory Procedure]
   793   C0034606:Scanning [Diagnostic Procedure]
   793   C0441633:Scanning [Diagnostic Procedure]
   793   C3463986:Electron [Bird]
   760 E C2826292:SCAN [Finding]
   721 E C0013850:Electronic [Manufactured Object]
   721 E C0205288:Microscopic [Qualitative Concept]
   721 E C1547561:Electronic [Idea or Concept]
Processing 00000000.tx.284: Micrographs are representative of two independent experiments with similar results.  

Phrase: "Micrographs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   893   C0240341:Micrographia [Finding]
   893   C0596928:micrography [Laboratory Procedure]

Phrase: "are"

Phrase: "representative of two independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.285: Caspase 3 is activated in N2a cells treated with Al-Malt. 

Phrase: "Caspase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "is"

Phrase: "activated in N2a cells"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1879547:Activated [Activity]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1515877:Activate [Functional Concept]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "treated with Al-Malt."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0024651:malt [Food]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   770   C2985262:MALT [Qualitative Concept]
   737 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.286: The activation of caspase 3 is an integral step in the majority of apoptotic events. 

Phrase: "The activation of caspase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1159825:Caspase Activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "is"

Phrase: "an integral step in"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1261552:Step [Conceptual Entity]
   827   C1704379:Step [Functional Concept]
   827   C1705117:Step [Quantitative Concept]
   827   C2825408:Step [Manufactured Object]

Phrase: "the majority of apoptotic events."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0680220:majority [Social Behavior]
Processing 00000000.tx.287: This enzyme belongs to the cysteine protease family and is responsible for cleaving substrates, such as DNA fragmentation factor that can go on to damage DNA (Sharif-Askari et al., 2001), and is thus considered to be an effector caspase. 

Phrase: "This enzyme"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0014442:Enzyme [Enzyme,Organic Chemical]
   916 E C0014445:enzymes [Functional Concept]

Phrase: "belongs to the cysteine protease family"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0758959:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   790   C0769345:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   790   C2717970:Cysteine Protease [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0010654:Cysteine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0015576:Family [Family Group]
   753   C0030946:Protease [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   753   C1704727:Family [Conceptual Entity]
   753   C1947941:Protease [Enzyme]

Phrase: "and"

Phrase: "is"

Phrase: "responsible for cleaving substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "such as DNA fragmentation factor"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]
   734   C0376669:DNA Fragmentation [Molecular Function]

Phrase: "that"

Phrase: "can"

Phrase: "go on to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1822658:GO [Gene or Genome]

Phrase: "damage"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010957:Damage [Injury or Poisoning]
  1000   C1883709:Damage [Functional Concept]

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(Sharif-Askari et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "is"

Phrase: "thus"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "an effector caspase."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.288: Caspase 3 activity was markedly increased in a concentration-dependent manner in N2a cells treated with Al-malt (Fig. 6). 

Phrase: "Caspase 3 activity"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1150132:caspase-3 activity [Molecular Function]
   913   C1150130:caspase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "markedly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522501:Markedly [Qualitative Concept]

Phrase: "increased in a concentration-dependent manner"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0086045:Concentration [Mental Process]
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1446561:Concentration [Quantitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "in N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(Fig. 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.289: A slight increase in caspase 3 activity was noted in the maltolate-treated cells (open bar in Fig. 6) indicative of a small increase in apoptosis. 

Phrase: "A slight increase in caspase 3 activity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "noted in the maltolate-treated cells"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   753   C0007634:Cells [Cell]
   753   C0332293:treated [Therapeutic or Preventive Procedure]
   753   C1522326:Treated [Functional Concept]
   753   C3282337:Cells [Cell]
   719 E C1269647:Cell [Cell]
   719 E C1292734:TREAT [Functional Concept]
   719   C1316572:Note [Clinical Attribute]
   719   C1317574:Note [Intellectual Product]
   719   C1369612:Note [Clinical Attribute]
   719 E C1704653:Cell [Medical Device]
   719 E C1948049:Cell [Spatial Concept]

Phrase: "(open bar in Fig. 6"

Phrase: ")"

Phrase: "indicative of a small increase"

Phrase: "in apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.290: The specificity of the assay was demonstrated by using a specific inhibitor of caspase 3, Ac-DEVD-CHO, which abolished the activity in Al-malt-treated lysates (solid bar in Fig. 6). 

Phrase: "The specificity of the assay"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "was"

Phrase: "demonstrated by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a specific inhibitor of caspase 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1516312:Caspase Inhibitor [Pharmacologic Substance]
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "Ac-DEVD-CHO,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0388991:Ac-DEVD-CHO [Amino Acid, Peptide, or Protein]
   901   C0666879:DEVD-CHO [Amino Acid, Peptide, or Protein]

Phrase: "which"

Phrase: "abolished"

Phrase: "the activity in Al-malt-treated lysates"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "(solid bar in Fig. 6"

Phrase: ")."
Processing 00000000.tx.291: The caspase 3 activity of washed cells was much lower than that present in cells lysed in the treatment media (data not shown). 

Phrase: "The caspase 3 activity of washed cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   814   C1150132:caspase-3 activity [Molecular Function]
   774   C1150130:caspase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "much lower than"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0441994:Lower [Spatial Concept]
   790   C1548802:Lower [Body Location or Region]
   790   C2003888:Lower [Activity]

Phrase: "that present in cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "lysed in the treatment media"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   760   C0009458:Media [Intellectual Product]
   760   C0024348:lysed [Pathologic Function]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0162867:Media [Tissue]
   760   C1254021:Media [Tissue]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]
   726 E C0439536:Medium [Quantitative Concept]
   726 E C1705217:Medium [Substance]
   726 E C3244283:medium [Intellectual Product]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.292: This could be due to removal of apoptotic cells during washing, or more likely, due to the release of caspase 3 from dying cells into the media as reported previously (Jemmerson et al., 2002). 

Phrase: "This"

Phrase: "could"

Phrase: "be due to removal of apoptotic cells"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   793   C1523908:apoptotic cell removal [Cell Function]
   778   C0678226:Due to [Functional Concept]
           due
   748   C0007634:Cells [Cell]
   748   C0015252:Removal [Therapeutic or Preventive Procedure]
   748   C0728940:Removal [Therapeutic or Preventive Procedure]
   748   C1516044:Apoptotic [Qualitative Concept]
   748   C2987476:Be [Conceptual Entity]
   748   C3146286:Due [Idea or Concept]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]

Phrase: "during washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "or"

Phrase: "more likely,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205172:More [Functional Concept]
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "due to the release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "of caspase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "from dying cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "into the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "as"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(Jemmerson et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.293: View larger version (28K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.294: 6. 

Phrase: "6."
Processing 00000000.tx.295: Treatment of N2a cells with Al-malt results in activation of caspase 3. 

Phrase: "Treatment of N2a cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with Al-malt results"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   793   C1274040:Result [Functional Concept]
   793   C1546471:Result [Idea or Concept]
   793   C2825142:Result [Finding]
   734   C0081548:aluminum maltolate [Organic Chemical]

Phrase: "in activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1879547:Activation [Activity]

Phrase: "of caspase 3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.296: Cells were treated with Al-malt (62.5500 M) and maltolate (1500 M, open bar) at the indicated concentrations for 24 h, and then caspase 3-like activity was determined using the CaspACETM system as outlined in the Materials and Methods. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(62.5500"

Phrase: "M)"

Phrase: "and"

Phrase: "maltolate"

Phrase: "(1500 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "open bar) at the indicated concentrations"

Phrase: "for 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "then caspase 3-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "like activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the CaspACETM system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "as"

Phrase: "outlined in the Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.297: To confirm the specificity of the assay, lysates from cells treated with 500 M Al-malt were pretreated with Ac-DEVD-CHO (solid bar), a specific inhibitor of caspase 3. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "the specificity of the assay,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0037791:Specificity [Quantitative Concept]
   760   C1511884:Specificity [Quantitative Concept]

Phrase: "lysates from cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   824   C1881488:Cell Lysate [Physical Object]
           Lysate

Phrase: "treated with 500 M Al-malt"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0081548:aluminum maltolate [Organic Chemical]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1522326:Treated [Functional Concept]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "were"

Phrase: "pretreated with Ac-DEVD-CHO (solid bar"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   814   C0388991:Ac-DEVD-CHO [Amino Acid, Peptide, or Protein]
   778   C0666879:DEVD-CHO [Amino Acid, Peptide, or Protein]
   748   C0205208:Solid [Qualitative Concept]
   748   C0302909:Solid [Substance]
   748   C1378566:Solid [Biomedical or Dental Material]
   748   C1412573:AC [Gene or Genome]
   748   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   748   C3539770:AC [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "a specific inhibitor of caspase 3."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1516312:Caspase Inhibitor [Pharmacologic Substance]
   753   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.298: Mean  SE (n = 3 wells/treatment). 

Phrase: "Mean  SE (n = 3 wells/treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0039798:treatment [Functional Concept]
   799   C0087111:Treatment [Therapeutic or Preventive Procedure]
   799   C1522326:Treatment [Functional Concept]
   799   C1533734:Treatment [Therapeutic or Preventive Procedure]
   799   C1705169:Treatment [Conceptual Entity]
   799   C3538994:TREATMENT [Research Activity]

Phrase: ")."
Processing 00000000.tx.299: The experiment was repeated three times with similar results. 

Phrase: "The experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "three times with similar results."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.300: Significantly different from the control group at *p < 0.001.  

Phrase: "Significantly different from the control group at *p < 0.001."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.301: Al-Malt-Induced Apoptosis Requires de Novo Protein Synthesis Apoptosis is an active form of cell death and can require de novo protein synthesis to initiate and/or complete the process (Chow et al., 1995). 

Phrase: "Al-Malt-Induced Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "Requires"

Phrase: "de Novo Protein Synthesis Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0162638:Apoptosis [Cell Function]
   733 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "an active form of cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "and"

Phrase: "can"

Phrase: "require"

Phrase: "de novo protein synthesis to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   840   C0597295:Protein Synthesis [Molecular Function]
   804   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C0220781:synthesis [Biologic Function]
   804   C1883254:Synthesis [Activity]

Phrase: "initiate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "and/or"

Phrase: "complete"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Complete [Qualitative Concept]

Phrase: "the process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "(Chow et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.302: Cycloheximide is a potent inhibitor of gene translation and has been used extensively in apoptosis research. 

Phrase: "Cycloheximide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "is"

Phrase: "a potent inhibitor of gene translation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1999216:Inhibitor [Qualitative Concept]

Phrase: "and"

Phrase: "has"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "extensively in apoptosis research."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035168:research [Research Activity]
   770   C0162638:Apoptosis [Cell Function]
   770   C0242481:Research [Research Activity]
Processing 00000000.tx.303: Pretreatment of N2a cells with 0.5 g/ml of CHX for 30 min prior to the addition of Al-malt produced a marked inhibition of cell death as evidenced by reduced release of LDH into the media (Fig. 7, solid bars). 

Phrase: "Pretreatment of N2a cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1550147:Pretreatment [Substance]
   760   C2709094:pre treatment [Temporal Concept]
   760   C3539075:Pretreatment [Temporal Concept]
   760   C3539076:Pretreatment [Activity]

Phrase: "with 0.5 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "of CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "prior to the addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "produced"

Phrase: "a marked inhibition of cell death"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   820   C1516339:Cell Death Inhibition [Cell Function]
   753   C0021467:Inhibition [Mental Process]
   753   C0021469:Inhibition [Molecular Function]
   753   C1628982:% inhibition [Quantitative Concept]
   753   C3463820:Inhibition [Activity]

Phrase: "as"

Phrase: "evidenced by reduced release of LDH"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   778   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   757   C0332120:Evidence of [Functional Concept]
           Evidence
   748   C0022924:lactate [Organic Chemical]
   748   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0030685:Release [Health Care Activity]
   748   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]
   748   C0391871:Release [Functional Concept]
   748   C0392756:Reduced [Qualitative Concept]
   748   C0439180:% release [Quantitative Concept]
   748   C0680255:release [Health Care Activity]
   748   C1283071:Release [Functional Concept]
   748   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "into the media"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0009458:Media [Intellectual Product]
  1000   C0162867:Media [Tissue]
  1000   C1254021:Media [Tissue]
   966 E C0439536:Medium [Quantitative Concept]
   966 E C1705217:Medium [Substance]
   966 E C3244283:medium [Intellectual Product]

Phrase: "(Fig. 7,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "solid bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.304: Flow cytometric examination using acridine orange/ethidium bromide dual staining showed that CHX almost completely inhibited apoptosis but not necrosis (Fig. 8). 

Phrase: "Flow cytometric examination"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "acridine orange/ethidium bromide dual staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0487602:Staining [Laboratory Procedure]
   799   C1704680:Staining [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that CHX almost completely"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   827   C0205197:Completely [Qualitative Concept]
   771 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "but"

Phrase: "not necrosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027540:Necrosis [Organ or Tissue Function]
   861   C1334928:Necrosis [Finding]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.305: These findings were confirmed by cell cycle analysis and the detection of hypodiploid nuclei. 

Phrase: "These findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "were"

Phrase: "confirmed by cell cycle analysis"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   806   C0007586:Cell Cycle [Cell Function]
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   806   C1155839:Cell Cycle [Cell Function]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0007634:Cell [Cell]
   760   C0750484:Confirmed [Idea or Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1269647:Cell [Cell]
   760   C1511572:Cycle [Temporal Concept]
   760   C1524024:analysis [Functional Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "and"

Phrase: "the detection of hypodiploid nuclei."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511790:Detection [Therapeutic or Preventive Procedure]
Processing 00000000.tx.306: Al-malt dose-dependently increased the hypodiploid population, and this was abolished in cells pretreated with CHX (Fig. 8). 

Phrase: "Al-malt dose-dependently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0081548:aluminum maltolate [Organic Chemical]
   812   C0002367:Aluminium [Element, Ion, or Isotope]
   812   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the hypodiploid population,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "and"

Phrase: "this"

Phrase: "was"

Phrase: "abolished in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0007634:Cells [Cell]
   790   C3282337:Cells [Cell]
   756 E C1269647:Cell [Cell]
   756 E C1704653:Cell [Medical Device]
   756 E C1948049:Cell [Spatial Concept]

Phrase: "pretreated with CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   734 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.307: Al-malt appeared to induce cell cycle arrest in the G2/M phase, a phenomenon often associated with toxicant-induced apoptosis in cultured cells (Zaffaroni et al., 2001). 

Phrase: "Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "cell cycle arrest in the G2/M phase,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   848   C3178829:M Phase Cell Cycle Arrest [Cell Function]
   822   C3178824:G2 Cell Cycle Arrest [Cell Function]
   800   C1155873:Cell Cycle Arrest [Cell Function]
   800   C1516332:Cell Cycle Arrest [Cell Function]
   793   C1517345:G2/M Arrest [Molecular Function]
   793   C1518147:M Phase Arrest [Cell Function]
   789   C1517348:G2 Phase Arrest [Cell Function]
   744   C0237477:Arrest [Temporal Concept]
   744   C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "a phenomenon often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1882365:Phenomenon [Phenomenon or Process]

Phrase: "associated with toxicant-induced apoptosis"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0162638:Apoptosis [Cell Function]
   760   C0205263:Induced [Functional Concept]
   760   C0599787:toxicant [Hazardous or Poisonous Substance]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in cultured cells"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
  1000   C0007600:cultured cells [Cell]
  1000   C0007635:Cultured Cells [Cell]
  1000   C3282338:Cells, Cultured [Cell]
   966 E C0007585:culture cell [Laboratory Procedure]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827   C0010453:Culture [Idea or Concept]
   827   C0220814:culture [Functional Concept]
   827   C0430400:Culture [Laboratory Procedure]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
   827   C2242979:Culture [Laboratory Procedure]

Phrase: "(Zaffaroni et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.308: Therefore, perturbations of cell cycle progression may be involved in Al-malt-induced neurotoxicity. 

Phrase: "Therefore,"

Phrase: "perturbations of cell cycle progression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0332453:perturbation [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "involved in Al-malt-induced neurotoxicity."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0081548:aluminum maltolate [Organic Chemical]
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0205263:Induced [Functional Concept]
   753   C0235032:Neurotoxicity [Injury or Poisoning]
   753   C1314939:Involved [Functional Concept]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.309: View larger version (27K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(27K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.310: 7. 

Phrase: "7."
Processing 00000000.tx.311: Al-malt-induced cell death in N2a cells is inhibited by pretreatment with the protein synthesis inhibitor cycloheximide. 

Phrase: "Al-malt-induced cell death in N2a cells"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0007587:Cell Death [Cell Function]
           cells death
   742   C0007634:Cell [Cell]
   742   C0011065:Death [Organism Function]
   742   C1269647:Cell [Cell]
   742   C1306577:Death, NOS [Finding]
   742   C1704653:Cell [Medical Device]
   742   C1948049:Cell [Spatial Concept]

Phrase: "is"

Phrase: "inhibited by pretreatment"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   790   C0311403:Inhibited [Qualitative Concept]
   790   C1550147:Pretreatment [Substance]
   790   C2709094:pre treatment [Temporal Concept]
   790   C3539075:Pretreatment [Temporal Concept]
   790   C3539076:Pretreatment [Activity]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]

Phrase: "with the protein synthesis inhibitor cycloheximide."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   756   C0033671:Protein Synthesis Inhibitor [Pharmacologic Substance]
   756 E C0947670:Actidione [Antibiotic,Organic Chemical]
Processing 00000000.tx.312: Cells were treated with Al-malt (62.5500 M) for 24 h in the presence (solid bars) or absence (hatched bars) of a 30 min pretreatment with CHX (0.5 g/ml). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(62.5500"

Phrase: "M) for 24 h"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   819   C2348952:H/m [Quantitative Concept]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "(solid bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "or"

Phrase: "absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(hatched bars"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1707156:BARS [Gene or Genome]
   861   C3274014:BARS [Intellectual Product]
   861   C3541345:BARS [Intellectual Product]

Phrase: ")"

Phrase: "of a 30 min pretreatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1550147:Pretreatment [Substance]
   827   C2709094:pre treatment [Temporal Concept]
   827   C3539075:Pretreatment [Temporal Concept]
   827   C3539076:Pretreatment [Activity]
   734   C0456693:/30 min [Temporal Concept]
   734   C1442458:30 min [Temporal Concept]

Phrase: "with CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "(0.5 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.313: The release of LDH from the cells was then determined as outlined in the Materials and Methods. 

Phrase: "The release of LDH"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "determined"

Phrase: "as"

Phrase: "outlined in the Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.314: Mean  SE (n = 5 wells/treatment). 

Phrase: "Mean  SE (n = 5 wells/treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0039798:treatment [Functional Concept]
   799   C0087111:Treatment [Therapeutic or Preventive Procedure]
   799   C1522326:Treatment [Functional Concept]
   799   C1533734:Treatment [Therapeutic or Preventive Procedure]
   799   C1705169:Treatment [Conceptual Entity]
   799   C3538994:TREATMENT [Research Activity]

Phrase: ")."
Processing 00000000.tx.315: Data are representative of three independent experiments with similar results. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.316: Significantly different from the control group at *p < 0.05, **p < 0.001. 

Phrase: "Significantly different from the control group at *p < 0.05,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1705242:Different [Qualitative Concept]

Phrase: "*"

Phrase: "*p < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.317: Significantly different from the respective group treated with Al-malt only at p < 0.005.  

Phrase: "Significantly different from the respective group"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705242:Different [Qualitative Concept]

Phrase: "treated with Al-malt only"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0081548:aluminum maltolate [Organic Chemical]
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0002367:Aluminium [Element, Ion, or Isotope]
   760   C0205171:Only [Quantitative Concept]
   760   C1522326:Treated [Functional Concept]
   760   C1720467:Only [Intellectual Product]
   760   C2348254:ALUMINUM [Element, Ion, or Isotope]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "at p < 0.005."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.318: View larger version (31K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(31K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.319: 8. 

Phrase: "8."
Processing 00000000.tx.320: Al-malt-induced apoptosis is inhibited by cycloheximide. 

Phrase: "Al-malt-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "inhibited by cycloheximide."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   790   C0311403:Inhibited [Qualitative Concept]
   734 E C0947670:Actidione [Antibiotic,Organic Chemical]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]
Processing 00000000.tx.321: Cells were treated with Al-malt (62.5500 M) at the indicated concentrations for 24 h in the presence or absence of CHX (0.5 g/ml; 30 min pretreatment prior to addition of Al-malt). 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(62.5500"

Phrase: "M) at the indicated concentrations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086045:Concentrations [Mental Process]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1444656:Indicated [Finding]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of CHX"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "(0.5 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "; 30 min pretreatment prior to addition of Al-malt"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C1550147:Pretreatment [Substance]
   742   C2709094:pre treatment [Temporal Concept]
   742   C3539075:Pretreatment [Temporal Concept]
   742   C3539076:Pretreatment [Activity]

Phrase: ")."
Processing 00000000.tx.322: Discrimination of live, apoptotic, and necrotic cell populations was determined using the acridine orange/ethidium bromide flow cytometry assay as outlined in the Materials and Methods. 

Phrase: "Discrimination of live, apoptotic,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0012632:Discrimination [Mental Process]
   770   C2987623:Discrimination [Social Behavior]

Phrase: "and"

Phrase: "necrotic cell populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the acridine orange/ethidium bromide flow cytometry assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0005507:Assay [Laboratory Procedure]
   795   C0243073:assay [Qualitative Concept]
   795   C1510438:Assay [Laboratory Procedure]

Phrase: "as"

Phrase: "outlined in the Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.323: Live cells are defined by the oval labeled L, and apoptotic and necrotic populations are labeled Ap and N, respectively. 

Phrase: "Live cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "are"

Phrase: "defined by the oval labeled L,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C1704788:Defined [Conceptual Entity]
   753   C1708632:Labeled [Qualitative Concept]
   753   C1709367:Oval [Qualitative Concept]
   753   C3539106:Defined [Intellectual Product]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "apoptotic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1516044:Apoptotic [Qualitative Concept]
   928 E C0162638:Apoptosis [Cell Function]

Phrase: "and"

Phrase: "necrotic populations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "are"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "Ap"

Phrase: "and"

Phrase: "N,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "respectively."
Processing 00000000.tx.324: The protection of N2a by pretreatment with CHX was confirmed by examining the cell cycle in response to treatment. 

Phrase: "The protection of N2a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1545588:Protection [Finding]

Phrase: "by pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1550147:Pretreatment [Substance]
  1000   C2709094:pre treatment [Temporal Concept]
  1000   C3539075:Pretreatment [Temporal Concept]
  1000   C3539076:Pretreatment [Activity]

Phrase: "with CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "was"

Phrase: "confirmed by examining"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   882   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   790   C0332128:examining [Finding]
   790   C0750484:Confirmed [Idea or Concept]
   790   C2004054:Examining [Activity]
   756 E C1456348:Confirm [Qualitative Concept]

Phrase: "the cell cycle in response"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0007586:Cell Cycle [Cell Function]
   806   C0007634:THE CELL [Cell]
           Cell
   806   C1155839:Cell Cycle [Cell Function]
   760   C1269647:Cell [Cell]
   760   C1511572:Cycle [Temporal Concept]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]

Phrase: "to treatment."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.325: CHX pretreatment inhibited the appearance of a hypodiploid DNA peak. 

Phrase: "CHX pretreatment"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1550147:Pretreatment [Substance]
   861   C2709094:pre treatment [Temporal Concept]
   861   C3539075:Pretreatment [Temporal Concept]
   861   C3539076:Pretreatment [Activity]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the appearance of a hypodiploid DNA peak."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0233426:Appearance [Organism Attribute]
   748   C0700364:Appearance [Qualitative Concept]
Processing 00000000.tx.326: Data are representative of three independent experiments with similar results.  

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "with similar results."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]
Processing 00000000.tx.327: Confirming a role for de novo protein synthesis in the initiation of apoptotic cell death induced by Al-malt is the finding that pretreatment of N2a cells with CHX prevented the activation of caspase 3 (Fig. 9). 

Phrase: "Confirming"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirming [Qualitative Concept]
  1000   C0750484:confirming [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "a role for de novo protein synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in the initiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0589507:Initiation [Mental Process]
  1000   C1158830:Initiation [Genetic Function]
  1000   C1704686:Initiation [Functional Concept]

Phrase: "of apoptotic cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:apoptotic cell death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "induced by Al-malt"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0081548:aluminum maltolate [Organic Chemical]
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0205263:Induced [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "the finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0037088:Finding [Sign or Symptom]
  1000   C0243095:Finding [Finding]
  1000   C2825141:Finding [Finding]

Phrase: "that pretreatment of N2a cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1550147:Pretreatment [Substance]
   753   C2709094:pre treatment [Temporal Concept]
   753   C3539075:Pretreatment [Temporal Concept]
   753   C3539076:Pretreatment [Activity]

Phrase: "with CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the activation of caspase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1159825:Caspase Activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.328: The activation of caspase 3 by Al-malt did not increase significantly beyond 250 M (Figs. 6 and 9). 

Phrase: "The activation of caspase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1159825:Caspase Activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "by Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "significantly beyond 250"

Phrase: "M ("

Phrase: "Figs. 6"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0349966:Figs [Food]
   827 E C1337208:FIG [Food]

Phrase: "and"

Phrase: "9"

Phrase: ")."
Processing 00000000.tx.329: Pretreatment with CHX completely abolished caspase 3 activation induced by 250 M Al-malt but only reduced the activation in cells treated with 500 M Al-malt (Fig. 9). 

Phrase: "Pretreatment with CHX completely abolished caspase 3 activation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C1550147:Pretreatment [Substance]
   744   C2709094:pre treatment [Temporal Concept]
   744   C3539075:Pretreatment [Temporal Concept]
   744   C3539076:Pretreatment [Activity]

Phrase: "induced by 250 M Al-malt"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0081548:aluminum maltolate [Organic Chemical]
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0205263:Induced [Functional Concept]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "but"

Phrase: "only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the activation in cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C1326120:activation cells [Cell Function]
   770   C1879547:Activation [Activity]

Phrase: "treated with 500 M Al-malt"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0081548:aluminum maltolate [Organic Chemical]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1522326:Treated [Functional Concept]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "(Fig. 9"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.330: The same trend is evident in Figure 7, showing complete inhibition of cell death by CHX in cells treated with 250 M but only partial inhibition in cells treated with 500 M Al-malt. 

Phrase: "The same trend"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1521798:trend [Temporal Concept]

Phrase: "is"

Phrase: "evident in Figure 7,"

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "complete inhibition of cell death"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C1516339:Cell Death Inhibition [Cell Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "by CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "in cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "treated with 250 M"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "but"

Phrase: "only partial inhibition in cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "treated with 500 M Al-malt."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0081548:aluminum maltolate [Organic Chemical]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1522326:Treated [Functional Concept]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]
   719 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.331: It is possible that 0.5 g/ml of CHX does not completely inhibit transcription in N2a cells, thus accounting for these results. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that 0.5 g/ml of CHX"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   778   C1300565:g/mL [Quantitative Concept]
   774 E C1637390:mL/g [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]

Phrase: "does"

Phrase: "not completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "transcription in N2a cells,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040649:Transcription [Genetic Function]

Phrase: "thus"

Phrase: "accounting for these results."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0000938:Accounting [Occupational Activity]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737 E C1551359:account [Idea or Concept]
   737 E C2741673:Account # [Clinical Attribute]
   737   C2825142:Result [Finding]
   737 E C2981730:Account [Classification]
Processing 00000000.tx.332: Higher doses of CHX need to be investigated to confirm this hypothesis. 

Phrase: "Higher doses of CHX"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   799   C0444956:High dose [Quantitative Concept]
   770   C0178602:Doses [Quantitative Concept]
   737 E C0869039:Dose [Quantitative Concept]
   737 E C1114758:Dose # [Clinical Attribute]
   737 E C1428722:DOS [Gene or Genome]

Phrase: "need"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027552:Need [Qualitative Concept]
  1000   C0686904:need [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "investigated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigated [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this hypothesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]
Processing 00000000.tx.333: View larger version (35K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.334: 9. 

Phrase: "9."
Processing 00000000.tx.335: Inhibition of protein synthesis inhibits caspase 3 activation by Al-malt. 

Phrase: "Inhibition of protein synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   881   C1519619:Protein Synthesis Inhibition [Genetic Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "caspase 3 activation by Al-malt."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1159825:Caspase Activation [Molecular Function]
   753   C1879547:Activation [Activity]
Processing 00000000.tx.336: Cells were treated with Al-malt (62.5500 M) at the indicated concentrations for 24 h in the presence or absence of CHX (0.5 g/ml; 30 min pretreatment prior to addition of Al-malt), and then caspase 3-like activity was determined using the CaspACETM system as outlined in the Materials and Methods. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "(62.5500"

Phrase: "M) at the indicated concentrations"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0086045:Concentrations [Mental Process]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   760   C1444656:Indicated [Finding]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "for 24 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of CHX"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "(0.5 g/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1300565:g/mL [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "; 30 min pretreatment prior to addition of Al-malt"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C1550147:Pretreatment [Substance]
   742   C2709094:pre treatment [Temporal Concept]
   742   C3539075:Pretreatment [Temporal Concept]
   742   C3539076:Pretreatment [Activity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "then caspase 3-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "like activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the CaspACETM system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "as"

Phrase: "outlined in the Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.337: Mean  SE (n = 3 wells/treatment). 

Phrase: "Mean  SE (n = 3 wells/treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0039798:treatment [Functional Concept]
   799   C0087111:Treatment [Therapeutic or Preventive Procedure]
   799   C1522326:Treatment [Functional Concept]
   799   C1533734:Treatment [Therapeutic or Preventive Procedure]
   799   C1705169:Treatment [Conceptual Entity]
   799   C3538994:TREATMENT [Research Activity]

Phrase: ")."
Processing 00000000.tx.338: The experiment was repeated three times with similar results. 

Phrase: "The experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "repeated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205341:Repeated [Functional Concept]
   966 E C1547730:Repeat [Temporal Concept]
   966 E C1705914:Repeat [Conceptual Entity]

Phrase: "three times with similar results."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0040223:times [Temporal Concept]
   760   C1632851:Times [Quantitative Concept]
   726 E C3541383:Time [Temporal Concept]
Processing 00000000.tx.339: Significantly different from the control group at *p < 0.001.  

Phrase: "Significantly different from the control group at *p < 0.001."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1705242:Different [Qualitative Concept]
Processing 00000000.tx.340: Al-Malt Alters Expression of Key Regulators of the p53 Apoptotic Pathway Previous studies have demonstrated the presence of p53 protein in N2a cells and that this pathway can induce apoptosis in these cells (Jin et al., 2002). 

Phrase: "Al-Malt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0024651:malt [Food]
   861   C2985262:MALT [Qualitative Concept]

Phrase: "Alters"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "Expression of Key Regulators of the p53 Apoptotic Pathway Previous studies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "have"

Phrase: "demonstrated"

Phrase: "the presence of p53 protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "in N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "that"

Phrase: "this pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "can"

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis in these cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0162638:Apoptosis [Cell Function]

Phrase: "(Jin et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.341: Treatment of N2a cells with 250 M Al-malt increased the expression of p53 nearly twofold (Fig. 10). 

Phrase: "Treatment of N2a cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with 250 M Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0081548:aluminum maltolate [Organic Chemical]
   812   C0002367:Aluminium [Element, Ion, or Isotope]
   812   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of p53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "nearly twofold"

Phrase: "(Fig. 10"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.342: A concomitant increase in Mdm2 expression was observed, suggesting the induction of a negative regulatory response to the increase in p53 expression. 

Phrase: "A concomitant increase in Mdm2 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the induction of a negative regulatory response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0205263:Induction [Functional Concept]
   748   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "to the increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "in p53 expression."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.343: These changes were accompanied by a marked down-regulation of Bcl2 and an increased expression of BAX. 

Phrase: "These changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:changes [Functional Concept]
  1000   C0443172:changes [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "accompanied by a"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: "down-regulation of Bcl2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0013081:Down-Regulation [Cell Function,Molecular Function]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1327622:Regulation [Biologic Function]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715   C2626739:Lanugo [Eukaryote]

Phrase: "and"

Phrase: "an increased expression of BAX."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.344: Thus, Al-malt induced a marked shift in the Bcl2/BAX expression ratio toward a state associated with apoptosis. 

Phrase: "Thus,"

Phrase: "Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "a marked shift in the Bcl2/BAX expression ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0333051:Shift [Functional Concept]
   742   C2347509:Shift [Phenomenon or Process]

Phrase: "toward a state"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1301808:State [Geographic Area]
  1000   C1442792:State [Functional Concept]
  1000   C3148680:State [Geographic Area]

Phrase: "associated with apoptosis."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   882   C0332281:Associated with [Qualitative Concept]
           Associated
   790   C0162638:Apoptosis [Cell Function]
   756 E C0750490:Associate [Idea or Concept]
   756 E C1706221:Associate [Professional or Occupational Group]
   718 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.345: View larger version (23K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(23K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.346: 10. 

Phrase: "10."
Processing 00000000.tx.347: Al-malt treatment up-regulates gene expression for pro-apoptotic factors. 

Phrase: "Al-malt treatment"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0081548:aluminum maltolate [Organic Chemical]

Phrase: "up-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "gene expression for pro-apoptotic factors."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0017262:Gene Expression [Genetic Function]
   753   C0017337:Gene [Gene or Genome]
   753   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.348: Cells were treated with 250 mM Al-malt for 24 h, and total RNA was immediately extracted and converted to cDNA. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated with 250 mM Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C0081548:aluminum maltolate [Organic Chemical]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C1522326:Treated [Functional Concept]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]
   719 E C1292734:TREAT [Functional Concept]

Phrase: "for 24 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "total RNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0035668:RNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "was"

Phrase: "immediately"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205548:Immediately [Temporal Concept]

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "and"

Phrase: "converted to cDNA."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.349: The expression of anti-apoptotic (Bcl2 and Mdm2) and pro-apoptotic (BAX and p53) genes was analyzed by real-time PCR using SYBR Green I. 

Phrase: "The expression of anti-apoptotic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Bcl2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376515:BCL2 [Gene or Genome]
  1000   C0597712:BCL2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "Mdm2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0812222:MDM2 [Gene or Genome]
  1000   C0971008:MDM2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")"

Phrase: "and"

Phrase: "pro-apoptotic"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   964   C3546359:pro-apoptosis [Cell Function]
   861   C0033382:Pro [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1516044:Apoptotic [Qualitative Concept]
   861   C2987124:PRO [Intellectual Product]
   789 E C0162638:Apoptosis [Cell Function]

Phrase: "(BAX"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "and"

Phrase: "p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: ")"

Phrase: "genes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017337:Genes [Gene or Genome]

Phrase: "was"

Phrase: "analyzed by real-time PCR"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   862   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   806   C1550177:Real Time [Idea or Concept]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0040223:Time [Temporal Concept]
   760   C0237400:Real [Qualitative Concept]
   760   C0677874:pCR [Finding]
   760   C0936012:Analyzed [Research Activity]
   760   C3272377:REAL [Intellectual Product]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "SYBR Green I."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0386577:SYBR Green I [Indicator, Reagent, or Diagnostic Aid]
   827   C0021966:I- [Inorganic Chemical]
   827   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0332583:Green [Qualitative Concept]
Processing 00000000.tx.350: Target gene expression is normalized to GAPDH expression, and the results are expressed as fold change from media-only control cultures. 

Phrase: "Target gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C1332838:Target Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "normalized to GAPDH expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]
   770   C1414968:GAPDH [Gene or Genome]
   770   C1882115:Normalized [Research Activity]

Phrase: "and"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "expressed as fold change"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1880833:Fold Change [Quantitative Concept]
   770   C0332462:Fold [Spatial Concept]
   770   C0392747:Change [Functional Concept]
   770   C0443172:change [Quantitative Concept]
   770   C1705241:Change [Quantitative Concept]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "from media-only"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   861   C0009458:Media [Intellectual Product]
   861   C0162867:Media [Tissue]
   861   C0205171:Only [Quantitative Concept]
   861   C1254021:Media [Tissue]
   861   C1720467:Only [Intellectual Product]
   827 E C0439536:Medium [Quantitative Concept]
   827 E C1705217:Medium [Substance]
   827 E C3244283:medium [Intellectual Product]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "cultures."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.351: Mean  SE (n = 6 wells/treatment). 

Phrase: "Mean  SE (n = 6 wells/treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0039798:treatment [Functional Concept]
   799   C0087111:Treatment [Therapeutic or Preventive Procedure]
   799   C1522326:Treatment [Functional Concept]
   799   C1533734:Treatment [Therapeutic or Preventive Procedure]
   799   C1705169:Treatment [Conceptual Entity]
   799   C3538994:TREATMENT [Research Activity]

Phrase: ")."
Processing 00000000.tx.352: Results are representative of three independent experiments showing similar changes. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "representative of three independent experiments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1882932:Representative [Activity]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "similar changes."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.353: Significantly different from the control group at *p < 0.05; 

Phrase: "Significantly different from the control group at *p < 0.05"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1705242:Different [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.354: **p < 0.001.   

Phrase: "*"

Phrase: "*p < 0.001."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.355: DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Apoptosis has been implicated as a prominent form of cell death in many human neurodegenerative diseases including AD (Marx, 2001, 2003). 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "implicated as a prominent form of cell death"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0007587:Cell Death [Cell Function]
   744   C0007634:Cell [Cell]
   744   C0011065:Death [Organism Function]
   744   C0205402:Prominent [Qualitative Concept]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1269647:Cell [Cell]
   744   C1306577:Death, NOS [Finding]
   744   C1522492:Form [Functional Concept]
   744   C1704653:Cell [Medical Device]
   744   C1948049:Cell [Spatial Concept]

Phrase: "in many human neurodegenerative diseases"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   827   C0012634:Diseases [Disease or Syndrome]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "AD (Marx,"

Phrase: "2001,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.356: Understanding the role of environmental factors in the induction of apoptosis in the brain or alterations in natural apoptotic processes is vital to defining the etiology of neurodegenerative diseases. 

Phrase: "Understanding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0162340:Understanding [Mental Process]

Phrase: "the role of environmental factors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "in the brain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006104:Brain [Body Part, Organ, or Organ Component]
  1000   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "or"

Phrase: "alterations in natural apoptotic processes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1515926:Alteration [Idea or Concept]

Phrase: "is"

Phrase: "vital to defining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0442732:Vital [Qualitative Concept]
   790   C1875856:VITAL [Food]

Phrase: "the etiology of neurodegenerative diseases."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   781   C1314792:disease etiology [Functional Concept]
           Aetiology
   760   C0015127:aetiology [Functional Concept]
   760   C1524003:Etiology [Conceptual Entity]
Processing 00000000.tx.357: Recent studies have generated a strong body of evidence indicating the potential of Al-malt to induce apoptosis and neurodegeneration in the brain (Ghribi et al., 2001a, 2002a; Savory et al., 1999) as well as in vitro (Griffioen et al., 2004; Kawahara et al., 2003; Ohyashiki et al., 2002; Savory et al., 2001). 

Phrase: "Recent studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "have"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "a strong body of evidence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0242821:body [Human]
   760   C0460148:Body [Anatomical Structure]
   760   C1268086:Body [Anatomical Structure]

Phrase: "indicating"

Phrase: "the potential of Al-malt to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C3245505:Potential [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "neurodegeneration in the brain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "(Ghribi et al.,"

Phrase: "2001a,"

Phrase: "2002a"

Phrase: "; Savory et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: "as well as"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(Griffioen et al.,"

Phrase: "2004"

Phrase: "; Kawahara et al.,"

Phrase: "2003"

Phrase: "; Ohyashiki et al.,"

Phrase: "2002"

Phrase: "; Savory et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.358: In vitro models represent an effective system for determining the mechanisms involved in Al-malt-induced neurodegeneration. 

Phrase: "In vitro models"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   983   C1515654:In Vitro Model [Research Activity]
   827   C3161035:Models [Intellectual Product]
   734   C0021135:In Vitro [Intellectual Product]
   734   C1533691:in vitro [Qualitative Concept]
   734   C2827718:In Vitro [Functional Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an effective system for determining"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0449913:System [Functional Concept]
   760   C1553451:System [Manufactured Object]
   760   C1704459:System [Medical Device]

Phrase: "the mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in Al-malt-induced neurodegeneration."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0081548:aluminum maltolate [Organic Chemical]
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   753   C0205263:Induced [Functional Concept]
   753   C1314939:Involved [Functional Concept]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.359: The present study focused on characterizing the mode of cell death in N2a cells treated with Al-malt. 

Phrase: "The present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "focused on characterizing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205234:Focused [Spatial Concept]
   790   C1285542:focused [Functional Concept]

Phrase: "the mode of cell death"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1513371:Mode [Functional Concept]
   760   C1705738:Mode [Quantitative Concept]
   760   C2347637:Mode [Quantitative Concept]
   760   C2348146:Mode [Quantitative Concept]

Phrase: "in N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "treated with Al-malt."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.360: The results clearly show that apoptosis is induced by Al-malt and that necrosis also plays a role in the neurotoxicity. 

Phrase: "The results clearly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "induced by Al-malt"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0081548:aluminum maltolate [Organic Chemical]
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0205263:Induced [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "that necrosis also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027540:Necrosis [Organ or Tissue Function]
   861   C1334928:Necrosis [Finding]

Phrase: "plays"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:Plays [Finding]

Phrase: "a role in the neurotoxicity."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.361: We also determined the effects of pharmacological intervention on the toxicity of Al-malt. 

Phrase: "We also"

Phrase: "determined"

Phrase: "the effects of pharmacological intervention"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C1280500:effects [Qualitative Concept]
   747   C0728866:pharmacologic effects [Functional Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on the toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "of Al-malt."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.362: Al-malt-induced apoptosis was dependent upon de novo protein synthesis, as evidenced by a marked inhibition of toxicity in the presence of CHX. 

Phrase: "Al-malt-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "was"

Phrase: "dependent upon de novo protein synthesis,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0851827:Dependent [Qualitative Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "as"

Phrase: "evidenced by a marked inhibition of toxicity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   757   C0332120:Evidence of [Functional Concept]
           Evidence
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0040539:toxicity [Qualitative Concept]
   748   C0522501:Marked [Qualitative Concept]
   748   C0600688:Toxicity [Injury or Poisoning]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C1706089:Marked [Qualitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of CHX."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]
Processing 00000000.tx.363: Necrosis induced by Al-malt was not inhibited by CHX. 

Phrase: "Necrosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027540:Necrosis [Organ or Tissue Function]
  1000   C1334928:Necrosis [Finding]

Phrase: "induced by Al-malt"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0081548:aluminum maltolate [Organic Chemical]
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0205263:Induced [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibited by CHX."
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   790   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   790   C0311403:Inhibited [Qualitative Concept]
   734 E C0947670:Actidione [Antibiotic,Organic Chemical]
   718 E C0018790:arrested [Disease or Syndrome]
   718 E C0237477:Arrest [Temporal Concept]
   718 E C0392351:arrest [Governmental or Regulatory Activity]
   718 E C0521111:Retarded [Qualitative Concept]
Processing 00000000.tx.364: The manner in which a cell dies can have a great impact on the resulting response in the surrounding tissue. 

Phrase: "The manner in which a cell dies"

Phrase: "can"

Phrase: "have"

Phrase: "a great impact on the resulting response"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1825598:IMPACT [Gene or Genome]

Phrase: "in the surrounding tissue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.365: Death by necrosis has been shown to act as a natural adjuvant, inducing oxidative stress and the production of numerous pro-inflammatory cytokines (Anderson et al., 2002). 

Phrase: "Death by necrosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011065:Death [Organism Function]
   790   C1306577:Death, NOS [Finding]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act as a natural adjuvant,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0001551:Adjuvant, NOS [Immunologic Factor,Pharmacologic Substance]
   760   C0001552:Adjuvant [Chemical Viewed Functionally]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0205296:Natural [Functional Concept]
   760   C1522673:Adjuvant [Functional Concept]

Phrase: "inducing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Inducing [Functional Concept]

Phrase: "oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "and"

Phrase: "the production of numerous pro-inflammatory cytokines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1327413:cytokine production [Organism Function]
   748   C0033268:production [Occupational Activity]

Phrase: "(Anderson et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.366: This is due to the indiscriminant release of the cytoplasmic contents from the dying cells. 

Phrase: "This"

Phrase: "is due to the indiscriminant release of the cytoplasmic contents"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
   760   C0678226:Due to [Functional Concept]
           due
   739   C0010834:Cytoplasmic [Cell Component]
   739   C0030685:Release [Health Care Activity]
   739   C0391871:Release [Functional Concept]
   739   C0439180:% release [Quantitative Concept]
   739   C0456205:Contents [Conceptual Entity]
   739   C0521449:Cytoplasmic [Body Location or Region]
   739   C0680255:release [Health Care Activity]
   739   C1283071:Release [Functional Concept]
   739   C1552853:contents [Idea or Concept]
   739   C1963578:Release [Therapeutic or Preventive Procedure]
   739   C3146286:Due [Idea or Concept]
   706 E C0423896:Content [Mental Process]

Phrase: "from the dying cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.367: The result is an area of inflammation leading to immune-mediated damage of innocent cells surrounding the initial insult. 

Phrase: "The result"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "is"

Phrase: "an area of inflammation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0017446:Area [Geographic Area]
   770   C0205146:Area [Spatial Concept]

Phrase: "leading to immune-mediated damage of innocent cells"
Meta Candidates (Total=17; Excluded=7; Pruned=0; Remaining=10)
   767   C0599732:cells damage [Cell or Molecular Dysfunction]
   744   C0007634:Cells [Cell]
   744   C0010957:Damage [Injury or Poisoning]
   744   C0086597:mediated [Social Behavior]
   744   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   744   C0332152:Leading [Temporal Concept]
   744   C0439662:Immune [Functional Concept]
   744   C1522538:Leading [Functional Concept]
   744   C1883709:Damage [Functional Concept]
   744   C3282337:Cells [Cell]
   711 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   711 E C1269647:Cell [Cell]
   711 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
   711 E C2348269:Lead [Element, Ion, or Isotope]
   711 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "surrounding"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282914:Surrounding [Spatial Concept]

Phrase: "the initial insult."
Processing 00000000.tx.368: In contrast, death by apoptosis is a controlled event, usually with minimal loss of membrane integrity until the later stages termed secondary necrosis. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "death by apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0011065:Death [Organism Function]
   790   C1306577:Death, NOS [Finding]

Phrase: "is"

Phrase: "a controlled event,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441471:Event [Event]

Phrase: "usually with minimal loss of membrane integrity"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   748   C0025255:Membrane [Tissue]
   748   C0205266:integrity [Qualitative Concept]
   748   C0547040:Minimal [Qualitative Concept]
   748   C0596901:Membrane [Cell Component]
   748   C0872403:integrity [Individual Behavior]
   748   C1517945:Loss [Quantitative Concept]
   748   C1524031:MINIMAL [Qualitative Concept]
   748   C1706182:Membrane [Manufactured Object]
   748   C1947912:Integrity [Qualitative Concept]
   748   C2945599:Minimal [Qualitative Concept]

Phrase: "until the later stages"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   983   C1279941:late stages [Temporal Concept]
   861   C1306673:Stages [Qualitative Concept]
   827 E C0205390:Stage [Temporal Concept]
   827 E C1300072:Stage [Clinical Attribute]

Phrase: "termed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1515273:Term [Temporal Concept]
   966   C1705313:Term [Idea or Concept]
   966   C2826302:TERM [Intellectual Product]

Phrase: "secondary necrosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027540:Necrosis [Organ or Tissue Function]
   861   C1334928:Necrosis [Finding]
Processing 00000000.tx.369: Instead, the cytoplasmic contents are systematically degraded from within. 

Phrase: "Instead,"

Phrase: "the cytoplasmic contents"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0456205:Contents [Conceptual Entity]
   861   C1552853:contents [Idea or Concept]
   827 E C0423896:Content [Mental Process]

Phrase: "are"

Phrase: "systematically"

Phrase: "degraded from"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1881707:DEGRADED [Phenomenon or Process]

Phrase: "within."
Processing 00000000.tx.370: This type of cell death often involves phagocytosis by resident tissue macrophages and the release of anti-inflammatory cytokines (Fadok et al., 1998). 

Phrase: "This type of cell death often"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0449475:Type of cell [Intellectual Product]
           cell type
   783   C0007634:Cell Type [Cell]
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "involves"

Phrase: "phagocytosis by resident tissue macrophages"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031308:Phagocytosis [Cell Function]

Phrase: "and"

Phrase: "the release of anti-inflammatory cytokines"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "(Fadok et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.371: However, a recent study suggested that this contention may not always apply. 

Phrase: "However,"

Phrase: "a recent study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "this contention"

Phrase: "may"

Phrase: "not always"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1518422:Not [Functional Concept]
   861   C2003902:Always [Temporal Concept]

Phrase: "apply."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0185125:Apply [Health Care Activity]
  1000   C1632850:Apply [Functional Concept]
  1000   C1879355:Apply [Functional Concept]
Processing 00000000.tx.372: Jemmerson et al. 

Phrase: "Jemmerson et al."
Processing 00000000.tx.373: (2002) showed that cytochrome c, active caspase 3, and LDH were all released from apoptotic cells and that release began within 2 h of the initiating stimulus. 

Phrase: "(2002"

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that cytochrome c,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "active caspase 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "LDH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "all"

Phrase: "released from apoptotic cells"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C1516044:Apoptotic [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "that release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030685:Release [Health Care Activity]
  1000   C0391871:Release [Functional Concept]
  1000   C0439180:% release [Quantitative Concept]
  1000   C0680255:release [Health Care Activity]
  1000   C1283071:Release [Functional Concept]
  1000   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "began within 2 h of the initiating stimulus."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   767   C0011744:h 2 [Element, Ion, or Isotope]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0234402:Stimulus [Phenomenon or Process]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]
   711   C0439659:Begin [Temporal Concept]
   711   C1548602:Initiate [Idea or Concept]
   711   C1704686:Initiate [Functional Concept]
Processing 00000000.tx.374: Previously, it was thought that all of these proteins were degraded in the cytoplasm of apoptotic cells. 

Phrase: "Previously,"

Phrase: "it"

Phrase: "was"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "that"

Phrase: "all of these proteins"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]

Phrase: "were"

Phrase: "degraded in the cytoplasm of apoptotic cells."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   748   C0007634:Cells [Cell]
   748   C0010834:Cytoplasm [Cell Component]
   748   C1516044:Apoptotic [Qualitative Concept]
   748   C1881707:DEGRADED [Phenomenon or Process]
   748   C3282337:Cells [Cell]
   714 E C1269647:Cell [Cell]
   714 E C1704653:Cell [Medical Device]
   714 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.375: Therefore, apoptotic cell death may also substantially contribute to death-induced secondary inflammation and damage to surrounding tissues. 

Phrase: "Therefore,"

Phrase: "apoptotic cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:apoptotic cell death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "also substantially"

Phrase: "contribute to death-induced secondary inflammation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   783   C0175668:Secondary to [Temporal Concept]
           Secondary
   753   C0011065:Death [Organism Function]
   753   C0021368:Inflammation [Pathologic Function]
   753   C0027627:secondary [Neoplastic Process]
   753   C0205263:Induced [Functional Concept]
   753   C0205436:Secondary [Quantitative Concept]
   753   C1306577:Death, NOS [Finding]
   753   C1880177:Contribute [Activity]

Phrase: "and"

Phrase: "damage to surrounding tissues."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0010957:damage tissues [Injury or Poisoning]
           Damage
   770   C1883709:Damage [Functional Concept]
Processing 00000000.tx.376: The findings of this study confirm that LDH and active caspase 3 are released from apoptotic cells, since inhibition of apoptosis with CHX reduced LDH release and caspase 3 activity in the media. 

Phrase: "The findings of this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   797   C0683954:study findings [Finding]
   760   C2607943:findings [Functional Concept]
   760   C2926606:Findings [Clinical Attribute]
   760   C3539655:Findings [Intellectual Product]
   726 E C0037088:Finding [Sign or Symptom]
   726 E C0243095:Finding [Finding]
   726 E C2825141:Finding [Finding]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that LDH"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0022924:lactate [Organic Chemical]
   861   C0030016:Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0376261:Lactate [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "active caspase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "released from apoptotic cells,"
Meta Candidates (Total=12; Excluded=7; Pruned=0; Remaining=5)
   770   C0007634:Cells [Cell]
   770   C0391871:Released [Functional Concept]
   770   C1283071:Released [Functional Concept]
   770   C1516044:Apoptotic [Qualitative Concept]
   770   C3282337:Cells [Cell]
   737 E C0030685:Release [Health Care Activity]
   737 E C0439180:% release [Quantitative Concept]
   737 E C0680255:release [Health Care Activity]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1948049:Cell [Spatial Concept]
   737 E C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "since"

Phrase: "inhibition of apoptosis"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C1512772:Inhibition of Apoptosis [Cell Function]
           Apoptosis Inhibition
   790   C0021467:Inhibition [Mental Process]
   790   C0021469:Inhibition [Molecular Function]
   790   C1628982:% inhibition [Quantitative Concept]
   790   C3463820:Inhibition [Activity]
   718 E C0311403:Inhibited [Qualitative Concept]

Phrase: "with CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "LDH release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   734   C0022917:Lactate Dehydrogenase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "caspase 3 activity in the media."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C1150132:caspase-3 activity [Molecular Function]
   783   C1150130:caspase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.377: Results presented here support the hypothesis that the apoptosis seen in vivo following treatment with Al-malt could contribute to secondary immune-mediated damage and further neurodegeneration. 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "that"

Phrase: "the apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "seen"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0205397:Seen [Qualitative Concept]
   966 E C0042789:see [Organism Function]
   966 E C1947903:See [Activity]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment with Al-malt"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "could"

Phrase: "contribute to secondary immune-mediated damage"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   783   C0175668:Secondary to [Temporal Concept]
           Secondary
   753   C0010957:Damage [Injury or Poisoning]
   753   C0027627:secondary [Neoplastic Process]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0205436:Secondary [Quantitative Concept]
   753   C0439662:Immune [Functional Concept]
   753   C1880177:Contribute [Activity]
   753   C1883709:Damage [Functional Concept]

Phrase: "and"

Phrase: "further neurodegeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
Processing 00000000.tx.378: Caspases are important mediators of apoptosis, and caspase activation has been demonstrated in Al-malt-induced neurodegeneration (Ghribi et al., 2001a, 2002a,b). 

Phrase: "Caspases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010656:Caspases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "are"

Phrase: "important mediators of apoptosis,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   737 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "caspase activation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1159825:Caspase Activation [Molecular Function]
   861   C1879547:Activation [Activity]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated in Al-malt-induced neurodegeneration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0081548:aluminum maltolate [Organic Chemical]
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   753   C0205263:Induced [Functional Concept]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "(Ghribi et al.,"

Phrase: "2001a,"

Phrase: "2002a,"

Phrase: "b"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.379: Our in vitro N2a cell model also showed strong caspase 3 activation in response to Al-malt treatment. 

Phrase: "Our in vitro N2a cell model also"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   884   C1515654:In Vitro Model [Research Activity]
   795   C3161035:Model [Intellectual Product]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "strong caspase 3 activation in response"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C1159825:Caspase Activation [Molecular Function]
   753   C1879547:Activation [Activity]

Phrase: "to Al-malt treatment."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0039798:treatment [Functional Concept]
   827   C0087111:Treatment [Therapeutic or Preventive Procedure]
   827   C1522326:Treatment [Functional Concept]
   827   C1533734:Treatment [Therapeutic or Preventive Procedure]
   827   C1705169:Treatment [Conceptual Entity]
   827   C3538994:TREATMENT [Research Activity]
   734   C0081548:aluminum maltolate [Organic Chemical]
Processing 00000000.tx.380: Inhibition of protein synthesis using CHX inhibited apoptotic cell death and the activation of caspase 3 in Al-malt-treated cells, implicating de novo protein synthesis in the activation of this death effector. 

Phrase: "Inhibition of protein synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   881   C1519619:Protein Synthesis Inhibition [Genetic Function]
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "CHX"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   944 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "apoptotic cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:apoptotic cell death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "and"

Phrase: "the activation of caspase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1159825:Caspase Activation [Molecular Function]
   760   C1879547:Activation [Activity]

Phrase: "in Al-malt-treated cells,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   812   C0007634:Cells [Cell]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "implicating"

Phrase: "de novo protein synthesis in the activation of this death effector."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   756   C0597295:Protein Synthesis [Molecular Function]
   754   C0599177:protein activation [Genetic Function]
   738   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   738   C0220781:synthesis [Biologic Function]
   738   C1883254:Synthesis [Activity]
   718 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.381: Protein synthesis could affect the regulation of caspase 3 in two ways: (1) new pro-caspase 3 synthesis and (2) synthesis of other proteins required for caspase 3 activation. 

Phrase: "Protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0597295:Protein Synthesis [Molecular Function]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0220781:synthesis [Biologic Function]
   861   C1883254:Synthesis [Activity]

Phrase: "could"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the regulation of caspase 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0851285:Regulation [Governmental or Regulatory Activity]
   760   C1327622:Regulation [Biologic Function]

Phrase: "in two ways"

Phrase: ":"

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "new pro-caspase 3 synthesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0220781:synthesis [Biologic Function]
   804   C1883254:Synthesis [Activity]
   717   C0758915:Pro-Caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and ("

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "synthesis of other proteins"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   802   C0597295:Protein Synthesis [Molecular Function]
   770   C0220781:synthesis [Biologic Function]
   770   C1883254:Synthesis [Activity]
   767 E C0597552:synthetic protein [Amino Acid, Peptide, or Protein]

Phrase: "required for caspase 3 activation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   797   C1159825:Caspase Activation [Molecular Function]
   760   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1514873:Required [Functional Concept]
   760   C1879547:Activation [Activity]
Processing 00000000.tx.382: Our results show that the expression of BAX mRNA is increased in N2a cells following treatment with Al-malt. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "that"

Phrase: "the expression of BAX mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1515670:mRNA Expression [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "increased in N2a cells"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007634:Cells [Cell]
   760   C0205217:Increased [Quantitative Concept]
   760   C0442805:Increased [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment with Al-malt."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]
Processing 00000000.tx.383: BAX is an important mediator of the mitochondrial intrinsic pathway leading to caspase 3 activation and apoptosis and likely represents one of the pro-apoptotic factors down-regulated by CHX in this system. 

Phrase: "BAX"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0812198:BAX [Gene or Genome]

Phrase: "is"

Phrase: "an important mediator of the mitochondrial intrinsic pathway"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "leading to caspase 3 activation"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   806   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
   797   C1159825:Caspase Activation [Molecular Function]
   760   C0010656:caspase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0332152:Leading [Temporal Concept]
   760   C1522538:Leading [Functional Concept]
   760   C1879547:Activation [Activity]
   726 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   726 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   726 E C2348269:Lead [Element, Ion, or Isotope]
   726 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "one of the pro-apoptotic factors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "down-regulated by CHX"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   715   C0423866:Lanugo [Body Part, Organ, or Organ Component]
   715 E C0947670:Actidione [Antibiotic,Organic Chemical]
   715   C2626739:Lanugo [Eukaryote]

Phrase: "in this system."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0449913:System [Functional Concept]
  1000   C1553451:System [Manufactured Object]
  1000   C1704459:System [Medical Device]
   928 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.384: The involvement of de novo protein synthesis in toxicant-induced apoptosis has been demonstrated previously (Chow et al., 1995). 

Phrase: "The involvement of de novo protein synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1314939:Involvement [Functional Concept]

Phrase: "in toxicant-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "previously"

Phrase: "(Chow et al.,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.385: Our finding of a marked decrease in the neurotoxicity of Al-malt in the presence of the protein synthesis inhibitor CHX suggests that Al-malt-induced apoptosis is at least partially dependent on de novo protein synthesis. 

Phrase: "Our finding of a marked decrease"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0037088:Finding [Sign or Symptom]
   753   C0243095:Finding [Finding]
   753   C2825141:Finding [Finding]

Phrase: "in the neurotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0235032:Neurotoxicity [Injury or Poisoning]

Phrase: "of Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of the protein synthesis inhibitor CHX"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0010572:Cycloheximide [Antibiotic,Organic Chemical]
   756   C0033671:Protein Synthesis Inhibitor [Pharmacologic Substance]
   756 E C0947670:Actidione [Antibiotic,Organic Chemical]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that Al-malt-induced apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0162638:Apoptosis [Cell Function]
   741 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is at least partially dependent"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0851827:Dependent [Qualitative Concept]
   760   C1701901:Dependent [Qualitative Concept]
   760   C3244310:dependent [Functional Concept]

Phrase: "on de novo protein synthesis."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0597295:Protein Synthesis [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220781:synthesis [Biologic Function]
   812   C1883254:Synthesis [Activity]
Processing 00000000.tx.386: Several candidate proteins have been identified from in vivo studies in the rabbit brain. 

Phrase: "Several candidate proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "identified from in vivo studies"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   845   C0681829:in vivo study [Research Activity]
           studies vivo
   806   C1515655:In Vivo [Spatial Concept]
           vivo
   760   C0205396:Identified [Qualitative Concept]
   760   C0947630:studies [Laboratory Procedure]
   760   C1550043:Identified [Finding]
   760   C1551388:Identified [Functional Concept]
   726 E C0557651:Study [Manufactured Object]
   726 E C2603343:Study [Research Activity]

Phrase: "in the rabbit brain."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.387: The pro-apoptotic protein BAX has been implicated in Al-malt-induced neurodegeneration in the rabbit (Ghribi et al., 2001a, 2002a; Savory et al., 1999). 

Phrase: "The pro-apoptotic protein BAX"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0812198:BAX [Gene or Genome]
   708   C0379214:pro protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "implicated in Al-malt-induced neurodegeneration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0081548:aluminum maltolate [Organic Chemical]
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   753   C0205263:Induced [Functional Concept]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "in the rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "(Ghribi et al.,"

Phrase: "2001a,"

Phrase: "2002a"

Phrase: "; Savory et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.388: Present data demonstrates that Al-malt increased the expression of BAX in N2a cells. 

Phrase: "Present data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "demonstrates"

Phrase: "that Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression of BAX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in N2a cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.389: Studies with other chemicals including nitric oxide (NO) showed that apoptosis can be accompanied by an increase in BAX protein synthesis (Chen et al., 2002). 

Phrase: "Studies with other chemicals"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0947630:studies [Laboratory Procedure]
   737 E C0557651:Study [Manufactured Object]
   737 E C2603343:Study [Research Activity]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "nitric oxide (NO)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "can"

Phrase: "be"

Phrase: "accompanied by an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442805:Increase [Functional Concept]

Phrase: "in BAX protein synthesis"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0219474:Bax protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C0597295:Protein Synthesis [Molecular Function]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0220781:synthesis [Biologic Function]
   827   C1883254:Synthesis [Activity]

Phrase: "(Chen et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.390: Inhibition of protein synthesis partially inhibited the apoptosis suggesting that de novo synthesis of BAX may be responsible for the apoptosis induced by NO. 

Phrase: "Inhibition of protein synthesis partially"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   844   C1519619:Protein Synthesis Inhibition [Genetic Function]
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that de novo synthesis of BAX"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0220781:synthesis [Biologic Function]
   753   C1883254:Synthesis [Activity]

Phrase: "may"

Phrase: "be"

Phrase: "responsible for the apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1273518:Responsible [Finding]

Phrase: "induced by NO."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   770   C0030015:oxide [Inorganic Chemical]
   770   C0205263:Induced [Functional Concept]
   770   C2986642:oxide [Chemical Viewed Functionally]
Processing 00000000.tx.391: The demonstration of increased BAX immunoreactivity in the CA1 region of the hippocampus (Ghribi et al., 2002b; Savory et al., 1999) of rabbits treated with Al-malt and our data showing increase BAX mRNA expression strongly support a role for new BAX synthesis in the induction of apoptosis in these models. 

Phrase: "The demonstration of increased BAX immunoreactivity"

Phrase: "in the CA1 region"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0017446:Region [Geographic Area]
   861   C0205147:Region [Spatial Concept]
   789 E C0205276:Regional [Spatial Concept]
   789 E C1947913:Regional [Spatial Concept]

Phrase: "of the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "(Ghribi et al.,"

Phrase: "2002b"

Phrase: "; Savory et al.,"

Phrase: "1999"

Phrase: ")"

Phrase: "of rabbits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "showing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "increase BAX mRNA expression strongly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C1515670:mRNA Expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "a role for new BAX synthesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205263:Induction [Functional Concept]
  1000   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "of apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "in these models."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3161035:Models [Intellectual Product]
Processing 00000000.tx.392: We also observed a dramatic down-regulation of Bcl2 expression following treatment of N2a cells with Al-malt. 

Phrase: "We also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "a dramatic down-regulation of Bcl2 expression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0013081:Down-Regulation [Cell Function,Molecular Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment of N2a cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "with Al-malt."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.393: A similar down-regulation of Bcl2 immunoreactivity is observed in the brain of aged rabbits following treatment with Al-malt (Savory et al., 1999). 

Phrase: "A similar down-regulation of Bcl2 immunoreactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C0013081:Down-Regulation [Cell Function,Molecular Function]
   748   C0851285:Regulation [Governmental or Regulatory Activity]
   748   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "observed in the brain of aged rabbits"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0001779:Aged [Organism Attribute]
   748   C0001792:Aged [Population Group]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0034493:Rabbit [Mammal]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1441672:Observed [Functional Concept]
   748   C1999167:aged [Population Group]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "treatment with Al-malt"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "(Savory et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.394: It is clearly evident that the intrinsic pathway of apoptosis involving altered Bcl2/BAX ratio is critical to Al-malt apoptosis. 

Phrase: "It"

Phrase: "is"

Phrase: "clearly evident"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the intrinsic pathway of apoptosis"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   844   C1720828:Apoptosis, Intrinsic Pathway [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   811 E C3269143:intrinsic apoptotic pathway [Molecular Function]
   797   C0162638:Apoptosis Pathway [Cell Function]
   797   C3269144:intrinsic apoptosis [Molecular Function]
   760   C0205102:Intrinsic [Spatial Concept]
   760   C0439674:Intrinsic [Functional Concept]
   760   C1704259:Pathway [Molecular Function]
   760   C1705987:Pathway [Conceptual Entity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "altered Bcl2/BAX ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0456603:Ratio [Quantitative Concept]
   812   C1547037:Ratio [Intellectual Product]

Phrase: "is"

Phrase: "critical to Al-malt apoptosis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511545:Critical [Qualitative Concept]
Processing 00000000.tx.395: The tumor suppressor gene product p53 is an important activator of the intrinsic apoptotic pathway. 

Phrase: "The tumor suppressor gene product p53"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   911   C0079419:tumor suppressor p53 [Gene or Genome]
           gene p53
           P53
   911   C0080055:Tumor Suppressor p53 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   804   C1705526:p53 [Gene or Genome]
   717   C0079427:Tumor suppressor gene [Gene or Genome]

Phrase: "is"

Phrase: "an important activator of the intrinsic apoptotic pathway."
Processing 00000000.tx.396: Here, we demonstrate for the first time that Al-malt induces the expression of p53 in neuronal cells. 

Phrase: "Here,"

Phrase: "we"

Phrase: "demonstrate for the first time"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   760   C0040223:Time [Temporal Concept]
   760   C0205435:First [Quantitative Concept]
   760   C1279901:First [Qualitative Concept]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]

Phrase: "that Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the expression of p53"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in neuronal cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.397: Up-regulation of p53 is commonly observed following exposure to DNA-damaging agents such as UV light. 

Phrase: "Up-regulation of p53"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0041904:Up-Regulation [Cell Function,Molecular Function]
   833   C0162493:Up-Regulation [Genetic Function]
   770   C0547043:Up [Spatial Concept]
   770   C0851285:Regulation [Governmental or Regulatory Activity]
   770   C1282911:Up [Spatial Concept]
   770   C1327622:Regulation [Biologic Function]

Phrase: "is"

Phrase: "commonly"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "exposure to DNA-damaging agents"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332157:Exposure to [Clinical Attribute]
           Exposure
   760   C0274281:Exposure, NOS [Injury or Poisoning]

Phrase: "such as UV light."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0041625:UV Light [Natural Phenomenon or Process]
           UV
   861   C0023693:Light [Natural Phenomenon or Process]
   861   C1306462:Light [Functional Concept]
   861   C1881376:Light [Qualitative Concept]
   861   C1961129:uV [Quantitative Concept]
Processing 00000000.tx.398: Increased production of growth arrest and DNA damage inducible factor 153 suggests that DNA damage may be induced in the brain of Al-malt-treated rabbits (Ghribi et al., 2001b) and could lead to activation of p53. 

Phrase: "Increased production of growth arrest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "DNA damage inducible factor 153"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   840   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   804   C0010957:Damage [Injury or Poisoning]
   804   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0205263:Inducible [Functional Concept]
   804   C0669372:Inducible NOS [Amino Acid, Peptide, or Protein,Enzyme]
   804   C1521761:Factor [Functional Concept]
   804   C1883709:Damage [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that DNA damage"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012860:DNA Damage [Cell or Molecular Dysfunction]
   861   C0010957:Damage [Injury or Poisoning]
   861   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   861   C1883709:Damage [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "induced in the brain of Al-malt-treated rabbits"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C0081548:aluminum maltolate [Organic Chemical]
   742   C0002367:Aluminium [Element, Ion, or Isotope]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0034493:Rabbit [Mammal]
   742   C0205263:Induced [Functional Concept]
   742   C0332293:treated [Therapeutic or Preventive Procedure]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C1522326:Treated [Functional Concept]
   742   C2348254:ALUMINUM [Element, Ion, or Isotope]
   708 E C1292734:TREAT [Functional Concept]

Phrase: "(Ghribi et al.,"

Phrase: "2001b"

Phrase: ")"

Phrase: "and"

Phrase: "could"

Phrase: "lead to activation of p53."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   760   C0079419:P53 [Gene or Genome]
   760   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   760   C1522538:Lead [Functional Concept]
   760   C1705526:p53 [Gene or Genome]
   760   C1879547:Activation [Activity]
   760   C2348269:Lead [Element, Ion, or Isotope]
   760   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.399: Tumor suppressor p53 has been shown to differentially regulate Bcl2 and BAX levels both in vitro and in vivo (Miyashita et al., 1994b). 

Phrase: "Tumor suppressor p53"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0079419:tumor suppressor p53 [Gene or Genome]
           P53
  1000   C0080055:Tumor Suppressor p53 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1705526:p53 [Gene or Genome]
   734   C0079427:Tumor Suppressor [Gene or Genome]
   734   C1325410:tumor suppressor [Cell Function]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to differentially"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "regulate"

Phrase: "Bcl2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376515:BCL2 [Gene or Genome]
  1000   C0597712:BCL2 [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "BAX levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "(Miyashita et al.,"

Phrase: "1994b"

Phrase: ")."
Processing 00000000.tx.400: Increased production of BAX following p53 activation is due to p53 being a direct transactivator of BAX gene expression (Miyashita and Reed, 1995). 

Phrase: "Increased production of BAX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "p53 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "is due to p53"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0079419:P53 [Gene or Genome]
   770   C1705526:p53 [Gene or Genome]
   770   C3146286:Due [Idea or Concept]

Phrase: "being"

Phrase: "a direct transactivator of BAX gene expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0040627:Trans-Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Miyashita"

Phrase: "and"

Phrase: "Reed,"

Phrase: "1995"

Phrase: ")."
Processing 00000000.tx.401: Importantly, a p53-dependent negative response element is present in the 5' untranslated region of the Bcl2 gene and is responsible for potent transcriptional down-regulation following p53 activation (Miyashita et al., 1994a). 

Phrase: "Importantly,"

Phrase: "a p53-dependent negative response element"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0600508:Response Element [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   804   C0013879:Element [Element, Ion, or Isotope]
   804   C0871261:Response [Organism Attribute]
   804   C1704632:Response [Finding]
   804   C1705248:Element [Conceptual Entity]
   804   C1706817:Response [Intellectual Product]
   804   C2911692:Response [Mental Process]

Phrase: "is"

Phrase: "present in the 5' untranslated region of the Bcl2 gene"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0150312:Present [Quantitative Concept]
   739   C0449450:Present [Idea or Concept]

Phrase: "and"

Phrase: "is"

Phrase: "responsible for potent transcriptional down-regulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1273518:Responsible [Finding]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "p53 activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "(Miyashita et al.,"

Phrase: "1994a"

Phrase: ")."
Processing 00000000.tx.402: Our observations of decreased Bcl2 and increased BAX expression concomitant with increased p53 expression suggest that apoptosis induced by Al-malt in N2a cells may be controlled by the p53 pathway, and further studies are warranted. 

Phrase: "Our observations of decreased Bcl2"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0302523:observations [Research Activity]
   760   C0700325:observations [Health Care Activity]
   760   C3244290:observations [Functional Concept]
   726 E C1964257:Observation [Diagnostic Procedure]

Phrase: "and"

Phrase: "increased BAX expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "concomitant with increased p53 expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0521115:Concomitant [Temporal Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induced by Al-malt"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0081548:aluminum maltolate [Organic Chemical]
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0205263:Induced [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "in N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "may"

Phrase: "be"

Phrase: "controlled by the p53 pathway,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   806   C0332298:Controlled by [Functional Concept]
   806   C2984374:p53 pathway [Functional Concept]
   760   C0079419:P53 [Gene or Genome]
   760   C1704259:Pathway [Molecular Function]
   760   C1705526:p53 [Gene or Genome]
   760   C1705987:Pathway [Conceptual Entity]
   760   C2587213:Controlled [Functional Concept]
   726 E C0243148:control [Qualitative Concept]
   726 E C1550141:Control [Substance]
   726 E C1882979:Control [Conceptual Entity]
   726 E C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "further studies"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0947630:studies [Laboratory Procedure]
   827 E C0557651:Study [Manufactured Object]
   827 E C2603343:Study [Research Activity]

Phrase: "are"

Phrase: "warranted."
Processing 00000000.tx.403: In conclusion, the results of the present study strongly suggest that apoptosis is a prominent form of cell death in N2a cells treated with Al-malt, thus supporting previous in vivo findings. 

Phrase: "In conclusion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "the results of the present study strongly"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   774   C0683954:results study [Finding]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "is"

Phrase: "a prominent form of cell death"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "in N2a cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "treated with Al-malt,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "thus"

Phrase: "supporting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0183683:Support [Medical Device]
   966   C1521721:Support [Conceptual Entity]

Phrase: "previous in vivo findings."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   812   C2607943:findings [Functional Concept]
   812   C2926606:Findings [Clinical Attribute]
   812   C3539655:Findings [Intellectual Product]
   779 E C0037088:Finding [Sign or Symptom]
   779 E C0243095:Finding [Finding]
   779 E C2825141:Finding [Finding]
Processing 00000000.tx.404: However, necrotic cell death was also apparent in N2a cells and may play a role in the neurotoxicity of Al-malt observed in vivo. 

Phrase: "However,"

Phrase: "necrotic cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0027540:necrotic cell death [Organ or Tissue Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "was"

Phrase: "also apparent in N2a cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0750489:apparent [Idea or Concept]

Phrase: "and"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the neurotoxicity of Al-malt"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0035820:Role [Social Behavior]
   744   C1705810:Role [Conceptual Entity]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.405: The substantial release of intracellular enzymes observed in these cells even when dying by apoptosis has implications for the involvement of secondary damage induced by immune activation and inflammation in Al-malt neurotoxicity. 

Phrase: "The substantial release of intracellular enzymes"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "observed in these cells even"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0007634:Cells [Cell]
   760   C1441672:Observed [Functional Concept]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "when"

Phrase: "dying by apoptosis"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
   790   C0162638:Apoptosis [Cell Function]
   790   C0184532:dying [Organism Function]
   718 E C0011065:Expired [Organism Function]
   718 E C0231800:Expired [Organ or Tissue Function]
   718 E C1516044:Apoptotic [Qualitative Concept]
   718 E C1704631:Expire [Idea or Concept]

Phrase: "has"

Phrase: "implications for the involvement of secondary damage induced"

Phrase: "by immune activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "inflammation in Al-malt neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0021368:Inflammation [Pathologic Function]
Processing 00000000.tx.406: Furthermore, the inhibitory effect of CHX on Al-malt-induced cell death indicates that de novo protein synthesis is intimately involved in the resulting neurotoxicity. 

Phrase: "Furthermore,"

Phrase: "the inhibitory effect of CHX"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "on Al-malt-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   840   C0007587:Cell Death [Cell Function]
   804   C0007634:Cell [Cell]
   804   C0011065:Death [Organism Function]
   804   C1269647:Cell [Cell]
   804   C1306577:Death, NOS [Finding]
   804   C1704653:Cell [Medical Device]
   804   C1948049:Cell [Spatial Concept]

Phrase: "indicates"

Phrase: "that de novo protein synthesis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0597295:Protein Synthesis [Molecular Function]
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0220781:synthesis [Biologic Function]
   812   C1883254:Synthesis [Activity]

Phrase: "is"

Phrase: "intimately"

Phrase: "involved in the resulting neurotoxicity."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   797   C0332294:Resulting in [Functional Concept]
   760   C0235032:Neurotoxicity [Injury or Poisoning]
   760   C0678226:resulting [Functional Concept]
   760   C1314939:Involved [Functional Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]
Processing 00000000.tx.407: The observed shift in Bcl2/BAX ratio confirms in vivo findings, and our data suggest that p53 is a potential mediator of this effect. 

Phrase: "The observed shift in Bcl2/BAX ratio"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0333051:Shift [Functional Concept]
   748   C2347509:Shift [Phenomenon or Process]

Phrase: "confirms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "in vivo findings,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   827   C2607943:findings [Functional Concept]
   827   C2926606:Findings [Clinical Attribute]
   827   C3539655:Findings [Intellectual Product]
   793 E C0037088:Finding [Sign or Symptom]
   793 E C0243095:Finding [Finding]
   793 E C2825141:Finding [Finding]
   734   C1515655:In Vivo [Spatial Concept]

Phrase: "and"

Phrase: "our data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that p53"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079419:P53 [Gene or Genome]
  1000   C1705526:p53 [Gene or Genome]

Phrase: "is"

Phrase: "a potential mediator of this effect."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.408: Detailed investigation of the p53 pathway in response to treatment with Al-malt will greatly improve our understanding of the mechanisms involved in Al neurotoxicity and may provide insight into the etiology of neurodegenerative diseases including AD. 

Phrase: "Detailed investigation of the p53 pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1261322:Investigation [Health Care Activity]
   753   C1552578:investigation [Idea or Concept]

Phrase: "in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0871261:Response [Organism Attribute]
  1000   C1704632:Response [Finding]
  1000   C1706817:Response [Intellectual Product]
  1000   C2911692:Response [Mental Process]

Phrase: "to treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "with Al-malt"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0081548:aluminum maltolate [Organic Chemical]
   861   C0002367:Aluminium [Element, Ion, or Isotope]
   861   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "will"

Phrase: "greatly"

Phrase: "improve"

Phrase: "our understanding of the mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0162340:Understanding [Mental Process]

Phrase: "involved in Al neurotoxicity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C0235032:Neurotoxicity [Injury or Poisoning]
   770   C1314939:Involved [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "may"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "insight into the etiology of neurodegenerative diseases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0233820:Insight [Mental Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "AD."
Processing 00000000.tx.409: Such research may also lead to effective strategies for therapeutic intervention in human neurodegenerative diseases. 

Phrase: "Such research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "may"

Phrase: "also"

Phrase: "lead to effective strategies"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0679199:strategies [Mental Process]
   770   C1280519:effective [Qualitative Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C1704419:Effective [Qualitative Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "for therapeutic intervention"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0808232:Therapeutic Intervention [Therapeutic or Preventive Procedure]
   861   C0886296:intervention [Health Care Activity]
   861   C1273869:Intervention [Health Care Activity]
   861   C1948041:Intervention [Therapeutic or Preventive Procedure]
   789 E C3274035:INTERVENTIONAL [Research Activity]

Phrase: "in human neurodegenerative diseases."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   901   C0524851:Neurodegenerative Diseases [Disease or Syndrome]
   827   C0012634:Diseases [Disease or Syndrome]
   755 E C1836721:MALS [Finding]
   755 E C3538764:MALS [Gene or Genome]
   755 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.410: The present in vitro model shows many of the molecular characteristics present in the brains of rabbits treated with Al-malt and thus is an important in vitro alternative for further mechanistic studies.  

Phrase: "The present in vitro model"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   923   C1515654:In Vitro Model [Research Activity]
   812   C3161035:Model [Intellectual Product]

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "many of the molecular characteristics"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439064:Many [Quantitative Concept]
   760   C0747726:many [Conceptual Entity]
   760   C1521970:Characteristics [Qualitative Concept]
   760   C1521991:Molecular [Qualitative Concept]

Phrase: "present in the brains of rabbits"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0034493:Rabbit [Mammal]
   753   C0150312:Present [Quantitative Concept]
   753   C0449450:Present [Idea or Concept]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "treated with Al-malt"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   833   C0081548:aluminum maltolate [Organic Chemical]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C1522326:Treated [Functional Concept]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "thus"

Phrase: "is"

Phrase: "an important in vitro alternative for further mechanistic studies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1523987:Alternative [Conceptual Entity]
Processing 00000000.tx.411: ACKNOWLEDGMENTS  Partial support of this work by Center for Academic Excellence in Toxicology at the University of Georgia and Fred C. 

Phrase: "ACKNOWLEDGMENTS  Partial support of this work"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0183683:Support [Medical Device]
   753   C1521721:Support [Conceptual Entity]

Phrase: "by Center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: "for Academic Excellence"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   789   C1548784:Excellent [Qualitative Concept]
   789   C1961136:Excellent [Qualitative Concept]

Phrase: "in Toxicology"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0040541:Toxicology [Biomedical Occupation or Discipline]
  1000   C1548006:Toxicology [Intellectual Product]
   928 E C0205472:Toxicologic [Functional Concept]

Phrase: "at the University of Georgia"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0017452:Georgia [Geographic Area]
   827   C0017454:Georgia [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   755 E C0337804:georgian [Population Group]

Phrase: "and"

Phrase: "Fred C."
Processing 00000000.tx.412: Davison Endowment is gratefully acknowledged.  

Phrase: "Davison Endowment"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0014265:Endowment [Quantitative Concept]

Phrase: "is"

Phrase: "gratefully"

Phrase: "acknowledged."
Processing 00000000.tx.413: NOTES  1 Current address for V. 

Phrase: "NOTES"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "1 Current address for V."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0376649:Address [Intellectual Product]
   760   C1442065:Address [Spatial Concept]
Processing 00000000.tx.414: J. 

Phrase: "J."
Processing 00000000.tx.415: Johnson, Toxicology abd Molecular Biology Branch, National Institute of Occupational Safety and Health, Morgan Town, WV 26505. 

Phrase: "Johnson,"

Phrase: "Toxicology abd Molecular Biology Branch,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1253959:Branch [Body Part, Organ, or Organ Component]
   804   C1881507:Branch [Chemical Viewed Structurally]
   804   C2700383:Branch [Plant]
   804   C2826234:BRANCH [Intellectual Product]

Phrase: "National Institute of Occupational Safety and Health,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   900   C0027468:national institute health [Health Care Related Organization]
   852   C0262668:occupational safety health [Biomedical Occupation or Discipline]
   845   C0079920:Occupational Health [Occupation or Discipline]
   818   C0079921:Safety, Occupational [Idea or Concept]
   795   C0018684:Health [Idea or Concept]
   795   C0021622:institute [Organization]
   795   C0036043:Safety [Human-caused Phenomenon or Process]
   795   C0521127:Occupational [Functional Concept]
   795   C1272753:Institute [Idea or Concept]
   795   C1705187:SAFETY [Research Activity]
   795   C3245503:national [Intellectual Product]

Phrase: "Morgan Town,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0557750:Town [Geographic Area]

Phrase: "WV 26505."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0043127:WV [Geographic Area]
Processing 00000000.tx.416: 2 To whom correspondence should be addressed at Department of Physiology and Pharmacology, College of Veterinary Medicine, The University of Georgia, Athens, GA 306027389. 

Phrase: "2 To whom correspondence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0282413:Correspondence [Intellectual Product]
   770   C0740116:+2 [Quantitative Concept]
   770   C2827735:2+ [Quantitative Concept]
   770   C2981700:2+ [Classification]

Phrase: "should"

Phrase: "be"

Phrase: "addressed at Department of Physiology"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0031842:Physiology [Biomedical Occupation or Discipline]
   760   C0031843:physiology [Physiologic Function]
   760   C1704729:Department [Organization]
   726   C0376649:Address [Intellectual Product]
   726   C1442065:Address [Spatial Concept]

Phrase: "and"

Phrase: "Pharmacology,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0031330:Pharmacology [Biomedical Occupation or Discipline]
  1000   C1524059:pharmacology [Functional Concept]
   928 E C0205464:Pharmacologic [Functional Concept]

Phrase: "College of Veterinary Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0557806:College [Manufactured Object]

Phrase: "The University of Georgia,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0017452:Georgia [Geographic Area]
   827   C0017454:Georgia [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   755 E C0337804:georgian [Population Group]

Phrase: "Athens,"

Phrase: "GA 306027389."
Processing 00000000.tx.417: Fax: (706) 542-3015. 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "(706"

Phrase: ")"

Phrase: "542-3015."
Processing 00000000.tx.418: E-mail: rpsharma{at}vet.uga.edu .  REFERENCES TOP ABSTRACT INTRODUCTION MATERIALS AND METHODS RESULTS DISCUSSION REFERENCES  Abreo, K., Abreo, F., Sella, M. 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "rpsharma{at}vet.uga.edu ."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0059804:EDU [Organic Chemical,Pharmacologic Substance]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION MATERIALS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "AND"

Phrase: "METHODS RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Abreo,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Abreo,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Sella,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.419: L., and Jain, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Jain,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0337694:Jain [Idea or Concept]
  1000   C1998092:Jain [Population Group]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.420: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.421: Aluminum enhances iron uptake and expression of neurofibrillary tangle protein in neuroblastoma cells. 

Phrase: "Aluminum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "iron uptake"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243144:Uptake [Physiologic Function]
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0347980:% uptake [Quantitative Concept]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "and"

Phrase: "expression of neurofibrillary tangle protein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C1171362:expression protein [Genetic Function]
   760   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in neuroblastoma cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   983   C0815000:neuroblastoma cell [Cell]
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.422: J. 

Phrase: "J."
Processing 00000000.tx.423: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.424: 72, 20592064.[CrossRef][ISI][Medline] Akiyama, H., Barger, S., Barnum, S., Bradt, B., Bauer, J., Cole, G. 

Phrase: "72,"

Phrase: "20592064."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Akiyama,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Barger,"

Phrase: "S."

Phrase: ","

Phrase: "Barnum,"

Phrase: "S."

Phrase: ","

Phrase: "Bradt,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Bauer,"

Phrase: "J.,"

Phrase: "Cole,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.425: M., Cooper, N. 

Phrase: "M."

Phrase: ","

Phrase: "Cooper,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0335912:Cooper [Professional or Occupational Group]

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.426: R., Eikelenboom, P., Emmerling, M., Fiebich, B. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Eikelenboom,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Emmerling,"

Phrase: "M."

Phrase: ","

Phrase: "Fiebich,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.427: L., et al. 

Phrase: "L., et al."
Processing 00000000.tx.428: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.429: Inflammation and Alzheimer's disease. 

Phrase: "Inflammation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021368:Inflammation [Pathologic Function]

Phrase: "and"

Phrase: "Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.430: Neurobiol. 

Phrase: "Neurobiol."
Processing 00000000.tx.431: Aging 21, 383421.[CrossRef][ISI][Medline] Anderson, H. 

Phrase: "Aging"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0001811:Aging [Organism Function]
   966 E C0001779:Age [Organism Attribute]

Phrase: "21,"

Phrase: "383421."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Anderson,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.432: A., Englert, R., Gursel, I., and Shacter, E. 

Phrase: "A.,"

Phrase: "Englert,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gursel,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Shacter,"

Phrase: "E."
Processing 00000000.tx.433: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.434: Oxidative stress inhibits the phagocytosis of apoptotic cells that have externalized phosphatidylserine. 

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the phagocytosis of apoptotic cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   781   C2936268:Cell Phagocytosis [Cell Function]
   760   C0031308:Phagocytosis [Cell Function]

Phrase: "that"

Phrase: "have"

Phrase: "externalized phosphatidylserine."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031623:phosphatidylserine [Lipid]
   861   C0301704:Phosphatidyl serine [Lipid]
Processing 00000000.tx.435: Cell Death Differ. 

Phrase: "Cell Death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "Differ."
Processing 00000000.tx.436: 9, 616625.[CrossRef][ISI][Medline] Bertholf, R. 

Phrase: "9,"

Phrase: "616625."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bertholf,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.437: L., Herman, M. 

Phrase: "L., Herman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.438: M., Savory, J., Carpenter, R. 

Phrase: "M."

Phrase: ","

Phrase: "Savory,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1135885:Savory [Food]

Phrase: "J.,"

Phrase: "Carpenter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336362:Carpenter [Professional or Occupational Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.439: M., Sturgill, B. 

Phrase: "M."

Phrase: ","

Phrase: "Sturgill,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.440: C., Katsetos, C. 

Phrase: "C., Katsetos,"

Phrase: "C."
Processing 00000000.tx.441: D., Vandenberg, S. 

Phrase: "D."

Phrase: ","

Phrase: "Vandenberg,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.442: R., and Wills, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Wills,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042950:wills [Mental Process]
  1000   C0043177:Wills [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.443: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.444: (1989). 

Phrase: "(1989"

Phrase: ")."
Processing 00000000.tx.445: A long-term intravenous model of aluminum maltol toxicity in rabbits: Tissue distribution, hepatic, renal, and neuronal cytoskeletal changes associated with systemic exposure. 

Phrase: "A long-term intravenous model of aluminum maltol toxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C3161035:Model [Intellectual Product]

Phrase: "in rabbits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: ":"

Phrase: "Tissue distribution,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0040287:Tissue Distribution [Quantitative Concept]
  1000   C0220927:tissue distribution [Functional Concept]
   861   C0040300:Tissue [Tissue]
   861   C0520511:distribution [Idea or Concept]
   861   C1547928:Tissue [Intellectual Product]
   861   C1704711:Distribution [Functional Concept]

Phrase: "hepatic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205054:Hepatic [Body Location or Region]

Phrase: "renal,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022646:Renal [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "neuronal cytoskeletal changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0392747:changes [Functional Concept]
   827   C0443172:changes [Quantitative Concept]
   793 E C1705241:Change [Quantitative Concept]

Phrase: "associated with systemic exposure."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0205373:Systemic [Functional Concept]
   770   C0274281:Exposure, NOS [Injury or Poisoning]
   770   C0332157:Exposure [Clinical Attribute]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.446: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.447: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.448: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.449: 98, 5874.[ISI][Medline] Campbell, A., Prasad, K. 

Phrase: "98,"

Phrase: "5874."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "A.,"

Phrase: "Prasad,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.450: N., and Bondy, S. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Bondy,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.451: C. 

Phrase: "C."
Processing 00000000.tx.452: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.453: Aluminum-induced oxidative events in cell lines: Glioma are more responsive than neuroblastoma. 

Phrase: "Aluminum-induced oxidative events in cell lines"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   818   C0007600:Cell lines [Cell]
   795   C0205132:lines [Spatial Concept]
   762 E C1550648:Line [Substance]
   762 E C1552960:Line [Quantitative Concept]

Phrase: ":"

Phrase: "Glioma"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017638:Glioma [Neoplastic Process]
  1000   C0555198:[M]Glioma NOS [Neoplastic Process]
  1000   C2984291:Glioma [Functional Concept]

Phrase: "are"

Phrase: "more responsive than neuroblastoma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205342:Responsive [Functional Concept]
Processing 00000000.tx.454: Free Radic. 

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.455: Biol. 

Phrase: "Biol."
Processing 00000000.tx.456: Med. 

Phrase: "Med."
Processing 00000000.tx.457: 26, 11661171.[CrossRef][ISI][Medline] Chen, R. 

Phrase: "26,"

Phrase: "11661171."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.458: M., Liu, H. 

Phrase: "M."

Phrase: ","

Phrase: "Liu,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.459: C., Lin, Y. 

Phrase: "C., Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0861352:LIN [Neoplastic Process]

Phrase: "Y."
Processing 00000000.tx.460: L., Jean, W. 

Phrase: "L., Jean,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0453932:jean [Manufactured Object]

Phrase: "W."
Processing 00000000.tx.461: C., Chen, J. 

Phrase: "C., Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0999213:Chen [Bird]

Phrase: "J."
Processing 00000000.tx.462: S., and Wang, J. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Wang,"

Phrase: "J."
Processing 00000000.tx.463: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.464: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.465: Nitric oxide induces osteoblast apoptosis through the de novo synthesis of Bax protein. 

Phrase: "Nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "osteoblast apoptosis through the de novo synthesis of Bax protein."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.466: J. 

Phrase: "J."
Processing 00000000.tx.467: Orthop. 

Phrase: "Orthop."
Processing 00000000.tx.468: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.469: 20, 295302.[CrossRef][ISI][Medline] Chow, S. 

Phrase: "20,"

Phrase: "295302."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Chow,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0324335:chow [Mammal]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.470: C., Peters, I., and Orrenius, S. 

Phrase: "C., Peters,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Orrenius,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.471: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.472: Reevaluation of the role of de novo protein synthesis in rat thymocyte apoptosis. 

Phrase: "Reevaluation of the role of de novo protein synthesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0681840:re-evaluation [Research Activity]

Phrase: "in rat thymocyte apoptosis."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C2610925:thymocyte apoptosis [Cell Function]
   827   C0162638:Apoptosis [Cell Function]
   755 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.473: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.474: Cell Res. 

Phrase: "Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.475: 216, 149159.[CrossRef][ISI][Medline] Combarros, O., Alvarez-Arcaya, A., Sanchez-Guerra, M., Infante, J., and Berciano, J. 

Phrase: "216,"

Phrase: "149159."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Combarros,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Alvarez-Arcaya,"

Phrase: "A.,"

Phrase: "Sanchez-Guerra,"

Phrase: "M."

Phrase: ","

Phrase: "Infante,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Berciano,"

Phrase: "J."
Processing 00000000.tx.476: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.477: Candidate gene association studies in sporadic Alzheimer's disease. 

Phrase: "Candidate gene association"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0004083:Association [Mental Process]
   827   C0439849:Association [Qualitative Concept]
   827   C0596306:Association [Phenomenon or Process]
   827   C0699792:association [Social Behavior]
   734   C1332838:Candidate Gene [Gene or Genome]

Phrase: "studies in sporadic Alzheimer's disease."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   760   C0205422:Sporadic [Temporal Concept]
   760   C0557651:Study [Manufactured Object]
   760   C0947630:studies [Laboratory Procedure]
   760   C2603343:Study [Research Activity]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.478: Dement. 

Phrase: "Dement."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0860630:dement [Mental or Behavioral Dysfunction]
   900 E C0011265:dementia [Mental or Behavioral Dysfunction]
   900 E C0497327:Dementia [Mental or Behavioral Dysfunction]
Processing 00000000.tx.479: Geriatr. 

Phrase: "Geriatr."
Processing 00000000.tx.480: Cogn. 

Phrase: "Cogn."
Processing 00000000.tx.481: Disord. 

Phrase: "Disord."
Processing 00000000.tx.482: 14, 4154.[CrossRef][ISI][Medline] Fadok, V. 

Phrase: "14,"

Phrase: "4154."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fadok,"

Phrase: "V."
Processing 00000000.tx.483: A., Bratton, D. 

Phrase: "A.,"

Phrase: "Bratton,"

Phrase: "D."
Processing 00000000.tx.484: L., Konowal, A., Freed, P. 

Phrase: "L., Konowal,"

Phrase: "A.,"

Phrase: "Freed,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0332296:free [Functional Concept]
   966   C1880497:Free [Qualitative Concept]
   966   C1996904:Free [Qualitative Concept]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.485: W., Westcott, J. 

Phrase: "W., Westcott,"

Phrase: "J."
Processing 00000000.tx.486: Y., and Henson, P. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Henson,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.487: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.488: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.489: Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. 

Phrase: "Macrophages"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0024432:Macrophages [Cell]
  1000   C1546706:Macrophages [Intellectual Product]
  1000   C1550652:Macrophages [Body Substance]

Phrase: "that"

Phrase: "have"

Phrase: "ingested apoptotic cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "proinflammatory cytokine production through autocrine/paracrine mechanisms"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C1327413:cytokine production [Organism Function]
   748   C0033268:production [Occupational Activity]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "TGF-beta,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0040690:TGF-beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1366557:TGF-BETA [Gene or Genome]
  1000   C1527196:TGF-Beta [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0040691:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0330390:Beta [Plant]
   861   C0439096:Beta [Intellectual Product]
   861   C1527194:TGF [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C2004068:Beta [Qualitative Concept]

Phrase: "PGE2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012472:PGE2 [Eicosanoid,Hormone,Pharmacologic Substance]
  1000   C3538990:PGE2 [Laboratory Procedure]

Phrase: "and"

Phrase: "PAF."
Processing 00000000.tx.490: J. 

Phrase: "J."
Processing 00000000.tx.491: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.492: Invest. 

Phrase: "Invest."
Processing 00000000.tx.493: 101, 890898.[Abstract/Free FullText] Fernandez-Segura, E., Canizares, F. 

Phrase: "101,"

Phrase: "890898."

Phrase: "[Abstract/Free FullText"

Phrase: "] Fernandez-Segura,"

Phrase: "E.,"

Phrase: "Canizares,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.494: J., Cubero, M. 

Phrase: "J.,"

Phrase: "Cubero,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.495: A., Warley, A., and Campos, A. 

Phrase: "A.,"

Phrase: "Warley,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Campos,"

Phrase: "A."
Processing 00000000.tx.496: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.497: Changes in elemental content during apoptotic cell death studied by electron probe X-ray microanalysis. 

Phrase: "Changes in elemental content"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "during apoptotic cell death"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0162638:apoptotic cell death [Cell Function]
   901   C0007587:Cell Death [Cell Function]
   827   C0007634:Cell [Cell]
   827   C0011065:Death [Organism Function]
   827   C1269647:Cell [Cell]
   827   C1306577:Death, NOS [Finding]
   827   C1704653:Cell [Medical Device]
   827   C1948049:Cell [Spatial Concept]

Phrase: "studied by electron probe X-ray microanalysis."
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   897   C0013844:X-Ray Microanalysis, Electron Probe [Laboratory Procedure]
           X-Ray Microanalysis
           Electron Probe Microanalysis
   778   C0034571:X-ray [Functional Concept]
   778   C0043299:X-ray, NOS [Diagnostic Procedure]
   778   C0043309:X-ray [Natural Phenomenon or Process]
   778   C1306645:X-ray [Diagnostic Procedure]
   778   C1962945:X-ray [Diagnostic Procedure]
   748   C0013852:Electron [Quantitative Concept]
   748   C0086894:ray [Fish]
   748   C0182400:Probe [Medical Device]
   748   C0851346:ray [Natural Phenomenon or Process]
   748   C1704681:Probe [Gene or Genome]
   748   C2314876:ray [Fish]
   748   C2347609:Probe [Chemical Viewed Functionally]
   748   C3463986:Electron [Bird]
   748   C3536729:Probe [Manufactured Object]
   714   C0557651:Study [Manufactured Object]
   714   C2603343:Study [Research Activity]
Processing 00000000.tx.498: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.499: Cell Res. 

Phrase: "Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.500: 253, 454462.[CrossRef][ISI][Medline] Ghribi, O., DeWitt, D. 

Phrase: "253,"

Phrase: "454462."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ghribi,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "DeWitt,"

Phrase: "D."
Processing 00000000.tx.501: A., Forbes, M. 

Phrase: "A.,"

Phrase: "Forbes,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.502: S., Herman, M. 

Phrase: "S."

Phrase: ","

Phrase: "Herman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.503: M., and Savory, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Savory,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1135885:Savory [Food]

Phrase: "J."
Processing 00000000.tx.504: (2001a). 

Phrase: "(2001a"

Phrase: ")."
Processing 00000000.tx.505: Co-involvement of mitochondria and endoplasmic reticulum in regulation of apoptosis: Changes in cytochrome c, Bcl-2 and Bax in the hippocampus of aluminum-treated rabbits. 

Phrase: "Co-involvement of mitochondria"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "and"

Phrase: "endoplasmic reticulum in regulation of apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0014239:Endoplasmic Reticulum [Cell Component]
   753   C0035295:Reticulum [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "Changes in cytochrome c,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "Bcl-2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0376515:Bcl-2 [Gene or Genome]

Phrase: "and"

Phrase: "Bax in the hippocampus of aluminum-treated rabbits."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0219474:BAX [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0812198:BAX [Gene or Genome]
Processing 00000000.tx.506: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.507: 903, 6673.[CrossRef][ISI][Medline] Ghribi, O., Herman, M. 

Phrase: "903,"

Phrase: "6673."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ghribi,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Herman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.508: M., DeWitt, D. 

Phrase: "M."

Phrase: ","

Phrase: "DeWitt,"

Phrase: "D."
Processing 00000000.tx.509: A., Forbes, M. 

Phrase: "A.,"

Phrase: "Forbes,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.510: S., and Savory, J. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Savory,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1135885:Savory [Food]

Phrase: "J."
Processing 00000000.tx.511: (2001b). 

Phrase: "(2001b"

Phrase: ")."
Processing 00000000.tx.512: Abeta(142) and aluminum induce stress in the endoplasmic reticulum in rabbit hippocampus, involving nuclear translocation of gadd 153 and NF-kappaB. 

Phrase: "Abeta"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1420510:A-BETA [Gene or Genome]
  1000   C1705543:ABETA [Gene or Genome]

Phrase: "(142"

Phrase: ")"

Phrase: "and"

Phrase: "aluminum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "stress in the endoplasmic reticulum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   844   C3178870:Endoplasmic Reticulum Stress [Cell or Molecular Dysfunction]
   760   C0038435:Stress [Finding]

Phrase: "in rabbit hippocampus,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "nuclear translocation of gadd 153"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1518440:Nuclear Translocation [Molecular Function]
   760   C0040715:Translocation [Cell or Molecular Dysfunction]
   760   C2987521:Translocation [Activity]

Phrase: "and"

Phrase: "NF-kappaB."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079904:NF-kappaB [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.513: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.514: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.515: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.516: 96, 3038.[ISI][Medline] Ghribi, O., Herman, M. 

Phrase: "96,"

Phrase: "3038."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ghribi,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Herman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.517: M., and Savory, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Savory,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1135885:Savory [Food]

Phrase: "J."
Processing 00000000.tx.518: (2002a). 

Phrase: "(2002a"

Phrase: ")."
Processing 00000000.tx.519: The endoplasmic reticulum is the main site for caspase-3 activation following aluminum-induced neurotoxicity in rabbit hippocampus. 

Phrase: "The endoplasmic reticulum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014239:Endoplasmic Reticulum [Cell Component]
   861   C0035295:Reticulum [Body Part, Organ, or Organ Component]
   789   C0598268:Endoplasm [Cell Component]

Phrase: "is"

Phrase: "the main site for caspase-3 activation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205145:Site [Spatial Concept]
   748   C1515974:Site [Body Location or Region]
   748   C2825164:Site [Spatial Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "aluminum-induced neurotoxicity in rabbit hippocampus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0235032:Neurotoxicity [Injury or Poisoning]
Processing 00000000.tx.520: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.521: Lett. 

Phrase: "Lett."
Processing 00000000.tx.522: 324, 217221.[CrossRef][ISI][Medline] Ghribi, O., Herman, M. 

Phrase: "324,"

Phrase: "217221."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ghribi,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Herman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.523: M., Spaulding, N. 

Phrase: "M."

Phrase: ","

Phrase: "Spaulding,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.524: K., and Savory, J. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "and"

Phrase: "Savory,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1135885:Savory [Food]

Phrase: "J."
Processing 00000000.tx.525: (2002b). 

Phrase: "(2002b"

Phrase: ")."
Processing 00000000.tx.526: Lithium inhibits aluminum-induced apoptosis in rabbit hippocampus, by preventing cytochrome c translocation, Bcl-2 decrease, Bax elevation and caspase-3 activation. 

Phrase: "Lithium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023870:Lithium [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "aluminum-induced apoptosis in rabbit hippocampus,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162638:Apoptosis [Cell Function]

Phrase: "by preventing cytochrome c translocation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0040715:Translocation [Cell or Molecular Dysfunction]
   812   C2987521:Translocation [Activity]

Phrase: "Bcl-2 decrease,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0392756:Decrease [Qualitative Concept]
   827   C0547047:Decrease [Quantitative Concept]
   734   C0376515:Bcl-2 [Gene or Genome]

Phrase: "Bax elevation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439775:Elevation [Therapeutic or Preventive Procedure]
   861   C0702240:Elevation [Spatial Concept]

Phrase: "and"

Phrase: "caspase-3 activation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C1159825:Caspase Activation [Molecular Function]
   827   C1879547:Activation [Activity]
   734   C0291573:caspase-3 [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.527: J. 

Phrase: "J."
Processing 00000000.tx.528: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.529: 82, 137145.[CrossRef][ISI][Medline] Gralla, E. 

Phrase: "82,"

Phrase: "137145."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gralla,"

Phrase: "E."
Processing 00000000.tx.530: J., Stebbins, R. 

Phrase: "J.,"

Phrase: "Stebbins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553261:Stebbins [Population Group]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.531: B., Coleman, G. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Coleman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.532: L., and Delahunt, C. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Delahunt,"

Phrase: "C."
Processing 00000000.tx.533: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.534: (1969). 

Phrase: "(1969"

Phrase: ")."
Processing 00000000.tx.535: Toxicity studies with ethyl maltol. 

Phrase: "Toxicity"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0040539:toxicity [Qualitative Concept]
  1000   C0600688:Toxicity [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   907 E C0032346:Poison [Hazardous or Poisonous Substance]
   907 E C1548769:Poison [Intellectual Product]
   907 E C1550590:poison [Idea or Concept]

Phrase: "studies with ethyl maltol."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0059773:ethyl maltol [Organic Chemical,Pharmacologic Substance]
   770   C0065605:maltol [Organic Chemical,Pharmacologic Substance]
   770   C0557651:Study [Manufactured Object]
   770   C0947630:studies [Laboratory Procedure]
   770   C2603343:Study [Research Activity]
Processing 00000000.tx.536: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.537: Appl. 

Phrase: "Appl."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1858559:APPL [Gene or Genome]
Processing 00000000.tx.538: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.539: 15, 604613.[CrossRef][ISI][Medline] Griffioen, K. 

Phrase: "15,"

Phrase: "604613."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Griffioen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.540: J., Ghribi, O., Fox, N., Savory, J., and DeWitt, D. 

Phrase: "J.,"

Phrase: "Ghribi,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Fox,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0016633:Fox [Mammal]
   928 E C0049564:FOXY [Organic Chemical]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Savory,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1135885:Savory [Food]

Phrase: "J.,"

Phrase: "and"

Phrase: "DeWitt,"

Phrase: "D."
Processing 00000000.tx.541: A. 

Phrase: "A."
Processing 00000000.tx.542: (2004). 

Phrase: "(2004"

Phrase: ")."
Processing 00000000.tx.543: Aluminum Maltolate-Induced Toxicity in NT2 Cells Occurs Through Apoptosis and Includes Cytochrome c Release. 

Phrase: "Aluminum Maltolate-Induced Toxicity in NT2 Cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0040539:toxicity [Qualitative Concept]
   748   C0600688:Toxicity [Injury or Poisoning]

Phrase: "Occurs Through Apoptosis"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0162638:Apoptosis [Cell Function]
   790   C1709305:Occur [Activity]
   790   C2745955:OCCUR [Temporal Concept]
   718 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "and"

Phrase: "Includes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:Includes [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "Cytochrome c Release."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]
   734   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
   734   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
   734   C1153524:cytochrome c [Molecular Function]
   734   C1426584:CYTOCHROME C [Gene or Genome]
Processing 00000000.tx.544: Neurotoxicology 25, 859867.[CrossRef][ISI][Medline] He, Q., Riley, R. 

Phrase: "Neurotoxicology 25,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597059:neurotoxicology [Organism Function]

Phrase: "859867."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "He,"

Phrase: "Q.,"

Phrase: "Riley,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.545: T., and Sharma, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Sharma,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.546: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.547: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.548: Pharmacological antagonism of fumonisin B1 cytotoxicity in porcine renal epithelial cells (LLC-PK1): A model for reducing fumonisin-induced nephrotoxicity in vivo. 

Phrase: "Pharmacological antagonism of fumonisin B1 cytotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0680242:antagonism [Social Behavior]

Phrase: "in porcine renal epithelial cells"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   890   C0806036:Renal epithelial cell [Cell]
   861   C0014597:Epithelial Cells [Cell]
   861   C1273342:Epithelial Cells [Laboratory Procedure]
   858   C0553257:Renal cell [Cell]
   812   C0007634:Cells [Cell]
   812   C0022646:Renal [Body Part, Organ, or Organ Component]
   812   C0221908:Epithelial [Qualitative Concept]
   812   C3282337:Cells [Cell]
   779 E C1269647:Cell [Cell]
   779 E C1704653:Cell [Medical Device]
   779 E C1948049:Cell [Spatial Concept]

Phrase: "(LLC-PK1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0701488:PK1 [Organic Chemical,Pharmacologic Substance]
   861   C1418609:PK1 [Gene or Genome]
   861   C1425526:PK1 [Gene or Genome]

Phrase: ")"

Phrase: ":"

Phrase: "A model for reducing fumonisin-induced nephrotoxicity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C3161035:Model [Intellectual Product]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.549: Pharmacol. 

Phrase: "Pharmacol."
Processing 00000000.tx.550: Toxicol. 

Phrase: "Toxicol."
Processing 00000000.tx.551: 90, 268277.[CrossRef][ISI][Medline] Hironishi, M., Kordek, R., Yanagihara, R., and Garruto, R. 

Phrase: "90,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: "268277."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hironishi,"

Phrase: "M."

Phrase: ","

Phrase: "Kordek,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Yanagihara,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Garruto,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.552: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.553: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.554: Maltol (3-hydroxy-2-methyl-4-pyrone) toxicity in neuroblastoma cell lines and primary murine fetal hippocampal neuronal cultures. 

Phrase: "Maltol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0065605:maltol [Organic Chemical,Pharmacologic Substance]

Phrase: "(3-hydroxy-2-methyl-4-pyrone"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0065605:3-hydroxy-2-methyl-4-pyrone [Organic Chemical,Pharmacologic Substance]
   913   C0072764:3-hydroxy-4-pyrone [Organic Chemical]
   799   C0034314:Pyrone [Organic Chemical]
   709   C0442757:3 4 [Finding]

Phrase: ")"

Phrase: "toxicity in neuroblastoma cell lines"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0040539:toxicity [Qualitative Concept]
   760   C0600688:Toxicity [Injury or Poisoning]

Phrase: "and"

Phrase: "primary murine fetal hippocampal neuronal cultures."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   799   C0010453:Cultures [Idea or Concept]
   766 E C0220814:culture [Functional Concept]
   766 E C0430400:Culture [Laboratory Procedure]
   766 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.555: Neurodegeneration 5, 325329.[CrossRef][ISI][Medline] Jemmerson, R., LaPlante, B., and Treeful, A. 

Phrase: "Neurodegeneration 5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]

Phrase: "325329."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jemmerson,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "LaPlante,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Treeful,"

Phrase: "A."
Processing 00000000.tx.556: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.557: Release of intact, monomeric cytochrome c from apoptotic and necrotic cells. 

Phrase: "Release of intact, monomeric cytochrome c"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030685:Release [Health Care Activity]
   753   C0391871:Release [Functional Concept]
   753   C0439180:% release [Quantitative Concept]
   753   C0680255:release [Health Care Activity]
   753   C1283071:Release [Functional Concept]
   753   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "from apoptotic"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1516044:Apoptotic [Qualitative Concept]
   928 E C0162638:Apoptosis [Cell Function]

Phrase: "and"

Phrase: "necrotic cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.558: Cell Death Differ. 

Phrase: "Cell Death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0007587:Cell Death [Cell Function]
   861   C0007634:Cell [Cell]
   861   C0011065:Death [Organism Function]
   861   C1269647:Cell [Cell]
   861   C1306577:Death, NOS [Finding]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "Differ."
Processing 00000000.tx.559: 9, 538548.[CrossRef][ISI][Medline] Jin, Q., Kang, C., Soh, Y., Sohn, N. 

Phrase: "9,"

Phrase: "538548."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jin,"

Phrase: "Q.,"

Phrase: "Kang,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Soh,"

Phrase: "Y.,"

Phrase: "Sohn,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.560: W., Lee, J., Cho, Y. 

Phrase: "W., Lee,"

Phrase: "J.,"

Phrase: "Cho,"

Phrase: "Y."
Processing 00000000.tx.561: H., Baik, H. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Baik,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.562: H., and Kang, I. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kang,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.563: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.564: Tetrandrine cytotoxicity and its dual effect on oxidative stress-induced apoptosis through modulating cellular redox states in Neuro 2a mouse neuroblastoma cells. 

Phrase: "Tetrandrine cytotoxicity"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0596402:cytotoxicity [Cell or Molecular Dysfunction]
   789 E C0677881:Cytotoxic [Therapeutic or Preventive Procedure]
   789 E C1511636:cytotoxic [Functional Concept]

Phrase: "and"

Phrase: "its dual effect on oxidative stress-induced apoptosis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "through modulating cellular redox states"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0030012:redox state [Molecular Function]
           Redox
   812   C1301808:states [Geographic Area]
   779 E C1442792:State [Functional Concept]
   779 E C3148680:State [Geographic Area]

Phrase: "in Neuro 2a mouse neuroblastoma cells."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   823   C0815000:neuroblastoma cell [Cell]
   804   C0007634:Cells [Cell]
   804   C3282337:Cells [Cell]
   771 E C1269647:Cell [Cell]
   771 E C1704653:Cell [Medical Device]
   771 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.565: Life Sci. 

Phrase: "Life Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.566: 71, 20532066.[CrossRef][ISI][Medline] Johnson, R. 

Phrase: "71,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: "20532066."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Johnson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.567: R., Alford, E. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Alford,"

Phrase: "E."
Processing 00000000.tx.568: D., and Kinzer, G. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Kinzer,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.569: W. 

Phrase: "W."
Processing 00000000.tx.570: (1969). 

Phrase: "(1969"

Phrase: ")."
Processing 00000000.tx.571: Formation of sucrose pyrolysis products. 

Phrase: "Formation of sucrose pyrolysis products."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   797   C1157171:sucrose formation [Molecular Function]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.572: J. 

Phrase: "J."
Processing 00000000.tx.573: Agr. 

Phrase: "Agr."
Processing 00000000.tx.574: Food Chem. 

Phrase: "Food Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.575: 17, 2224.[ISI] Johnson, V. 

Phrase: "17,"

Phrase: "2224."

Phrase: "[ISI] Johnson,"

Phrase: "V."
Processing 00000000.tx.576: J., and Sharma, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Sharma,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.577: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.578: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.579: Gender-dependent immunosuppression following subacute exposure to fumonisin B1. 

Phrase: "Gender-dependent immunosuppression"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0021079:Immunosuppression [Therapeutic or Preventive Procedure]
   827   C0021080:Immunosuppression [Organism Function]
   827   C1373218:Immunosuppression [Pathologic Function]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "subacute exposure to fumonisin B1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C0332157:Exposure to [Clinical Attribute]
           Exposure
   760   C0274281:Exposure, NOS [Injury or Poisoning]
Processing 00000000.tx.580: Int. 

Phrase: "Int."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0063789:INT [Organic Chemical]
  1000   C3272375:INT [Intellectual Product]
Processing 00000000.tx.581: Immunopharmacol. 

Phrase: "Immunopharmacol."
Processing 00000000.tx.582: 1, 20232034.[CrossRef][ISI][Medline] Johnson, V. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "20232034."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Johnson,"

Phrase: "V."
Processing 00000000.tx.583: J., and Sharma, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Sharma,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.584: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.585: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.586: Aluminum disrupts the pro-inflammatory cytokine/neurotrophin balance in primary brain rotation-mediated aggregate cultures: Possible role in neurodegeneration. 

Phrase: "Aluminum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "disrupts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupt [Qualitative Concept]

Phrase: "the pro-inflammatory cytokine/neurotrophin balance"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0014653:Balance [Organism Function]
   804   C0205415:Balance [Functional Concept]
   804   C0560184:Balance [Finding]

Phrase: "in primary brain rotation-mediated aggregate cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   799   C0010453:Cultures [Idea or Concept]
   766 E C0220814:culture [Functional Concept]
   766 E C0430400:Culture [Laboratory Procedure]
   766 E C2242979:Culture [Laboratory Procedure]

Phrase: ":"

Phrase: "Possible role in neurodegeneration."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.587: Neurotoxicology 24, 261268.[CrossRef][ISI][Medline] Kawahara, M., Kato-Negishi, M., Hosoda, R., Imamura, L., Tsuda, M., and Kuroda, Y. 

Phrase: "Neurotoxicology 24,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597059:neurotoxicology [Organism Function]

Phrase: "261268."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kawahara,"

Phrase: "M."

Phrase: ","

Phrase: "Kato-Negishi,"

Phrase: "M."

Phrase: ","

Phrase: "Hosoda,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Imamura,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Tsuda,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Kuroda,"

Phrase: "Y."
Processing 00000000.tx.588: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.589: Brain-derived neurotrophic factor protects cultured rat hippocampal neurons from aluminum maltolate neurotoxicity. 

Phrase: "Brain-derived neurotrophic factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "protects"

Phrase: "cultured rat hippocampal neurons from aluminum maltolate neurotoxicity."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0027882:Neurons [Cell]
Processing 00000000.tx.590: J. 

Phrase: "J."
Processing 00000000.tx.591: Inorg. 

Phrase: "Inorg."
Processing 00000000.tx.592: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.593: 97, 124131.[CrossRef][ISI][Medline] Kern, J. 

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "124131."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kern,"

Phrase: "J."
Processing 00000000.tx.594: C., and Kehrer, J. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Kehrer,"

Phrase: "J."
Processing 00000000.tx.595: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.596: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.597: Acrolein-induced cell death: A caspase-influenced decision between apoptosis and oncosis/necrosis. 

Phrase: "Acrolein-induced cell death"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   861   C0007587:Cell Death [Cell Function]
   812   C0007634:Cell [Cell]
   812   C0011065:Death [Organism Function]
   812   C1269647:Cell [Cell]
   812   C1306577:Death, NOS [Finding]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "A caspase-influenced decision between apoptosis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679006:Decision [Mental Process]

Phrase: "and"

Phrase: "oncosis/necrosis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0027540:Necrosis [Organ or Tissue Function]
   861   C1334928:Necrosis [Finding]
Processing 00000000.tx.598: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.599: Biol. 

Phrase: "Biol."
Processing 00000000.tx.600: Interact. 

Phrase: "Interact."
Processing 00000000.tx.601: 139, 7995.[CrossRef][ISI][Medline] Klatzo, I., Wi'Sniewski, H., and Streicher, E. 

Phrase: "139,"

Phrase: "7995."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Klatzo,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Wi'Sniewski,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Streicher,"

Phrase: "E."
Processing 00000000.tx.602: (1965). 

Phrase: "(1965"

Phrase: ")."
Processing 00000000.tx.603: Experimental Production of Neurofibrillary Degeneration. 

Phrase: "Experimental Production of Neurofibrillary Degeneration."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]
Processing 00000000.tx.604: I. 

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.605: Light Microscopic Observations. 

Phrase: "Light Microscopic Observations."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   884   C0369671:Microscopic observation [Laboratory Procedure]
   827   C0302523:observations [Research Activity]
   827   C0700325:observations [Health Care Activity]
   827   C3244290:observations [Functional Concept]
   793 E C1964257:Observation [Diagnostic Procedure]
   743 E C1518527:OBSERVATIONAL [Research Activity]
Processing 00000000.tx.606: J. 

Phrase: "J."
Processing 00000000.tx.607: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.608: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.609: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.610: 24, 187199.[ISI] Lecoeur, H. 

Phrase: "24,"

Phrase: "187199."

Phrase: "[ISI] Lecoeur,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.611: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.612: Nuclear apoptosis detection by flow cytometry: Influence of endogenous endonucleases. 

Phrase: "Nuclear apoptosis detection by flow cytometry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: ":"

Phrase: "Influence of endogenous endonucleases."
Processing 00000000.tx.613: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.614: Cell Res. 

Phrase: "Cell Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.615: 277, 114.[CrossRef][ISI][Medline] Levesque, L., Mizzen, C. 

Phrase: "277,"

Phrase: "114."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Levesque,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Mizzen,"

Phrase: "C."
Processing 00000000.tx.616: A., McLachlan, D. 

Phrase: "A.,"

Phrase: "McLachlan,"

Phrase: "D."
Processing 00000000.tx.617: R., and Fraser, P. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Fraser,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.618: E. 

Phrase: "E."
Processing 00000000.tx.619: (2000). 

Phrase: "(2000"

Phrase: ")."
Processing 00000000.tx.620: Ligand specific effects on aluminum incorporation and toxicity in neurons and astrocytes. 

Phrase: "Ligand specific effects on aluminum incorporation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "toxicity in neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0040539:toxicity [Qualitative Concept]
   790   C0600688:Toxicity [Injury or Poisoning]
   718 E C1407029:Toxic [Qualitative Concept]

Phrase: "and"

Phrase: "astrocytes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004112:Astrocytes [Cell]
Processing 00000000.tx.621: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.622: 877, 191202.[CrossRef][ISI][Medline] Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. 

Phrase: "877,"

Phrase: "191202."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Nijhawan,"

Phrase: "D."

Phrase: ","

Phrase: "Budihardjo,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Srinivasula,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.623: M., Ahmad, M., Alnemri, E. 

Phrase: "M."

Phrase: ","

Phrase: "Ahmad,"

Phrase: "M."

Phrase: ","

Phrase: "Alnemri,"

Phrase: "E."
Processing 00000000.tx.624: S., and Wang, X. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Wang,"

Phrase: "X."
Processing 00000000.tx.625: (1997). 

Phrase: "(1997"

Phrase: ")."
Processing 00000000.tx.626: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. 

Phrase: "Cytochrome c"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0010749:Cytochrome c [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C0010754:Cytochrome c' [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0653778:cytochrome c'' [Amino Acid, Peptide, or Protein]
  1000   C1153524:cytochrome c [Molecular Function]
  1000   C1426584:CYTOCHROME C [Gene or Genome]
   861   C0010798:Cytochrome [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1325304:cytochrome [Molecular Function]

Phrase: "and"

Phrase: "dATP-dependent formation of Apaf-1/caspase-9 complex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1157618:dATP formation [Molecular Function]
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]

Phrase: "initiates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1548602:Initiate [Idea or Concept]
  1000   C1704686:Initiate [Functional Concept]

Phrase: "an apoptotic protease cascade."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1707310:Cascade [Manufactured Object]
Processing 00000000.tx.627: Cell 91, 479489.[ISI][Medline] Liegler, T. 

Phrase: "Cell 91,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "479489."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Liegler,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.628: J., Hyun, W., Yen, T. 

Phrase: "J.,"

Phrase: "Hyun,"

Phrase: "W.,"

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.629: S., and Stites, D. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Stites,"

Phrase: "D."
Processing 00000000.tx.630: P. 

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.631: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.632: Detection and quantification of live, apoptotic, and necrotic human peripheral lymphocytes by single-laser flow cytometry. 

Phrase: "Detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "quantification of live, apoptotic,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709793:Quantification [Quantitative Concept]

Phrase: "and"

Phrase: "necrotic human peripheral lymphocytes by single-laser flow cytometry."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0024264:Lymphocytes [Cell]
Processing 00000000.tx.633: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.634: Diagn. 

Phrase: "Diagn."
Processing 00000000.tx.635: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.636: Immunol. 

Phrase: "Immunol."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.637: 2, 369376.[Abstract] Markesbery, W. 

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "369376."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Markesbery,"

Phrase: "W."
Processing 00000000.tx.638: R., Ehmann, W. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ehmann,"

Phrase: "W."
Processing 00000000.tx.639: D., Hossain, T. 

Phrase: "D."

Phrase: ","

Phrase: "Hossain,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.640: I., Alauddin, M., and Goodin, D. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Alauddin,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Goodin,"

Phrase: "D."
Processing 00000000.tx.641: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.642: (1981). 

Phrase: "(1981"

Phrase: ")."
Processing 00000000.tx.643: Instrumental neutron activation analysis of brain aluminum in Alzheimer disease and aging. 

Phrase: "Instrumental neutron activation analysis of brain aluminum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   814   C0027945:Neutron Activation Analysis [Laboratory Procedure]
   778   C0001282:Activation Analysis [Laboratory Procedure]
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0027946:Neutron [Substance]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   748   C1879547:Activation [Activity]

Phrase: "in Alzheimer disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "aging."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001811:Ageing [Organism Function]
Processing 00000000.tx.644: Ann. 

Phrase: "Ann."
Processing 00000000.tx.645: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.646: 10, 511516.[ISI][Medline] Martin, R. 

Phrase: "10,"

Phrase: "511516."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Martin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.647: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.648: (1991). 

Phrase: "(1991"

Phrase: ")."
Processing 00000000.tx.649: Aluminum in biological systems. 

Phrase: "Aluminum in biological systems."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0002367:Aluminium [Element, Ion, or Isotope]
   770   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.650: In Aluminum in Chemistry, Biology and Medicine (P. Nicolini, P. F. Zatta, and B. Corain, Eds.), pp. 

Phrase: "In Aluminum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "in Chemistry,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007996:Chemistry [Occupation or Discipline]
  1000   C0079107:chemistry [Classification]
  1000   C0201682:Chemistry [Laboratory Procedure]

Phrase: "Biology"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0005532:Biology [Biomedical Occupation or Discipline]
   928 E C0205460:Biologic [Qualitative Concept]
   928 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Medicine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013227:Medicine, NOS [Pharmacologic Substance]
  1000   C0025118:Medicine [Biomedical Occupation or Discipline]

Phrase: "(P. Nicolini,"

Phrase: "P. F. Zatta,"

Phrase: "and"

Phrase: "B. Corain,"

Phrase: "Eds."

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.651: 320. 

Phrase: "320."
Processing 00000000.tx.652: Raven Press, New York. 

Phrase: "Raven Press,"

Phrase: "New York."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:New York [Geographic Area]
   861   C0205314:New [Temporal Concept]
Processing 00000000.tx.653: Marx, J. 

Phrase: "Marx,"

Phrase: "J."
Processing 00000000.tx.654: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.655: Neuroscience. 

Phrase: "Neuroscience."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]
Processing 00000000.tx.656: New leads on the how of Alzheimer's. 

Phrase: "New"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205314:New [Temporal Concept]

Phrase: "leads on the how of Alzheimer's."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0181586:leads [Medical Device]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.657: Science 293, 21922194.[Free FullText] Marx, J. 

Phrase: "Science 293,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "21922194."

Phrase: "[Free FullText"

Phrase: "] Marx,"

Phrase: "J."
Processing 00000000.tx.658: (2003). 

Phrase: "(2003"

Phrase: ")."
Processing 00000000.tx.659: Neuroscience. 

Phrase: "Neuroscience."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0027910:Neuroscience [Biomedical Occupation or Discipline]
  1000   C1552241:Neuroscience [Professional or Occupational Group]
  1000   C1555991:Neuroscience [Professional or Occupational Group]
Processing 00000000.tx.660: Possible role for environmental copper in Alzheimer's disease. 

Phrase: "Possible role for environmental copper"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.661: Science 301, 905.[ISI][Medline] Mattson, M. 

Phrase: "Science 301,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "905."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mattson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.662: P., Chan, S. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Chan,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.663: L., and Duan, W. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Duan,"

Phrase: "W."
Processing 00000000.tx.664: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.665: Modification of brain aging and neurodegenerative disorders by genes, diet, and behavior. 

Phrase: "Modification of brain aging"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0392747:Modification [Functional Concept]
   770   C1554963:modification [Qualitative Concept]

Phrase: "and"

Phrase: "neurodegenerative disorders by genes,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0524851:Neurodegenerative Disorders [Disease or Syndrome]
   833   C1522560:Neurodegenerative Disorders [Functional Concept]
   770   C0012634:Disorders [Disease or Syndrome]

Phrase: "diet,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0012155:Diet [Food]
  1000   C1442959:Diet [Organism Function]
  1000   C1519433:DIET [Therapeutic or Preventive Procedure]
  1000   C2983588:DIET [Food]
   928 E C2699635:DIETARY [Functional Concept]

Phrase: "and"

Phrase: "behavior."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0004927:Behavior [Individual Behavior]
  1000   C2707008:Behavior [Clinical Attribute]
   928 E C2986890:Behavioral [Idea or Concept]
Processing 00000000.tx.666: Physiol. 

Phrase: "Physiol."
Processing 00000000.tx.667: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.668: 82, 637672.[Abstract/Free FullText] Miyashita, T., Harigai, M., Hanada, M., and Reed, J. 

Phrase: "82,"

Phrase: "637672."

Phrase: "[Abstract/Free FullText"

Phrase: "] Miyashita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Harigai,"

Phrase: "M."

Phrase: ","

Phrase: "Hanada,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Reed,"

Phrase: "J."
Processing 00000000.tx.669: C. 

Phrase: "C."
Processing 00000000.tx.670: (1994a). 

Phrase: "(1994a"

Phrase: ")."
Processing 00000000.tx.671: Identification of a p53-dependent negative response element in the bcl-2 gene. 

Phrase: "Identification of a p53-dependent negative response element"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0020792:Identification [Mental Process]
   744   C0205396:Identification [Qualitative Concept]

Phrase: "in the bcl-2 gene."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0376515:bcl-2 Gene [Gene or Genome]
           Bcl-2
  1000   C1704467:BCL-2 Gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
Processing 00000000.tx.672: Cancer Res. 

Phrase: "Cancer Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.673: 54, 31313135.[Abstract] Miyashita, T., Krajewski, S., Krajewska, M., Wang, H. 

Phrase: "54,"

Phrase: "31313135."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Miyashita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Krajewski,"

Phrase: "S."

Phrase: ","

Phrase: "Krajewska,"

Phrase: "M."

Phrase: ","

Phrase: "Wang,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.674: G., Lin, H. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.675: K., Liebermann, D. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Liebermann,"

Phrase: "D."
Processing 00000000.tx.676: A., Hoffman, B., and Reed, J. 

Phrase: "A.,"

Phrase: "Hoffman,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Reed,"

Phrase: "J."
Processing 00000000.tx.677: C. 

Phrase: "C."
Processing 00000000.tx.678: (1994b). 

Phrase: "(1994b"

Phrase: ")."
Processing 00000000.tx.679: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. 

Phrase: "Tumor suppressor p53"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0079419:tumor suppressor p53 [Gene or Genome]
           P53
  1000   C0080055:Tumor Suppressor p53 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1705526:p53 [Gene or Genome]
   734   C0079427:Tumor Suppressor [Gene or Genome]
   734   C1325410:tumor suppressor [Cell Function]

Phrase: "is"

Phrase: "a regulator of bcl-2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0182953:REGULATOR [Medical Device]
   760   C1704734:Regulator [Medical Device]
   760   C1704735:Regulator [Conceptual Entity]

Phrase: "and"

Phrase: "bax gene expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0017262:Gene Expression [Genetic Function]
   901   C0812198:BAX gene [Gene or Genome]
   827   C0017337:Gene [Gene or Genome]
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.680: Oncogene 9, 17991805.[ISI][Medline] Miyashita, T., and Reed, J. 

Phrase: "Oncogene 9,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0029016:Oncogene [Gene or Genome]

Phrase: "17991805."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Miyashita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Reed,"

Phrase: "J."
Processing 00000000.tx.681: C. 

Phrase: "C."
Processing 00000000.tx.682: (1995). 

Phrase: "(1995"

Phrase: ")."
Processing 00000000.tx.683: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. 

Phrase: "Tumor suppressor p53"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0079419:tumor suppressor p53 [Gene or Genome]
           P53
  1000   C0080055:Tumor Suppressor p53 [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1705526:p53 [Gene or Genome]
   734   C0079427:Tumor Suppressor [Gene or Genome]
   734   C1325410:tumor suppressor [Cell Function]

Phrase: "is"

Phrase: "a direct transcriptional activator of the human bax gene."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   764   C1336776:Transcriptional Activator [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.684: Cell 80, 293299.[ISI][Medline] Ohyashiki, T., Satoh, E., Okada, M., Takadera, T., and Sahara, M. 

Phrase: "Cell 80,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "293299."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ohyashiki,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Satoh,"

Phrase: "E.,"

Phrase: "Okada,"

Phrase: "M."

Phrase: ","

Phrase: "Takadera,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Sahara,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205654:Sahara [Geographic Area]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.685: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.686: Nerve growth factor protects against aluminum-mediated cell death. 

Phrase: "Nerve growth factor"
Meta Candidates (Total=16; Excluded=2; Pruned=0; Remaining=14)
  1000   C0027752:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0027754:Nerve growth factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522443:Nerve Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   901   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   873   C0814002:Neural Growth [Cell Function,Organism Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0027740:Nerve [Tissue]
   827   C0027757:NERVE [Tissue]
   827   C0220844:growth [Physiologic Function]
   827   C1280541:Nerve [Body Part, Organ, or Organ Component]
   827   C1521761:Factor [Functional Concept]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C2827422:Factor [Conceptual Entity]
   827   C2911660:Growth [Activity]
   771 E C0599851:Neural [Functional Concept]
   755 E C0027769:nervy [Sign or Symptom]

Phrase: "protects against aluminum-mediated cell death."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   790   C0007587:Cell Death [Cell Function]
   753   C0002367:Aluminium [Element, Ion, or Isotope]
   753   C0007634:Cell [Cell]
   753   C0011065:Death [Organism Function]
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C1269647:Cell [Cell]
   753   C1306577:Death, NOS [Finding]
   753   C1704653:Cell [Medical Device]
   753   C1948049:Cell [Spatial Concept]
   753   C2348254:ALUMINUM [Element, Ion, or Isotope]
Processing 00000000.tx.687: Toxicology 176, 195207.[CrossRef][ISI][Medline] Pfaffl, M. 

Phrase: "Toxicology 176,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0040541:Toxicology [Biomedical Occupation or Discipline]
   861   C1548006:Toxicology [Intellectual Product]
   789 E C0205472:Toxicologic [Functional Concept]

Phrase: "195207."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Pfaffl,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.688: W., Horgan, G. 

Phrase: "W., Horgan,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.689: W., and Dempfle, L. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Dempfle,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.690: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.691: Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. 

Phrase: "Relative expression software tool (REST) for group-wise comparison"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0037589:Tool, Software [Intellectual Product]
   744   C0336791:Tool [Manufactured Object]
   744   C2827396:Tool [Manufactured Object]

Phrase: "and"

Phrase: "statistical analysis of relative expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0871424:statistical analysis [Research Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]

Phrase: "results in real-time PCR."
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   862   C1709846:Real-Time PCR [Molecular Biology Research Technique]
   806   C1550177:Real Time [Idea or Concept]
   760   C0032520:PCR [Laboratory Procedure,Molecular Biology Research Technique]
   760   C0040223:Time [Temporal Concept]
   760   C0237400:Real [Qualitative Concept]
   760   C0677874:pCR [Finding]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]
   760   C3272377:REAL [Intellectual Product]
   760   C3541383:Time [Temporal Concept]
   704 E C0442043:Temporal [Spatial Concept]
   704 E C2362314:Temporal [Temporal Concept]
Processing 00000000.tx.692: Nucleic Acids Res. 

Phrase: "Nucleic Acids Res."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2347379:RES [Finding]
   734   C0028606:Nucleic Acids [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.693: 30, e36.[Abstract/Free FullText] Pratico, D., Clark, C. 

Phrase: "30,"

Phrase: "e36."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pratico,"

Phrase: "D."

Phrase: ","

Phrase: "Clark,"

Phrase: "C."
Processing 00000000.tx.694: M., Liun, F., Rokach, J., Lee, V. 

Phrase: "M."

Phrase: ","

Phrase: "Liun,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Rokach,"

Phrase: "J.,"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.695: Y., and Trojanowski, J. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.696: Q. 

Phrase: "Q."
Processing 00000000.tx.697: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.698: Increase of brain oxidative stress in mild cognitive impairment: A possible predictor of Alzheimer disease. 

Phrase: "Increase of brain oxidative stress"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0442805:Increase [Functional Concept]

Phrase: "in mild cognitive impairment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1270972:Mild Cognitive Impairment [Mental or Behavioral Dysfunction]
   901   C0338656:Cognitive impairment [Mental or Behavioral Dysfunction]
   827   C0684336:Impairment [Pathologic Function]

Phrase: ":"

Phrase: "A possible predictor of Alzheimer disease."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C2698872:Predictor [Idea or Concept]
Processing 00000000.tx.699: Arch. 

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.700: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.701: 59, 972976.[Abstract/Free FullText] Pratico, D., Lee, V.M-Y., Trojanowski, J. 

Phrase: "59,"

Phrase: "972976."

Phrase: "[Abstract/Free FullText"

Phrase: "] Pratico,"

Phrase: "D."

Phrase: ","

Phrase: "Lee,"

Phrase: "V.M-Y.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C2349138:V/m [Quantitative Concept]

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.702: Q., Rokach, J., and Fitzgerald, G. 

Phrase: "Q., Rokach,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Fitzgerald,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.703: A. 

Phrase: "A."
Processing 00000000.tx.704: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.705: Increased F2-isoprostanes in Alzheimer's disease: Evidence for enhanced lipid peroxidation in vivo. 

Phrase: "Increased F2-isoprostanes in Alzheimer's disease"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0949861:F2-Isoprostanes [Biologically Active Substance,Eicosanoid]
   773 E C2700042:F2-Isoprostane [Laboratory Procedure]
   753   C0949860:Isoprostanes [Biologically Active Substance,Eicosanoid]

Phrase: ":"

Phrase: "Evidence for enhanced lipid peroxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332120:Evidence [Functional Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.706: FASEB J. 

Phrase: "FASEB J."
Processing 00000000.tx.707: 12, 17771783.[Abstract/Free FullText] Savory, J., Ghribi, O., Forbes, M. 

Phrase: "12,"

Phrase: "17771783."

Phrase: "[Abstract/Free FullText"

Phrase: "] Savory,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1135885:Savory [Food]

Phrase: "J.,"

Phrase: "Ghribi,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Forbes,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.708: S., and Herman, M. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Herman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.709: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.710: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.711: Aluminium and neuronal cell injury: Inter-relationships between neurofilamentous arrays and apoptosis. 

Phrase: "Aluminium"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "neuronal cell injury"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0599732:cell injury [Cell or Molecular Dysfunction]
   827   C3263722:Injury [Injury or Poisoning]
   827   C3263723:Injury [Injury or Poisoning]

Phrase: ":"

Phrase: "Inter-relationships between neurofilamentous arrays"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0205103:Inter- [Spatial Concept]
   760   C0439849:Relationships [Qualitative Concept]
   760   C1548610:Inter [Temporal Concept]
   726 E C1705630:Relationship [Idea or Concept]
   726 E C1706279:Relationship [Idea or Concept]
   726 E C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "apoptosis."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]
Processing 00000000.tx.712: J. 

Phrase: "J."
Processing 00000000.tx.713: Inorg. 

Phrase: "Inorg."
Processing 00000000.tx.714: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.715: 87, 1519.[CrossRef][ISI][Medline] Savory, J., Huang, Y., Herman, M. 

Phrase: "87,"

Phrase: "1519."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Savory,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1135885:Savory [Food]

Phrase: "J.,"

Phrase: "Huang,"

Phrase: "Y.,"

Phrase: "Herman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.716: M., and Wills, M. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Wills,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042950:wills [Mental Process]
  1000   C0043177:Wills [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.717: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.718: (1996). 

Phrase: "(1996"

Phrase: ")."
Processing 00000000.tx.719: Quantitative image analysis of temporal changes in tau and neurofilament proteins during the course of acute experimental neurofibrillary degeneration; 

Phrase: "Quantitative image analysis of temporal changes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0200767:Image analysis, quantitative [Laboratory Procedure]
   790   C0200765:Image analysis [Laboratory Procedure]
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0936012:Analysis [Research Activity]
   753   C1524024:analysis [Functional Concept]
   753   C1704254:Image [Intellectual Product]
   753   C1704922:Image [Entity]
   753   C3542466:Image [Intellectual Product]

Phrase: "in tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720655:Tau [Intellectual Product]
  1000   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "neurofilament proteins during the course of acute experimental neurofibrillary degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0085418:Neurofilament Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ";"
Processing 00000000.tx.720: non-phosphorylated epitopes precede phosphorylation. 

Phrase: "non-phosphorylated epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0003316:Epitopes [Immunologic Factor]

Phrase: "precede"

Phrase: "phosphorylation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031715:Phosphorylation [Molecular Function]
  1000   C1158886:Phosphorylation [Molecular Function]
Processing 00000000.tx.721: Brain Res. 

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.722: 707, 272281.[CrossRef][ISI][Medline] Savory, J., Huang, Y., Wills, M. 

Phrase: "707,"

Phrase: "272281."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Savory,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1135885:Savory [Food]

Phrase: "J.,"

Phrase: "Huang,"

Phrase: "Y.,"

Phrase: "Wills,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042950:wills [Mental Process]
  1000   C0043177:Wills [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.723: R., and Herman, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Herman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.724: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.725: (1998). 

Phrase: "(1998"

Phrase: ")."
Processing 00000000.tx.726: Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: Implications for clinical trials in Alzheimer's disease. 

Phrase: "Reversal by desferrioxamine of tau protein aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443290:Reversal [Functional Concept]

Phrase: "following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "two days of treatment"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0439228:days [Temporal Concept]
   737 E C0332173:/day [Temporal Concept]
   737 E C0439505:/day [Temporal Concept]

Phrase: "in aluminum-induced neurofibrillary degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0085400:Neurofibrillary degeneration [Acquired Abnormality]
   812   C0011164:Degeneration [Pathologic Function]
   812   C1880269:Degeneration [Functional Concept]

Phrase: "in rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: ":"

Phrase: "Implications for clinical trials"

Phrase: "in Alzheimer's disease."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.727: Neurotoxicology 19, 209214.[ISI][Medline] Savory, J., Rao, J. 

Phrase: "Neurotoxicology 19,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597059:neurotoxicology [Organism Function]

Phrase: "209214."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Savory,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1135885:Savory [Food]

Phrase: "J.,"

Phrase: "Rao,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412430:RAO [Gene or Genome]

Phrase: "J."
Processing 00000000.tx.728: K., Huang, Y., Letada, P. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Huang,"

Phrase: "Y.,"

Phrase: "Letada,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.729: R., and Herman, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Herman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.730: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.731: (1999). 

Phrase: "(1999"

Phrase: ")."
Processing 00000000.tx.732: Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: Increased susceptibility with aging. 

Phrase: "Age-related hippocampal changes in Bcl-2"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: ":"

Phrase: "Bax ratio,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0456603:Ratio [Quantitative Concept]
   861   C1547037:Ratio [Intellectual Product]

Phrase: "oxidative stress,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "redox-active iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0376520:Iron [Inorganic Chemical]
   827   C1166521:iron [Pharmacologic Substance]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "associated with aluminum-induced neurodegeneration"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0002367:Aluminium [Element, Ion, or Isotope]
   760   C0027746:Neurodegeneration [Cell or Molecular Dysfunction]
   760   C0205263:Induced [Functional Concept]
   760   C2348254:ALUMINUM [Element, Ion, or Isotope]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: ":"

Phrase: "Increased susceptibility with aging."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0012655:Susceptibility [Clinical Attribute]
   770   C0220898:Susceptibility [Organism Attribute]
   770   C1264642:Susceptibility [Functional Concept]
   770   C1547045:*Susceptibility [Quantitative Concept]
Processing 00000000.tx.733: Neurotoxicology 20, 805817.[ISI][Medline] Sharif-Askari, E., Alam, A., Rheaume, E., Beresford, P. 

Phrase: "Neurotoxicology 20,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597059:neurotoxicology [Organism Function]

Phrase: "805817."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Sharif-Askari,"

Phrase: "E.,"

Phrase: "Alam,"

Phrase: "A.,"

Phrase: "Rheaume,"

Phrase: "E.,"

Phrase: "Beresford,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.734: J., Scotto, C., Sharma, K., Lee, D., DeWolf, W. 

Phrase: "J.,"

Phrase: "Scotto,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Sharma,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "D."

Phrase: ","

Phrase: "DeWolf,"

Phrase: "W."
Processing 00000000.tx.735: E., Nuttall, M. 

Phrase: "E.,"

Phrase: "Nuttall,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.736: E., Lieberman, J., et al. 

Phrase: "E.,"

Phrase: "Lieberman,"

Phrase: "J.,"

Phrase: "et al."
Processing 00000000.tx.737: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.738: Direct cleavage of the human DNA fragmentation factor-45 by granzyme B induces caspase-activated DNase release and DNA fragmentation. 

Phrase: "Direct cleavage of the human DNA fragmentation factor-45"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1721094:DNA Cleavage [Molecular Function]
   742   C0010813:cleavage [Cell Function]
   742   C0596311:Cleavage [Phenomenon or Process]
   742   C1330957:cleavage [Cell Function]

Phrase: "by granzyme B"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0061878:granzyme B [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1415380:GRANZYME B [Gene or Genome]
   861   C1333877:Granzyme [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "caspase-activated DNase release"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   812   C0030685:Release [Health Care Activity]
   812   C0391871:Release [Functional Concept]
   812   C0439180:% release [Quantitative Concept]
   812   C0680255:release [Health Care Activity]
   812   C1283071:Release [Functional Concept]
   812   C1963578:Release [Therapeutic or Preventive Procedure]
   756   C0669174:caspase-activated DNase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C1413983:CASPASE-ACTIVATED DNase [Gene or Genome]

Phrase: "and"

Phrase: "DNA fragmentation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0376669:DNA Fragmentation [Molecular Function]
   861   C0332472:Fragmentation [Anatomical Abnormality]
   861   C1881708:FRAGMENTATION [Phenomenon or Process]
Processing 00000000.tx.739: EMBO J. 

Phrase: "EMBO J."
Processing 00000000.tx.740: 20, 31013113.[Abstract/Free FullText] Strong, M. 

Phrase: "20,"

Phrase: "31013113."

Phrase: "[Abstract/Free FullText"

Phrase: "] Strong, M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.741: J. 

Phrase: "J."
Processing 00000000.tx.742: (2002). 

Phrase: "(2002"

Phrase: ")."
Processing 00000000.tx.743: Aluminum as an experimental neurotoxicant: The neuropathology and neurochemistry. 

Phrase: "Aluminum as an experimental neurotoxicant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0002367:Aluminium [Element, Ion, or Isotope]
   760   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: ":"

Phrase: "The neuropathology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0876934:Neuropathology [Biomedical Occupation or Discipline]
  1000   C1540677:neuropathology [Pathologic Function]
  1000   C1555824:Neuropathology [Intellectual Product]

Phrase: "and"

Phrase: "neurochemistry."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027820:Neurochemistry [Biomedical Occupation or Discipline]
  1000   C0699841:neurochemistry [Organ or Tissue Function]
Processing 00000000.tx.744: In Aluminum and Alzheimer's Disease: The Science that Describes the Link (C. Exley, Ed.), pp. 

Phrase: "In Aluminum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0002367:Aluminium [Element, Ion, or Isotope]
  1000   C2348254:ALUMINUM [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "Alzheimer's Disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "The Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "that"

Phrase: "Describes"

Phrase: "the Link"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517892:Link [Intellectual Product]
  1000   C1704666:Link [Intellectual Product]

Phrase: "(C. Exley,"

Phrase: "Ed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538926:ED [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "pp."
Processing 00000000.tx.745: 189202. 

Phrase: "189202."
Processing 00000000.tx.746: Elsevier Science B.V., Amsterdam. 

Phrase: "Elsevier Science B.V., Amsterdam."
Processing 00000000.tx.747: Tsubouchi, R., Htay, H. 

Phrase: "Tsubouchi,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Htay,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.748: H., Murakami, K., Haneda, M., and Yoshino, M. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Murakami,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Haneda,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Yoshino,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.749: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.750: Aluminum-induced apoptosis in PC12D cells. 

Phrase: "Aluminum-induced apoptosis in PC12D cells."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0162638:Apoptosis [Cell Function]
Processing 00000000.tx.751: Biometals 14, 181185.[CrossRef][ISI][Medline] van Ginkel, M. 

Phrase: "Biometals 14,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040577:Biometals [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "181185."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] van Ginkel,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.752: F., van der Voet, G. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "van der Voet,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557775:Van [Manufactured Object]
   827   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.753: B., D'Haese, P. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D'"

Phrase: "Haese,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.754: C., De Broe, M. 

Phrase: "C., De Broe,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.755: E., and de Wolff, F. 

Phrase: "E.,"

Phrase: "and"

Phrase: "de Wolff,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.756: A. 

Phrase: "A."
Processing 00000000.tx.757: (1993). 

Phrase: "(1993"

Phrase: ")."
Processing 00000000.tx.758: Effect of citric acid and maltol on the accumulation of aluminum in rat brain and bone. 

Phrase: "Effect of citric acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "maltol on the accumulation of aluminum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0081548:aluminum maltol [Organic Chemical]
   753   C0065605:maltol [Organic Chemical,Pharmacologic Substance]

Phrase: "in rat brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "bone."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0262950:Bone, NOS [Body Part, Organ, or Organ Component]
  1000   C0391978:Bone [Tissue]
  1000   C1266908:Bone [Body Part, Organ, or Organ Component]
  1000   C1266909:Bone [Body System]
   928 E C0443157:Bony [Functional Concept]
Processing 00000000.tx.759: J. 

Phrase: "J."
Processing 00000000.tx.760: Lab. 

Phrase: "Lab."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]
Processing 00000000.tx.761: Clin. 

Phrase: "Clin."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1315013:CLIN [Intellectual Product]
Processing 00000000.tx.762: Med. 

Phrase: "Med."
Processing 00000000.tx.763: 121, 453460.[ISI][Medline] Zaffaroni, N., De Marco, C., Villa, R., Riboldi, S., Daidone, M. 

Phrase: "121,"

Phrase: "453460."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zaffaroni,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "De Marco,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1417032:MARCO [Gene or Genome]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Villa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1188484:Villa [Eukaryote]

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Riboldi,"

Phrase: "S."

Phrase: ","

Phrase: "Daidone,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.764: G., and Double, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Double, J."
Processing 00000000.tx.765: A. 

Phrase: "A."
Processing 00000000.tx.766: (2001). 

Phrase: "(2001"

Phrase: ")."
Processing 00000000.tx.767: Cell growth inhibition, G2 M cell cycle arrest and apoptosis induced by the imidazoacridinone C1311 in human tumour cell lines. 

Phrase: "Cell growth inhibition,"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   901   C0007595:Cell Growth [Cell Function]
   827   C0018270:'growth' NOS [Organism Function]
   827   C0021467:Inhibition [Mental Process]
   827   C0021469:Inhibition [Molecular Function]
   827   C0220844:growth [Physiologic Function]
   827   C1621966:Growth [Organ or Tissue Function]
   827   C1628982:% inhibition [Quantitative Concept]
   827   C2911660:Growth [Activity]
   827   C3463820:Inhibition [Activity]
   755 E C0311403:Inhibited [Qualitative Concept]

Phrase: "G2 M cell cycle arrest"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   933   C3178824:G2 Cell Cycle Arrest [Cell Function]
   911   C1517345:G2/M Arrest [Molecular Function]
   884   C1155873:Cell Cycle Arrest [Cell Function]
   884   C1516332:Cell Cycle Arrest [Cell Function]
   804   C0237477:Arrest [Temporal Concept]
   804   C0392351:arrest [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "apoptosis"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0162638:Apoptosis [Cell Function]
   928 E C1516044:Apoptotic [Qualitative Concept]

Phrase: "induced by the imidazoacridinone C1311"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induced [Functional Concept]
   760   C0388612:C1311 [Organic Chemical,Pharmacologic Substance]

Phrase: "in human tumour cell lines."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   923   C0085983:Tumor Cell Lines [Cell]
   906   C0682523:Human Cell Line [Cell]
   861   C0007600:Cell lines [Cell]
   812   C0205132:lines [Spatial Concept]
   779 E C1550648:Line [Substance]
   779 E C1552960:Line [Quantitative Concept]
   708   C0427861:human cell [Laboratory or Test Result]
Processing 00000000.tx.768: Eur. 

Phrase: "Eur."
Processing 00000000.tx.769: J. 

Phrase: "J."
Processing 00000000.tx.770: Cancer 37, 19531962.[CrossRef][ISI][Medline]

Phrase: "Cancer 37,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0006826:Cancer [Neoplastic Process]
   861   C0998265:Cancer [Eukaryote]
   861   C1306459:Cancer [Finding]

Phrase: "19531962."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

